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1
GeNeRAl INTRoDuCTIoN
A transient ischemic attack (TIA) is characterized by sudden onset focal neurological symptoms 
of vascular origin that resolve completely within 24 hours.1 TIAs are common, and incidence 
increases with increasing age. In 2011, neurologists diagnosed more than 27,000 new TIAs 
in The Netherlands, mainly in patients aged ≥45 years.2 Because not all patients seek medical 
attention after a TIA, the true incidence is probably even higher.3
There is no gold standard for the diagnosis of TIA, which is largely based on careful history taking 
and interpretation by a specialist. Diffusion-weighted imaging (DWI) of the brain performed within 
hours to days after the event can show signs of acute infarction and thus provide evidence for a 
cerebrovascular cause of the attack. However, even in patients with a clinical diagnosis of TIA, 
only one third has a DWI lesion.4
Often patients are encountered with myriad acute onset and short lasting nonfocal symptoms 
not fulfilling the clinical criteria for TIA. In the absence of a clear alternative diagnosis, this is 
called a transient neurological attack (TNA). Although the causes of TNAs are unclear, they 
are as prevalent as TIAs.5 Box 1 provides clarification of the terminology on attacks of transient 
neurological symptoms as used in the literature and throughout this thesis.
Despite their transient nature, TIAs and TNAs are by no means benign conditions. TIAs are 
associated with an increased short and long-term risk of cardiovascular events, especially 
cerebral infarction.6-9 Rapid evaluation and start of adequate secondary prevention is effective 
in reducing the risk of subsequent vascular events after TIA.10, 11 TNAs are also associated with 
risk of stroke, ischemic heart disease, and vascular death.12 However, since this relationship is 
less well established than after TIA, secondary prevention is generally not started and a routine 
vascular workup is not performed after a TNA.
Box 1: Semantics - on the definitions of transient attacks of neurological 
dysfunction
Transient ischemic attack
DWI studies have found signs of acute infarction beyond the point of symptom resolution in 
>30% of TIA patients, which has caused debate concerning the diagnostic criteria for TIA.4 
Differences in DWI positivity between patients are not explained by clinical TIA characteristics 
such as type and duration of the event.4 However, high-risk TIA patients with a DWI lesion have a 
higher risk of subsequent stroke than those without a DWI lesion.24 This has led to the proposal 
of a new definition of TIA.25 The current definition states complete symptom resolution within 
24 hours and is therefore time-based. When symptoms last longer than 24 hours, a patient 
is considered to have cerebral infarction. The newly proposed definition has abandoned the 
arbitrary time limit, but rather takes into account brain imaging results and states that a TIA can 
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only be diagnosed in the absence of signs of acute brain infarction. Patients with a DWI lesion 
are considered to have cerebral infarction. This proposed definition is therefore tissue-based.
Although there is growing evidence for prognostic differences between TIA patients with and 
without a DWI lesion and thus for the use of the tissue-based definition, general implementation 
has not yet taken place. This is in part due to the limited availability and utility of imaging modalities 
capable of assessing hyperacute signs of infarction (MRI including DWI) and because of the 
implications a change of definition will have on the incidence, prevalence, and prognosis of both 
TIA and brain infarction.
In line with the definition mostly operated throughout current literature, in this thesis we will apply 
the time-based definition of TIA, unless specifically stated otherwise.
Transient neurological attack
The first internationally accepted classification of cerebrovascular disorders described the term 
transient neurological attack and attempted to distinguish between TNAs with a benign outcome 
and those with a more unfavourable course.26 The latter were presumed to have a vaso-occlusive 
cause and were thus called transient ischemic attacks. The term TNA has since then been used 
to describe an attack of sudden onset nonfocal neurological symptoms for which no clear 
diagnosis can be found. However, a TNA is not a clinical diagnosis or disease entity. Rather, 
it is a way to describe difficult-to-characterize events, which probably include syncope, TIA, 
migraine, or epilepsy.27 Nevertheless, the association with an increased risk of cardiovascular 
events suggests that at least some TNAs have a cerebrovascular etiology.12
In this thesis, the term transient neurological attack will be reserved for those attacks of sudden 
onset neurological symptoms that do not fulfill the clinical criteria for TIA and are not explained 
by an alternative diagnosis.
Neuroimaging and etiology of TIA and TNA
Over the past decades brain imaging has become incorporated in the diagnostic work-
up of possible TIA. Magnetic resonance imaging (MRI) is the method of choice, since it is 
more sensitive than computed tomography (CT) in the detection of neuroimaging markers of 
cerebrovascular disease, including white matter hyperintensities of presumed vascular origin 
(WMH) and lacunes (Box 2).13 DWI can provide direct evidence of an ischemic etiology for 
transient neurological symptoms by identifying cytotoxic edema (Box 3).14 In addition, imaging 
of the cerebropetal vessels (by ultrasound, CT- or MR-angiography) can identify large-vessel 
stenosis as a possible cause for cerebral ischemia. Neuroimaging may in this way provide clues 
for a specific underlying vascular etiologic mechanism for the TIA (large vessel disease, small 
vessel disease, cardioembolic, or unspecified), which in turn influences diagnostic workup and 
secondary prevention measures.13, 15 The goals of neuroimaging in possible TIA are therefore 
diagnostic (obtain evidence for a vascular cause and exclude an alternative nonischemic origin), 
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etiologic (ascertain an underlying vascular cause and if possible specific mechanism), as well 
as prognostic (the use of neuroimaging markers in risk assessment scores).13 Nevertheless, 
the relationship between clinical characteristics of an attack of transient neurological symptoms 
and the presence of both new and pre-existing cerebrovascular lesions is unclear, leading to 
uncertainties in etiology, diagnosis, and prognosis of patients with such an attack. By lack of a 
gold standard, the diagnosis of TIA and the distinction with TNA relies heavily on the expertise of 
a neurologist. Neuroimaging could play an important role in optimizing the diagnostic process 
of transient episodes of neurological dysfunction and thereby reduce the overall burden of 
cardiovascular disease. 
Box 2: Imaging of possible TIA patients - What conventional MRI may uncover
In patients suspected of having had a TIA brain imaging may be unremarkable, although a 
number of abnormalities associated with cerebral small vessel disease can be observed with 
conventional MRI sequences.
White matter hyperintensities of presumed vascular origin – WMHs are defined as hyperintense 
lesions in the white matter on T2-weighted sequences such as fluid-attenuated inversion 
recovery (FLAIR), which are not or only slightly hypointense on T1-weighted sequences.28 They 
are bilaterally and mostly symmetrically situated and range from small punctuate lesions to large 
confluent areas.
Lacunes of presumed vascular origin – A lacune is defined as a round or ovoid, subcortical, 
fluid-filled cavity with a signal intensity similar to that of cerebrospinal fluid (CSF) on T1- and T2-
weighted images. Although there are no absolute cutoff sizes, lesions that are less than 3 mm in 
diameter are considered to be more likely perivascular spaces, whereas those with a diameter 
of more than 15 mm are considered to be too large to be consistent with a previous acute small 
deep brain infarct or hemorrhage in the territory of one perforating arteriole.28
Silent brain infarcts – Evidence of completed brain infarct on neuroimaging without a history of 
corresponding stroke or TIA is called a silent brain infarct (SBI). SBI can be lacunes, small cortical 
infarcts, and territorial infarcts and are defined as hyperintense foci on T2-weighted sequences 
with a corresponding hypointensity on T1-weighted images.29
Cerebral microbleeds – Cerebral microbleeds are visible on paramagnetic-sensitive sequences 
such as T2*-weighted gradient-echo or susceptibility-weighted images as small (2-10 mm) 
round or ovoid areas of signal void.28 They are considered to represent hemosiderin deposits 
resulting from vascular leakage of blood cells.30, 31
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Box 3: Diffusion imaging – exploiting the motion of water molecules
Diffusion MRI is sensitive to the random motion of water molecules, which differs between 
tissues and is limited by anatomical boundaries such as cell membranes and macromolecules. 
Quantification of water molecule diffusion can therefore reveal details about tissue architecture. 
Two techniques are frequently used in neurovascular patients, both clinically and scientifically.
Diffusion-weighted imaging (DWI) – Diffusion-weighted imaging is capable of detecting the 
earliest changes that occur in ischemic brain tissue and therefore of great value in the diagnosis 
of TIA and stroke. An opposing pair of diffusion gradients achieves diffusion weighing. For 
stationary molecules, these gradients cancel each other out, whereas moving molecules cause 
signal loss.32 A DWI sequence generates calculated isotropic diffusion images in which areas 
with low diffusion (i.e. high signal loss) generally appear bright. However, DWI remains sensitive 
to T1- and T2-relaxation. To entangle true diffusion from relaxation effects, quantitative images of 
the diffusion coefficient (apparent diffusion coefficient, ADC) are generated, in which areas with 
impaired diffusion appear dark.33 Since ischemia leads to membrane failure, restriction of water 
molecules in the intracellular compartment (cytotoxic edema) and therefore impaired diffusion, a 
drop of the ADC is seen within minutes from onset.34
Diffusion tensor imaging (DTI) – Diffusion tensor imaging measures the anisotropy (differences 
in direction) in the self-diffusion of water molecules, providing valuable information on the 
microstructural integrity of the white matter. Diffusion of water molecules in tissues may not be 
the same in all directions. In and around axons for example, the diffusion of a water molecule will 
be mainly in one direction (i.e. anisotropic). By applying diffusion gradient pairs on all gradient 
axes, the resultant image is made sensitive to diffusion processes in different directions.35 Water 
diffusion at each voxel is modeled by a tensor, characterized by its three principal eigenvectors 
and their associated eigenvalues (λ1, λ2, λ3). The first is referred to as axial diffusivity, and 
represents the magnitude of diffusivity parallel to the white matter tracts. The average of λ2 and λ3 
is termed radial diffusivity, and reflects the magnitude of diffusivity perpendicular to these tracts.
Two different, but complimentary, common DTI metrics can be derived from these eigenvalues: 
the mean diffusivity (MD), which is the average of the three eigenvalues and represents the 
overall magnitude of water diffusion, and the fractional anisotropy (FA), a normalized ratio for 
diffusion anisotropy.36 The FA ranges between 0 and 1 and reflects the shape of the tensor, with 
more isotropic (spherical) tensors having lower FA values and more anisotropic tensors a higher 
FA. Tissues with intact axons will have a high FA, while tissues with axonal loss will have a low 
FA. The MD reflects the magnitude of water diffusion and is expressed in mm2/s. In intact axons, 
diffusion is restricted and the MD will therefore be low. In axonal loss, water molecules have more 
space to diffuse, and the MD will be high. In tissues such as the cerebrospinal fluid, diffusion is 
not restricted to boundaries and the MD will even be higher. Loss of microstructural integrity is 
therefore typically reflected by a reduction in FA and increase in MD.37
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Cognitive function after TIA or TNA
In contrast to the definition of TIA, stating that symptoms resolve completely within 24 hours, 
many patients experience cognitive problems afterwards.16 Furthermore, TNA patients are at 
increased risk of developing dementia.12 However the prevalence, profile and causes of cognitive 
impairment after TIA and TNA are unknown.17
Clinically manifest stroke can lead to cognitive decline and dementia.18 Even in the absence of 
acute focal symptoms cerebrovascular damage can give rise to cognitive decline. Both WMH 
and silent brain infarcts (SBI) are associated with worse cognitive function.19, 20 Furthermore, 
microstructural damage to the cerebral white matter, as detected by diffusion tensor imaging 
(DTI) has been related to cognitive dysfunction (Box 3).21, 22 Disruption of specific brain networks 
involved in cognitive functions might explain the occurrence of cognitive dysfunction in the 
presence of only subcortical damage.23 However, the mechanisms by which this may lead 
to cognitive decline and the relative contributions of damage type, location, and size remain 
unknown. 
Establishing that TIA or TNA can have cognitive consequences beyond the point of symptom 
resolution could identify a group of patients at risk of cognitive impairment and dementia, opposes 
the generally accepted idea that TIA leaves no permanent dysfunction, provides an opportunity 
to clarify how transient neurological symptoms relate to lasting cognitive consequences, and 
may give insight in the early mechanism of development of dementia.
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AIM AND ouTlINe oF The TheSIS
The aim of this thesis was to unravel the etiology and prognosis of the spectrum of transient 
neurological attacks, with an emphasis on neuroimaging and cognitive function. In chapter 2, 
we describe in detail the rationale and design of the Cohort study ON Neuroimaging, Etiology 
and Cognitive consequences of Transient neurological attacks (CONNECT); a prospective 
cohort study among 150 consecutive patients aged ≥45 years, without prior stroke or dementia, 
with a recent TIA or TNA. This cohort was the basis for most of the studies included in this thesis.
We aimed to provide answers to several key questions. First, we needed to establish the 
etiological similarities and differences between TIA and TNA, in order to adequately interpret 
our results. How often is cerebral ischemia the cause of a TIA and TNA, is it justified presuming 
a nonischemic etiology for TNAs, and is the currently applied clinical diagnosis of TIA or TNA 
correct? Therefore, in chapter 3, we determine the prevalence of recent ischemia on DWI 
performed within 7 days after a TIA or TNA, and compare this with the clinical diagnosis made 
by stroke experts.
Next, we focused on the cognitive prognosis of TIA and TNA. Is there evidence for cognitive 
impairment in TIA and TNA patients? What is the cognitive profile of this impairment? Are there 
differences between TIA and TNA patients concerning cognitive function, what is the influence 
of a DWI lesion on cognitive outcome, and what is the course of cognitive function after a TIA 
or TNA? And what are the determinants of cognitive outcome after TIA and TNA, specifically 
concerning neuroimaging? In chapters 4 and 5, we focus on cognitive impairment after TIA and 
assess the magnitude of the problem. We describe both a systematic review of the prevalence of 
cognitive impairment after TIA, and investigate the prevalence and profile of cognitive impairment 
in a cohort of relatively young TIA patients aged 45-65 years. In chapters 6 and 7, we describe 
cognitive function directly after TIA and TNA, and assess its course over the next six months. 
We determine the relationship between clinical diagnosis and cognitive outcome, as well as 
differences between DWI-positive and DWI-negative patients and the relationship between 
cognitive outcome and markers for cerebrovascular disease on conventional neuroimaging. 
We focus not only on objective cognitive function, but also on subjective complaints such as 
depressive symptoms, fatigue, and subjective cognitive impairment. Finally, in chapter 8, we 
study the microstructural integrity in TIA and TNA patients, and its relationship with clinical 
diagnosis and DWI-status.
In chapters 9 and 10 we summarize and discuss the main results of this thesis, reflect on the 
clinical implications, and provide suggestions for future research.
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ABSTRACT
Background
Transient ischemic attacks (TIA) are characterized by acute onset focal neurological symptoms 
and complete recovery within 24 hours. Attacks of nonfocal symptoms not fulfilling the criteria 
for TIA but lacking a clear alternative diagnosis are called transient neurological attacks (TNA). 
Although TIA symptoms are transient in nature, cognitive complaints may persist. In particular, 
attacks consisting of both focal and nonfocal symptoms (mixed TNA) have been found to be 
associated with an increased risk of dementia. We aim to study the prevalence, etiology and risk 
factors of cognitive impairment after TIA or TNA.
Methods/design
CONNECT is a prospective cohort study on cognitive function after TIA and TNA. In total, 150 
patients aged ≥45 years with a recent (<7 days after onset) TIA or TNA and no history of stroke 
or dementia will be included. We will classify events as: TIA, nonfocal TNA, or mixed TNA. 
Known short lasting paroxysmal neurological disorders like migraine aura, seizures and Ménière 
disease are excluded from the diagnosis of TNA. Patients will complete a comprehensive 
neuropsychological assessment and undergo MRI <7 days after the qualifying event and again 
after six months. The primary clinical outcomes will be cognitive function at baseline and six 
months after the primary event. Imaging outcomes include the prevalence and evolution of DWI 
lesions, white matter hyperintensities and lacunes, as well as resting state networks functionality 
and white matter microstructural integrity. Differences between types of event and DWI, as well 
as determinants of both clinical and imaging outcomes, will be assessed.
Discussion
CONNECT can provide insight in the prevalence, etiology and risk factors of cognitive impairment 
after TIA and TNA and thereby potentially identify a new group of patients at increased risk of 
cognitive impairment.
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BACkGRouND
Transient ischemic attacks (TIAs) are characterized by acute onset focal neurological symptoms 
of vascular origin that resolve completely within 24 hours.1 Often patients are encountered with a 
myriad of acute onset and short-lasting nonfocal symptoms, which do not fulfill the criteria for TIA 
and might have another cause than focal cerebral ischemia. In the absence of a clear alternative 
cause, these attacks are referred to as transient neurological attacks (TNAs).26 TNAs are almost 
as prevalent as TIAs, but their etiology is unknown.5
In contrast to the definition of TIA, which states symptom resolution within 24 hours, many 
patients report cognitive problems afterwards.16 In addition, particularly patients with a TNA or 
a mixture of focal and nonfocal symptoms (mixed TNA) have an increased risk of dementia.12
Diffusion-weighted imaging (DWI) studies show signs of cytotoxic edema beyond the point of 
symptom resolution in 30% of TIA patients.4 Cerebrovascular damage, even in the absence of 
clinical signs of stroke, may lead to cognitive decline.18-20 Moreover, reduced microstructural 
integrity and functional connectivity are associated with worse cognitive performance.38, 39 The 
influence of DWI lesions and other cerebrovascular damage on the cognitive outcome of TNA 
patients is unknown, In addition, the cognitive profile of TIA and TNA patients is unclear.
Previous studies on cognitive function after TNA are scarce and have focused almost exclusively 
on TIA patients.40-42 These were mostly cross-sectional studies, without brain imaging and 
information on previous cerebrovascular events. Furthermore, cognitive testing was often 
performed several months to years after the initial event. Since the risk of new stroke is highest 
shortly after TIA, a delay in testing can influence cognitive results.43
Establishing a relationship between TIA or TNA and cognitive decline could identify a group 
of patients at risk of cognitive impairment and dementia and provides an opportunity to clarify 
how transient neurological symptoms relate to lasting cognitive consequences. By widening the 
scope beyond TIA to ‘TNAs’ with nonfocal and mixed symptoms, the previously described but 
not understood association between TNA and worse cognitive outcome can be prospectively 
investigated. Finally, performing brain imaging in these patients could provide insight in the early 
developmental mechanisms of dementia.
We therefore set up the Cohort study ON Neuroimaging, Etiology and Cognitive consequences 
of Transient neurological attacks (CONNECT); a prospective cohort study on cognitive function 
and its determinants in patients with a TIA or TNA and aged ≥45 years.
MeThoDS/DeSIGN
Study design
CONNECT is a prospective cohort study on the cognitive function of patients with a TIA or 
TNA and aged ≥45 years. Patient recruitment takes place at a university hospital and a large 
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regional nonacademic hospital. The Medical Review Ethics Committee region Arnhem-Nijmegen 
approved the study (NL31651.091.10) and written informed consent is obtained from all 
participants.
objectives
The primary objective of our study is to determine the course and profile of cognitive function 
and the causes of cognitive impairment after TIA and TNA, and its relationship with DWI 
abnormalities. Secondary objectives are to determine the prevalence and course of subjective 
cognitive complaints, depressive symptoms, fatigue and sleep disorders and their effect on 
cognitive outcome in patients with TIA or TNA.
Study population
All consecutive patients referred to the specialized TIA clinics of the Radboud university medical 
center and the Rijnstate Hospital will be screened for eligibility. Patients with a final diagnosis 
of TIA or TNA within seven days after onset and aged ≥45 years at the time of the qualifying 
event are considered eligible for participation. TIA is defined as a sudden onset focal loss of 
brain function of vascular origin with complete resolution of focal symptoms within 24 hours.1 
TNA is defined as an attack of sudden nonfocal neurological symptoms that completely resolve 
within 24 hours, without clear evidence for migraine, epilepsy, Ménière disease, hyperventilation, 
cardiac syncope, hypoglycaemia, or orthostatic hypotension.12 In order to minimize the influence 
of concomitant neurological disorders on cognitive function, the following exclusion criteria will 
be applied:
• prior stroke with clinical symptoms;
• prior diagnosis of dementia;
• intracerebral space-occupying lesion;
•  prior neurological disease which can influence cognitive function (e.g. Parkinson’s disease, 
multiple sclerosis);
• inability to undergo MRI.
Prior TIA and TNA are not a reason for exclusion.
Procedures
Eligible patients will be recruited at a specialized TIA clinic. We intend to include 150 patients 
and expect to complete inclusion over a 3-year period. Patients formally enter the study after 
informed consent and written approval. Baseline assessments will take place during admission 
to the TIA clinic at the participating center and follow-up is performed six months later at the 
Radboud university medical center and Donders Institute for Brain, Cognition and Behaviour. 
Baseline and follow-up assessments are summarized in Table 1.
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Table 1 Schedule of assessments
Assessment Baseline Follow-up
Demographics
Age, sex X
Education X
Working status X
Marital status X
Structured assessment of TIA/TNA presentation
Duration of symptoms X
Number of episodes in week before inclusion X
Focal symptoms* X
Nonfocal symptoms* X
Incident focal symptoms* X
Incident nonfocal symptoms* X
Medical history
Hypertension X X
Dyslipidemia X X
Diabetes mellitus X X
Atrial fibrillation X X
Other cardiovascular diseases† X
First-degree relatives with cardiovascular disease X
Smoking status X X
Alcohol consumption X X
Drug abuse X X
Hypercoagulability X
Acute infection X
Migraine X
Previous TIA/TNA X
Carotid endarterectomy X X
Epilepsy X X
Depression X X
Current medication use X X
Incident cardiovascular events† X
Incident TIA, cerebral infarction or hemorrhage X
Physical examination
Length and weight, BMI X
Blood pressure X
Neurological examination X
eCG
(Paroxysmal) atrial fibrillation X
Ischemia X
Left ventricular hypertrophy X
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Neuropsychological assessment
Global cognitive function
Mini Mental State Examination X
Frontal Assessment Battery X X
Episodic memory
Rey Auditory Verbal Learning Test X X
Executive function
Verbal fluency X X
Stroop Color Word Test (interference score) X X
Brixton Spatial Anticipation Test X X
Information processing speed
Symbol-Digit Modalities Test X X
Stroop Color Word Test (Cards I and II) X X
Attention
Verbal Series Attention Test X X
Subjective cognitive failures
Cognitive failures Questionnaire X X
Depressive symptoms
Hospital Anxiety and Depression Scale X X
Sleep disorders
Scales for Outcomes in Parkinson’s Disease - Sleep X X
Fatigue
Checklist on Individual Strength X X
Prior cognitive performance
Informant Questionnaire on Cognitive Decline in the Elderly X X
MRI
Anatomical sequences (T1, T2, FLAIR, T2*) X X
Diffusion-weighted imaging X
MR angiography X
Susceptibility-weighted imaging X
Diffusion tensor imaging X
Resting-state functional MRI X
Empty cells indicate no assessment. BMI indicates body-mass index; FLAIR, fluid-attenuated inversion 
recovery; TNA, transient neurological attack; ToF, time-of-flight.
*presence of 18 predefined symptoms, both focal and nonfocal (see also Table 2).
†myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, 
valvular heart disease and peripheral revascularization procedures.
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Sample size and power calculation
The sample size is based on the ability to detect a difference in average cognitive performance 
between the three patient groups, expressed as z-score, equal to 0.5 standard deviation. With 
a power of 80% and a type-I error rate of 0.1, we need 50 patients per group to identify this 
difference.
Assessments – baseline
All patients referred to the TIA clinic are analyzed and treated according to a dedicated TIA 
protocol, which includes investigations as recommended in international guidelines.13
Symptom presentation
We will obtain a detailed history of the signs and symptoms of the qualifying event. The patient’s 
own account of events is noted, after which a structured interview consisting of 18 questions 
about the presence of specific neurological symptoms (nine focal and nine nonfocal symptoms, 
Table 2) will be administered. These symptoms are derived from the latest classification of the 
National Institute of Neurological Disorders and Stroke and previous research on nonfocal 
TNAs.1, 12 The duration of symptoms and number of episodes in the week before presentation 
are also recorded.
Table 2 Structured assessment of transient focal and nonfocal neurological symptoms
Focal Nonfocal
Hemiparesis Decreased consciousness or unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular blindness Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelings*
All symptoms should have a sudden onset, rapid clearance and last <24 hours.
*Considered referable to the central nervous system if the referring physician included transient ischemic 
attack in the differential diagnosis but patients were unable to specify what had been wrong.
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Demographics and medical history
Standardized, structured questionnaires will be used to obtain information on demographics and 
level of education (classified using seven categories, in accordance with the Dutch educational 
system: 1 being less than primary school and 7 reflecting an academic degree).44
The presence of established and potential stroke risk factors as classified by the American Heart 
Association will be determined by standardized, structured questionnaires.45 Established risk 
factors include age, sex, history of cardiovascular disease in first-degree relatives, hypertension, 
dyslipidemia, diabetes mellitus, smoking, atrial fibrillation and cardiovascular disease 
(myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary 
angioplasty, valvular heart disease and peripheral revascularization procedures). Potential risk 
factors include alcohol consumption (excess consumption defined as an intake of >200 g of 
pure alcohol per week), drug abuse, hypercoagulability, acute infection, a history of migraine, 
and the use of oral contraceptives. In addition, all patients will be asked about a history of 
TIA, carotid endarterectomy, epilepsy, and depression. Current medication use is recorded and 
classified according to the Anatomical Therapeutic Chemical (ATC) classification system (World 
Health Organization, WHO Collaborating Centre for drug statistics and methodology, http://www.
whocc.no/atcddd/).
Physical examination
All patients will undergo a neurological examination. Blood pressure will be measured in a supine 
position after five minutes of rest. The average of three measurements will be used for analysis. 
Hypertension is defined as a systolic blood pressure ≥135 mmHg and/or a diastolic blood 
pressure ≥85 mmHg and/or the use of blood pressure-lowering medication.
Neuropsychological assessment
Participants will undergo an extensive neuropsychological assessment covering the main 
cognitive domains. Neuropsychological tests are administered by a trained examiner in a quiet, 
well-lit room and under standard circumstances. The Mini-Mental State Examination and Frontal 
Assessment Battery are used as screening tools for global cognitive function and executive 
function, respectively.46, 47 The three-trial version of the Rey Auditory Verbal Learning Test (RAVLT) 
will be applied to assess verbal episodic memory. This test also includes delayed free-recall 
and recognition trials.48 To evaluate executive function three tests will be used; a verbal fluency 
test (naming as many animals and professions within 60 seconds each; response generation), 
the interference score of the abbreviated Stroop Color Word Test (response inhibition), and the 
Brixton Spatial Anticipation Test (rule detection).49, 50 Information processing speed will be tested 
with the Symbol-Digit Modalities Test and Cards I and II of the abbreviated Stroop Color Word 
Test.51, 52 Attention is measured with the Verbal Series Attention Test.53
In addition to cognitive tests, patients will complete several self-report questionnaires. Subjective 
cognitive failures will be registered with the modified Cognitive Failures Questionnaire (CFQ).54 
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Both nighttime sleep and daytime sleepiness will be assessed with the Scales for Outcomes 
in Parkinson’s Disease - Sleep, and the presence of depressive symptoms with the Hospital 
Anxiety and Depression Scale [28,29].55, 56 Furthermore, patients will fill out the Checklist on 
Individual Strength, a validated questionnaire on fatigue.57 Finally, cognitive function prior to the 
qualifying event will be assessed by asking relatives to complete the Informant Questionnaire on 
Cognitive Decline in the Elderly (IQCODE).58
Ancillary investigations
MRI protocol
All included patients will undergo MRI of the brain as well as MR angiography of the carotid and 
vertebral arteries. MRI scanning will be performed on a 1.5-Tesla Magnetom Scanner (Siemens, 
Erlangen, Germany). The scanning protocol of the brain includes transversal T1-weighted spin 
echo sequence (TR/TE 532/10 ms; flip angle 90°; voxel size 0.8 × 0.6 × 5.0 mm); transversal 
fluid-attenuated inversion recovery (FLAIR) pulse sequence (TR/TE/T1 9000/108/2500 ms; voxel 
size 0.9 × 0.7 × 5.0 mm), transversal T2-weighted turbo spin echo sequence (TR/TE 5010/98 
ms; voxel size 0.6 × 0.4 × 5.0 mm), transversal T2*-weighted gradient echo sequence (TR/TE 
727/19.1 ms; voxel size 1.0 × 0.7 × 5.0 mm), and single-shot echo planar diffusion-weighted 
sequence (TR/TE 6300/134 ms; EPI factor 192; voxel size 1.2 × 1.2 × 5.0 mm) with diffusion 
weighting applied in three directions and a b-value of 1000 s/mm2. The scanning protocol of the 
cerebropetal vessels includes three-dimensional time-of-flight (ToF), phase contrast angiography 
(PCA), transversal T1-, T2- and proton density weighted sequences. Furthermore, a maximum 
intensity projection ToF and PCA will be reconstructed. The complete scanning protocol takes 
approximately 30 minutes. All cerebropetal vessel studies will be assessed for the presence and 
degree of stenosis by an experienced neuroradiologist.
Electrocardiogram
A conventional 12-lead electrocardiogram (ECG) will be performed and assessed by an 
experienced physician. The presence of atrial fibrillation, prior myocardial infarction, and left 
ventricular hypertrophy is noted for every patient. In case of doubt a cardiologist is consulted for 
expertise.
Vena puncture
Fasting blood samples will be taken and analysis will include glucose, lipid profile and creatinine.
Classification of TNA
Three experienced stroke neurologists will independently adjudicate qualifying events as TIA, 
nonfocal TNA, or mixed TNA, based on the complete description of signs and symptoms as 
provided by the patient, the presence or absence of specific focal and nonfocal neurological 
symptoms, and the medical history. Fifty case descriptions will be assigned to each possible 
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pair of classifying neurologists, such that each event is independently adjudicated by two 
specialists. In case of disagreement a consensus meeting including the third stroke neurologist 
will be held. The classifying neurologists will be blinded to the results of neuropsychological 
tests, brain imaging studies, or any other ancillary investigations. An attack containing at least 
one focal neurological symptom will be classified as TIA or mixed TNA, depending on the 
presence of additional nonfocal symptoms. When only nonfocal symptoms are present, the 
event is categorized as nonfocal TNA.
Assessments - follow-up
Six months after baseline all patients are contacted for follow-up. In case of inability or 
unwillingness to undergo (part of) the follow-up investigations, the reasons are recorded. Follow-
up measurements are summarized in Table 1.
Incident events
Patients will be asked whether they have experienced any of the 18 predefined neurological 
symptoms between baseline and follow-up (Table 2). Symptoms had to develop within seconds 
to minutes, last less than 24 hours and disappear completely. Reported symptoms are evaluated 
for these features by an investigator.
In addition, a standardized, structured questionnaire will be administered to determine the 
occurrence of new cardiovascular events between baseline and follow-up. Whenever an event is 
suspected, additional information on the exact date of diagnosis, treating physician and initiated 
therapies will be gathered. When necessary, the treating physician will be contacted for further 
information. All suspected events will be evaluated and adjudicated by a medical specialist 
trained in the specific field. The following items are assessed: TIA, ischemic and hemorrhagic 
stroke, myocardial infarction, coronary artery bypass graft, percutaneous transluminal coronary 
angioplasty, and carotid endarterectomy.
Neuropsychological assessment
A comprehensive neuropsychological assessment covering the main cognitive domains will be 
performed under the same conditions as baseline. To minimize material-specific learning effects, 
parallel versions are used for the verbal fluency task (items of clothing and fruit) and the RAVLT.
Subjective cognitive failures occurring between baseline and follow-up will be assessed with the 
modified CFQ. The presence of depressive symptoms, fatigue and sleep disturbances will be 
determined with the same questionnaires as at baseline.54-57 Patients are specifically asked to 
reflect on the presence of these symptoms in the last two weeks. Furthermore, the influence of 
cognitive performance on daily functioning between baseline and follow-up as experienced by 
relatives will be determined by means of the IQCODE.58
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MRI protocol
MRI scanning at follow-up will be performed on a similar 1.5-Tesla Magnetom scanner (Siemens, 
Erlangen, Germany) as baseline. The scanning protocol consists of the following: whole brain 
3-dimensional T1 magnetization-prepared rapid gradient-echo (MPRAGE) sequence (TR/TE/
T1 2730/2.95/1000 ms; flip angle 7°; voxel size 1.0 × 1.0 × 1.0 mm), transversal FLAIR pulse 
sequence (TR/TE/T1 12220/85/2200 ms; voxel size 1.2 × 1.0 × 3.0 mm; slice gap 0.6 mm), 
transversal T2-weighted turbo spin echo sequence (TR/TE 7440/96 ms; voxel size 0.9 × 0.9 × 
3.0 mm), transversal T2*-weighted gradient echo sequence (TR/TE 727/19.1 ms; voxel size 1.0 
× 0.7 × 5.0 mm), gradient echo susceptibility weighted imaging sequence (TR/TE 49/40 ms; 
voxel size 0.8 × 0.7 × 1.0 mm), diffusion tensor imaging (DTI) (TR/TE 9100/98 ms; voxel size 2.2 
× 2.2 × 2.2 mm; 7 unweighted scans, 61 diffusion weighted scans, with non co-linear orientation 
of the diffusion weighting gradient and b-value 1000 s/mm3), and resting state imaging using 
a gradient echo EPI (TR/TE 1870/35 ms; voxel size 3.5 × 3.5 × 3.0 mm; slice gap 0.5 mm). 
During resting state, patients will be told to relax with their eyes closed, without concentrating on 
anything particular. The complete scanning protocol takes approximately 60 minutes.
ouTCoMe MeASuReS
Clinical outcomes
The primary clinical outcome measure will be domain-specific cognitive performance at baseline 
and six months after the qualifying event. Raw cognitive test results at baseline and follow-up 
will be transformed into z-scores, based on the mean and standard deviation of the baseline 
tests. Next, domain-specific compound scores will be computed by averaging z-scores of tests 
assessing the same cognitive domain. The compound score for global cognitive function is the 
average of the z-scores of all tests.59 Other clinical outcomes will be incident vascular events, 
subjective cognitive failures, fatigue, depressive symptoms, and sleep disorders.
Imaging outcomes
Two experienced raters will evaluate both baseline and follow-up brain MRI without knowledge 
of any clinical information.
Signs of acute brain infarction
A hyperintense lesion on DWI with a corresponding hypointensity on the apparent diffusion 
coefficient (ADC) map is considered cytotoxic edema and therefore a sign of acute brain 
infarction. In case of disagreement a consensus meeting will be held.
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Lacunes of presumed vascular origin and territorial infarcts
A lacune is defined as a hypo-intensity on T1-weighted and FLAIR images >2 mm and ≤15 mm, 
ruling out enlarged perivascular spaces and infraputaminal pseudolacunes.28 Territorial infarcts 
are defined as hypo-intense lesions on T1-weighted images >15 mm, with corresponding 
hyperintensity on FLAIR images.28 After rating the presence of lacunes and territorial infarcts, 
clinical information regarding the qualifying, previous or incident TNAs, or any incident stroke, 
will be made available and the lesion will be categorized as silent or symptomatic, based on the 
clinical symptoms and lesion location. In case of disagreement a consensus meeting is held.
White matter hyperintensities of presumed vascular origin
White matter hyperintensities of presumed vascular origin (WMH) are defined as hyperintense 
lesions in the white matter on FLAIR, which are not or only slightly hypointense on T1-weighted 
sequences. Gliosis surrounding infarcts is not considered WMH. Total WMH volume will be 
determined by an in-house developed, validated technique.
Brain volumetry
Probability maps for grey and white matter and cerebrospinal fluid will be computed using a six 
class segmentation tool in Statistical Parametric Mapping software (http://www.fil.ion.ucl.ac.uk/
spm) (SPM 8) on the T1 images. Total volumes of grey and white matter are defined as the sum 
of all voxel volumes belonging to that tissue class. Total brain volume is taken as the sum of 
total grey and total white matter volume. After computation of co-registration parameters of the 
FLAIR image to the T1 image, these are used to bring both the FLAIR and WMH segmentation 
images into the patients anatomical reference frame. Resulting images will be visually checked 
for co-registration errors. Finally, WMH segmentations are resampled to and combined with the 
white matter probability maps, thus resulting in a WMH map (intersection of WMH and white 
matter) and normal-appearing white matter map (complement of WMH in white matter) in the T1 
reference space.
Microbleeds
Microbleeds are defined as small, homogeneous, round or ovoid, hypo-intense foci on T2*-
weighted images with a diameter of 2-10 mm.28 Foci are not considered to be microbleeds 
when they are probable calcifications or iron deposits, symmetric hypo-intensities in the globus 
pallidus, flow void artifacts of pial blood vessels, or hypo-intense T2*-weighted signals inside 
an infarct, which are likely to be hemorrhagic transformation.60 Microbleeds will be counted per 
hemisphere separately and stratified into lobar, deep and infratentorial lesions.60
518780-L-bw-van Rooij
Processed on: 30-4-2018 PDF page: 33
CONNECT: sTudy raTiONalE aNd prOTOCOl
33
2
Diffusion tensor imaging
An in-house developed algorithm for patching artifacts from cardiac and head motion will be 
used for preprocessing of diffusion data.61 The output of this Matlab (The Mathworks, Inc.) based 
program comprises the tensor derivates fractional anisotropy and mean diffusivity.62 The mean 
unweighted image will be used to determine the coregistration parameters to the anatomical T1 
image, which are then applied to all diffusion-weighted images and results.63 All images will be 
visually checked for motion artifacts and coregistration errors.
Resting-state functional MRI
Resting-state images will be processed according to previously published methods, in order to 
gain motion corrected and spatially smoothed images with minimized effects of low and high 
non-neuronal noise,23 which in turn will be used to determine functional connectivity between 
different brain regions.
Analysis
In the first analyses cognitive domain-specific composite z-scores are the outcome variables. 
Analysis of (co) variance will be performed to test for differences in cognitive performance at 
baseline and follow-up (using baseline mean and SD as reference) between TIA, mixed, and 
nonfocal TNA patients, adjusting for known determinants of cognitive function. The relationship 
between cognitive function and DWI lesions will be determined, adjusting for differences in other 
MRI parameters (WMH volume, total brain volume, silent brain infarcts, microbleeds). Analyses 
will be performed before and after exclusion of patients with incident stroke during follow-up. Next, 
multinominal logistic regression analysis will be used to identify determinants of cognitive decline 
among demographics, type of event, MRI parameters and vascular risk factors. Subsequently, 
the relationship between DTI parameters at follow-up and both explanatory determinants and 
cognitive function will be determined. Finally, functional connectivity will be compared between 
TIA, mixed, and nonfocal TNA and between strata of cognitive performance.
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DISCuSSIoN
CONNECT provides an opportunity to identify patients who are not routinely included in 
cerebrovascular cohort studies but who are potentially at risk of cognitive decline.12 The 
added value of our study to the current knowledge of cognition after TIA and TNA lies in the 
longitudinal design and the combination of comprehensive neuropsychological testing with both 
conventional and advanced neuroimaging. This could potentially provide more clarity in the 
causes and mechanisms of decline in cognitive function after short-lasting neurological deficits.
CONNECT may therefore contribute to the growing notion that TIA is not just a warning sign but 
has lasting consequences of its own, and identify TNA as a potential new group of patients at 
risk of cognitive decline.
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ABSTRACT
Transient ischemic attack (TIA) can be difficult to diagnose. Episodes of acute atypical or nonfocal 
neurological symptoms, referred to as transient neurological attack (TNA), are as prevalent 
as TIAs. Diffusion-weighted imaging (DWI) provides evidence of acute cerebral ischemia in a 
third of TIA patients. We now report that DWI shows acute ischemia in 23% of patients clinically 
diagnosed as TNA by experienced stroke neurologists. This questions the accuracy of clinically 
diagnosing TIA and suggests added value for early MRI after an episode of acute onset atypical 
or nonfocal neurological symptoms.
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INTRoDuCTIoN
A transient ischemic attack (TIA) is defined as acute loss of focal brain function of presumed 
vascular origin, with complete recovery within 24 hours.1 The diagnosis can be difficult to make, 
illustrated by a low interobserver agreement even among stroke specialists.64 Diffusion-weighted 
imaging (DWI) can be of diagnostic value by showing signs of acute ischemia beyond symptom 
resolution in a third of TIA patients.4
Studies on DWI after TIA have included only patients with a clinically definite TIA.4 However, often 
patients are encountered with a myriad of acute onset, nonfocal neurological symptoms which 
are difficult to interpret and localize. In the absence of an alternative diagnosis, these episodes 
are referred to as ‘transient neurological attack’ (TNA).12 TNAs are almost as prevalent as TIAs 
in the general population and are associated with an increased risk of vascular events and 
dementia.5, 12
Although causes of TNAs are unknown and probably diverse, these associations suggest a role 
for cerebral ischemia. However, DWI studies in TNA patients are lacking. Therefore, we aimed to 
investigate the prevalence of DWI lesions in patients with a TNA not fulfilling the clinical criteria of 
TIA, to compare this with TIA patients, and to describe the clinical phenotype.
PATIeNTS AND MeThoDS
Patients and study design
This study was embedded in the prospective Cohort study ON Neuroimaging, Etiology and 
Cognitive consequences of Transient neurological attacks (CONNECT).65 Between June 2011 
and October 2014 we included consecutive patients aged ≥45 years who were referred to a 
specialized outpatient TIA clinic within seven days after an event of acute onset neurological 
symptoms lasting <24 hours. Exclusion criteria were prior stroke, inability to undergo MRI, 
clinical diagnosis other than TIA or TNA, intracerebral space-occupying lesion, Mini-Mental State 
Examination score <24, and prior neurological disease which can influence cognitive function 
(e.g. Parkinson’s disease, multiple sclerosis, dementia). The study was approved by the Medical 
Review Ethics Committee Region Arnhem-Nijmegen and written informed consent was obtained 
from all participants.
Clinical evaluation and event classification
A detailed description of the signs and symptoms of the event was obtained, consisting of a 
narrative account of events and a structured assessment of the presence or absence of 18 
predefined focal and nonfocal neurological symptoms (Table 1). Furthermore, duration of the 
qualifying episode, presence of vascular risk factors, and blood pressure were recorded and the 
prognostic ABCD2-score was calculated.9
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Table 1. Predefined focal and nonfocal neurological symptoms.
Focal Nonfocal
Hemiparesis Decreased consciousness or unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular blindness Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelingsa
All symptoms should have a sudden onset, rapid clearance, and a duration of <24 hours.
aConsidered referable to the nervous system if the referring physician included transient ischemic attack in 
the differential diagnosis but patients were unable to specify what had been wrong.
Above information was provided to a pool of three specialized stroke neurologists. Cases were 
distributed such that each event was independently adjudicated by 2 neurologists as TIA, TNA, 
or a specified alternative diagnosis, while blinded to DWI results. In case of disagreement 
a consensus meeting including the third stroke neurologist was held. TIA was defined as a 
sudden onset loss of focal brain function of presumed vascular origin with complete symptom 
resolution within 24 hours.1 TNA was defined as acute onset nonfocal neurological symptoms 
with spontaneous and complete recovery within 24 hours, without clinical evidence for alternative 
diagnoses such as migraine, epilepsy, Ménière disease, benign paroxysmal positional vertigo, 
hyperventilation, cardiac syncope, orthostatic hypotension, drug intoxication, hypoglycemia, or 
electrolyte imbalances. An episode with both focal and nonfocal symptoms was classified as 
TIA.
Diffusion-weighted imaging
All patients underwent MRI of the brain within seven days after the qualifying event, performed 
on a 1.5-Tesla Magnetom Scanner (Siemens, Erlangen, Germany). The diffusion scan consisted 
of a single-shot echo planar diffusion-weighted sequence (TR/TE 6300/134 ms; EPI factor 192; 
voxel size 1.2 × 1.2 × 5.0mm) with diffusion weighting applied in three directions and a b-value 
of 1000 s/mm2.
Two experienced raters individually evaluated each DWI scan for signs of acute infarction, 
defined as a hyperintense lesion on the b1000-image with corresponding hypointensity on the 
apparent diffusion coefficient (ADC) map. Only for small DWI lesions (diameter <5 mm) absence 
of low ADC signal was accepted, given the lower resolution of ADC images.66 Lesions were 
categorized as small cortical, small subcortical, or territorial lesions. Raters were unaware of any 
clinical information and in case of disagreement a consensus meeting was held.
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Analysis
Student t test, Pearson χ2 (continuity correction), or Mann-Whitney U test were used for 
comparisons. Overall diagnostic agreement (three possible diagnoses: TIA, TNA, and other) 
was defined as the mean Cohen’s κ of the 3 rater-pairs.67 Alpha was set at 0.05 and analyses 
were done with IBM SPSS Statistics version 20.0 (IBM Corp., Armonk, NY).
ReSulTS
In total, 150 patients were included, of whom 87 were classified as TIA and 56 as TNA. Seven 
were given a specific other diagnosis (migraine aura (n=2), peripheral vestibulopathy (n=2), 
orthostatic hypotension (n=2), and peripheral nerve compression (n=1)) and were excluded, 
leaving 143 patients for analysis. Overall diagnostic agreement was low (κ 0.36). Patient 
characteristics are presented by final classification in table 2. There were more women in the 
TIA group, while age, event duration, and individual vascular risk factors did not differ between 
TIA and TNA. ABCD2-scores were higher in TIA patients, owing to extra points for clinical 
characteristics. Signs of acute infarction on DWI were present in 31% of TIA patients and 23% of 
TNA patients (p=0.41). The yield of early (0-3 days after symptom onset) versus late (4-7 days) 
DWI scanning was not different in terms of lesion presence (p=0.60) and event duration was 
not related to DWI positivity (p=0.37). In total 72 DWI lesions were found in 40 patients. Lesion 
multiplicity was more frequent in TNA patients (p=0.05). Most DWI lesions were small cortical 
infarcts (61%) and located in the right anterior circulation (49%). Patients with a clinical diagnosis 
of TNA and accompanying DWI lesion most often reported confusion or paresthesias without 
hypoesthesia as main presenting symptom (Table 3 and Figure 1). Within both patient groups 
the event duration, type of symptoms, and vascular risk factors were unrelated to DWI positivity. 
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Table 2. Patient and diffusion-weighted imaging lesion characteristics by clinical diagnosis.
TIA (N=87) TNA (N=56) p-value*
Female 44 (51) 15 (27) 0.01
Mean age, years (SD) 65 (11) 64 (8) 0.47
Symptom duration 0.39
<10 minutes 26 (30) 17 (30)
10-60 minutes 32 (37) 15 (27)
>60 minutes 29 (33) 24 (43)
Hypertension 68 (78) 48 (86) 0.36
Diabetes 11 (13) 2 (4) 0.12
Hypercholesterolemia 62 (71) 34 (63) 0.36
Smoking 27 (31) 13 (23) 0.41
Atrial fibrillation 12 (14) 7 (13) 1.00
Median ABCD2-score (IQR) 4 (1-7) 3 (1-5) 0.001
Median ABD2-score (IQR) 3 (2-4) 3 (2-4) 0.88
Mean time from onset to DWI, days (SD) 3.8 (2.9) 3.5 (2.7) 0.53
Positive DWI 27 (31) 13 (23) 0.41
Mean maximal lesion diameter, mm (SD) 8.8 (7.9) 6.4 (5.0) 0.15
Multiple lesions (n = 40 patients) 6 (22) 7 (54) 0.05
Vascular territory (n = 72 lesions) 0.11
Left anterior circulation 10 (24) 13 (42)
Right anterior circulation 20 (49) 15 (48)
Posterior circulation 11 (27) 3 (10)
Lesion type (n = 72 lesions) 0.14
Small cortical 21 (51) 23 (74)
Small subcortical 15 (37) 6 (19)
Territorial 5 (12) 2 (7)
Numbers are N (%) unless stated otherwise. ABD2-score indicates ABCD2-score minus points for clinical 
characteristics (‘C’); DWI, diffusion-weighted imaging; IQR, interquartile range; SD, standard deviation; TIA, 
transient ischemic attack; TNA, transient neurological attack.
*Difference using Student t test, Pearson χ2 (continuity correction), or Mann-Whitney U test when appropriate. 
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Figure 1. Two examples of diffusion-weighted imaging lesions in transient neurological attack patients.
A. Sixty year old female who presented with isolated confusion with a duration of six hours. Diffusion-
weighted imaging performed three hours after symptom resolution showed signs of recent cortical ischemia 
in the left parietal lobe.
B. Seventy-four year old male who was seen after a 30-minute episode of paresthesias of the dorsum of the 
left hand, without hypoesthesia or motor symptoms. Diffusion-weighted imaging performed two days later 
showed a small subcortical lesion in the right precentral gyrus.
Table 3. Main symptoms, number of lesions, and lesion locations of transient neurological attack patients 
with signs of recent cerebral ischemia on diffusion-weighted imaging.
ID Sex Age, y Main symptoms N lesions DWI lesion locations
1 F 64 Isolated confusion 1 Right temporal
2 M 53 Paresthesias left arm, confusion 2 Right frontal, right parietal
3 M 69 Isolated confusion 1 Left parietal
4 M 58 Bilateral perioral paresthesias 5
Left and right cerebellar 
hemispheres, left parietal, left 
frontal
5 M 65 Nonrotatory dizziness 4 Left frontal, left parietal
6 M 72 Paresthesias left middle fi nger 2 Right frontal, right parietal
7 M 70 Isolated confusion 5 Right frontal, right parietal
8 M 63 Cramps right hand, amnesia 4 Left frontal, left parietal
9 M 63 Unsteadiness, blurred vision 1 Right thalamic
10 F 60 Isolated confusion 1 Left parietal
11 M 74 Paresthesias dorsum left hand 1 Right frontal
12 M 52 Bilateral paresthesias arms and legs 3 Right frontal, right parietal
13 M 59 Paresthesias fi ngers left hand 1 Right parietal
DWI indicates diffusion-weighted imaging; F, female; M, male.
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DISCuSSIoN
We showed that more than 20% of patients presenting within one week after an acute episode 
of neurological symptoms not fulfilling the clinical criteria of TIA have signs of acute ischemia 
on DWI. This was not different from the prevalence of DWI lesions in TIA patients. Within people 
referred for possible TIA, clinically diagnosing TIA fails to adequately identify those patients with 
proven cerebral ischemia on DWI.
Our study was not without limitations. The classifying neurologists had to make a choice between 
TIA, TNA or an alternative diagnosis. A more categorical judgment of the likelihood of a TIA might 
have improved the inter-rater reliability. However, the low interobserver agreement in our study 
is comparable with previous reports and confirms the difficulty in diagnosing TIA.64 Furthermore, 
recall bias may have led to an incomplete account of events, comparable with everyday practice. 
By acquiring both a narrative description and a standardized, structured assessment of the 
presence of specific neurological symptoms, we limited this bias. Additional investigations for 
alternative causes of the qualifying event were only performed if suspected by the attending 
vascular neurologist at the TIA outpatient clinic. Hereby we may have included some TNA 
patients with a definite nonvascular cause of the episode, underestimating the prevalence of 
DWI lesions in this population. Another potential limitation could be the maximal interval of 
seven days between the qualifying event and DWI scanning. This may have influenced lesion 
prevalence through pseudonormalization, transient DWI lesion reversal, or the occurrence of 
clinically silent new DWI lesions. Although the mean interval from event to imaging was only 3.7 
days and pseudonormalization generally starts after ten days, transient DWI lesion reversal may 
have influenced the yield of DWI performed several days after a TIA or TNA.68, 69 New, clinically 
unrelated DWI lesions arising after the index event would have increased the yield of late DWI 
relative to early scans, which was not the case in our study. Finally, patient numbers were rather 
small and our results remain to be validated in larger cohorts.
Previous studies including DWI after short lasting episodes of neurological dysfunction have 
included only patients with a clinically definite TIA.4 The prevalence of DWI lesions in clinically 
defined TIA patients in our cohort is comparable to these studies.4 We used the same diagnostic 
criteria for TNA as previous studies and found a similar prevalence of TNAs compared to TIAs 
in our hospital-based cohort as in the general population.5, 12 These studies performed no brain 
imaging, but there is some information about the prevalence of clinically silent DWI lesions. Two 
studies found a prevalence of less than one percent in participants with vascular risk factors 
but without spontaneous reports of neurological symptoms, which is far lower than in our TNA 
population.70, 71
Since the symptoms of a TNA are by definition nonfocal in nature, establishing a causal 
relationship between symptoms and a DWI positive lesion based on location is difficult.12 
Interestingly, although nonfocal neurological symptoms have been associated with posterior 
circulation ischemia, most DWI lesions in TNA patients were located in the anterior circulation.72, 
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73 In the TNA group frontoparietal cortical ischemia on either side was associated with symptoms 
that were afterwards described as confusion. Aphasia and apraxia can be misinterpreted as 
confusional states and thus result in the loss of focal symptoms at the gain of more nonfocal 
ones. There were also TNA patients in whom symptoms and DWI lesions were not anatomically 
related. TNA has been associated with cardiac arrhythmias, which in turn increase the odds of 
silent brain infarcts.74, 75 Possibly both TNA symptoms and DWI lesions emerged from the same 
arrhythmias, without any neuroanatomical correlation.
Our results illustrate the difficulty and imprecision of a clinical diagnosis of TIA and challenge 
the distinction made between TIA and TNA, where the diagnosis of TIA is reserved for events of 
presumed cerebrovascular origin, and TNA is considered an umbrella term for miscellaneous 
acute onset non-cerebrovascular neurological events.1, 26 DWI positive TIAs have a worse 
prognosis than DWI negative TIAs and are considered to be infarcts by the American Heart 
Association.13, 24 Similarly, the considerable proportion of TNA patients with a DWI lesion might 
be at increased risk of subsequent stroke as well. 
As there were no clinical features that adequately distinguished between DWI positive and negative 
TNA patients, DWI performed shortly after an attack of transient neurological dysfunction could 
be of added value, especially in those patients presenting with atypical and nonfocal symptoms. 
Future studies preferably include more patients, address the prognosis of TNA patients, and 
investigate the effect of secondary prevention in relation to DWI lesion presence.
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ABSTRACT
Background
Although by definition a transient ischemic attack (TIA) lasts less than 24 hours, many patients 
experience cognitive complaints beyond focal symptom resolution. Their prevalence, causes 
and profile are, however, unclear. We therefore performed a systematic review on cognitive 
impairment after TIA.
Summary
Medline and Embase were searched for relevant studies. Risk of bias was assessed and data 
synthesis was performed according to severity of cognitive impairment. Thirteen studies were 
included, with considerable heterogeneity concerning methods and timing of cognitive testing. 
Confounding, detection bias, and attrition were the main causes of a high risk of bias in several 
studies. The prevalence of post-TIA mild cognitive impairment ranged from 29% to 68%. Severe 
cognitive impairment was found in 8% to 22% of patients. Studies using a cognitive screening 
instrument and those performed shortly after TIA or several years later, reported the highest 
frequencies of impairment. Patients evaluated with a screening tool were substantially older than 
those who underwent a full neuropsychological assessment (weighted mean age difference 
10.9 years). Based on limited data, the post-TIA cognitive profile showed prominent executive 
function deficits. Insufficient data refrained us from drawing conclusions on causality. The few 
studies that reported neuroimaging results found a minor correlation with cognitive impairment.
key messages
Mild cognitive impairment is present in more than a third of TIA patients and has a profile 
comparable with vascular cognitive impairment. Reported rates of post-TIA cognitive impairment 
are highly variable and higher frequencies are found with cognitive screening tools. Considerable 
heterogeneity and insufficient data limit further conclusions about potential causative factors.
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1. INTRoDuCTIoN
The symptoms of a transient ischemic attack (TIA) by definition subside completely within 
24 hours.1, 76, 77 Only one third of patients has signs of acute infarction on diffusion weighted 
imaging (DWI).4 Despite the transient nature of focal symptoms associated with TIA and the 
absence of visible brain lesions in most patients, many experience persistent cognitive problems 
afterwards.16 The prevalence of objective cognitive impairment after TIA is, however, unclear.
The post-TIA cognitive profile is unknown, since cognitive assessment is not part of routine work-
up.13 Unrecognized cognitive dysfunction may affect quality of life, highlighting the importance 
of reliable prevalence estimates of post-TIA cognitive impairment as well as knowledge about its 
profile and potential determinants.78, 79
Symptom severity and infarct location are the main disease-related determinants of post-stroke 
cognitive impairment.18 Whether these characteristics also apply to TIA is to date unknown. A 
persistent ischemic lesion after TIA might be the substrate for cognitive impairment, but the 
severity of TIA symptoms only weakly corresponds to the presence of vascular lesions on 
neuroimaging.4 New cerebrovascular events that occur after a TIA might also have cognitive 
consequences, even though they often pass without recognized acute clinical symptoms.80, 81 
Vascular risk factors present in TIA patients increase the risk of progression of white matter 
hyperintensities, which are associated with cognitive decline as well.19, 20 Moreover anxiety, 
depressive symptoms, and delirium shortly after TIA can affect cognitive function.82
We performed a systematic review of the prevalence and profile of cognitive impairment in TIA 
patients. In addition we aimed to assess potentially causative factors.
2. MeThoDS
Reporting of this systematic review was done in accordance with the PRISMA guidelines 
(checklist provided in Supplementary Methods).83
2.1. Data sources
Relevant studies were identified with a literature search of the electronic medical databases 
Medline and Embase, last performed on May 20, 2015. Different medical subject headings 
and free search terms for “cognition” and “transient ischemic attack” were combined (search 
strategy provided in Supplementary Methods). In addition, reference lists of all included articles 
were screened to identify potentially missed papers.
2.2. Study selection and eligibility criteria
The search was limited to studies that had been performed in humans. Eligible articles were 
selected by a two-step approach. First, one reviewer screened titles and abstracts of all retrieved 
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records for the following characteristics: (1) original article published in English, (2) study 
concerning TIA patients defined by either the classical time-based definition or the newly proposed 
tissue-based definition,1, 13 and (3) presence of any information about cognitive function. From 
records fulfilling these criteria, full-text articles were obtained. These entered the next step of 
the selection process in which all papers were evaluated against the following inclusion criteria: 
(4) assessment of cognitive function by at least one test, (5) definition of cognitive impairment 
provided, (6) study concerning only TIA patients or results reported separately from other stroke 
patients, and (7) time interval between TIA and assessment of cognitive function reported. Two 
authors separately performed the second step of the selection process; in case of disagreement 
a consensus meeting was held.
2.3. Risk of bias assessment
Risk of bias assessment was performed with the Research Triangle Institute (RTI) item bank, a 
tool to evaluate the quality of observational studies with a focus on bias and confounding.84, 85 
In a recent comparison study, the RTI item bank was found to provide a more complete quality 
assessment than the Newcastle-Ottawa Scale.86, 87 In line with the developer’s instructions, 
the tool was tailored to match the review topic and designs of the included studies. Eleven 
items were selected, assessing selection bias, detection bias, attrition bias, selective outcome 
reporting, and confounding (Supplementary Methods).
2.4. Data extraction and synthesis
Reported frequencies of cognitive impairment were extracted, as were details on study design, 
inclusion and exclusion criteria, demographics, methods and timing of cognitive assessment, 
brain imaging results, and vascular risk factors. When present, information on domain-specific 
cognitive performance was recorded.
Studies were grouped according to the severity of cognitive impairment reported, defined 
as mild or severe cognitive impairment.88 Weighted mean age was calculated per study, with 
weighting according to study size. Qualitative synthesis of study results was performed with 
particular attention to the method and timing of cognitive testing, inclusion of TIA patients with a 
previous stroke, presence of vascular brain lesions, assessment of concurrent neuropsychiatric 
symptoms, and judgment of cognitive function before the TIA. Due to large between-study 
heterogeneity concerning methods and timing of cognitive testing, as well as inclusion criteria 
and patient characteristics, quantitative meta-analysis was deemed inappropriate.
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3. ReSulTS
3.1 literature search and study selection
The literature search yielded 4,058 records, 13 articles of which were eligible for inclusion 
(Figure 1). Twelve studies (including 1,167 patients [mean age range 57-74 years]) reported the 
prevalence of mild cognitive impairment and three studies (including 330 patients [mean age 
range 60-74 years]) provided data on the prevalence of severe cognitive impairment (Table 1). 
Supplementary Table S1 provides additional characteristics of the included studies on post-TIA 
cognitive impairment. 
Figure 1. Flowchart of the two-step approach to the selection of eligible articles on post-TIA cognitive 
impairment.
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3.2 Study characteristics and risk of bias assessment
All but one study prospectively included consecutive eligible patients.89 Two studies had a 
cross-sectional design,42, 90 one was a case-control study,91 and nine were cohort studies.40, 41, 
92-98 One study restricted inclusion to patients with symptomatic ipsilateral internal carotid artery 
occlusion.92
Seven studies assessed cognitive function with a neuropsychological test battery covering 
most cognitive domains42, 90, 92-94, 96, 97 while the other studies used brief cognitive screening tools, 
including the Montreal Cognitive Assessment (MoCA), Mini Mental State Examination (MMSE), 
or modified Telephone Interview for Cognitive Status (TICSm).40, 41, 89, 91, 95, 98 The time interval 
between TIA and cognitive testing varied from several days to five years. Different definitions 
of cognitive impairment were used. Studies using a cognitive screening instrument applied 
previously reported cut-off scores, while those performing a neuropsychological test battery 
used various cut-off criteria for a performance below age- and education-adjusted normative 
scores or a control group to define cognitive impairment (Table 1).
Risk of bias assessment of individual studies showed an unclear or high risk of confounding, 
especially taking into account age, level of education, previous stroke, and vascular risk 
factors. Although not invalidating the results of individual studies, it increased between-study 
heterogeneity and may as such be an important contributor to the large differences in observed 
rates of post-TIA cognitive impairment. To a lesser extent there was a risk of detection bias and 
attrition (Supplementary Figure S1, Supplementary Table S2).
3.3 Prevalence of cognitive impairment after TIA
The reported rates of mild cognitive impairment after TIA were highly variable, ranging from 29% 
to 68% (Table 1). Studies using MoCA or TICSm generally reported higher frequencies than 
those applying a neuropsychological test battery, with the exception of one study that reported 
a prevalence of mild cognitive impairment of 54% using a neuropsychological test battery in 
patients with an ipsilateral internal carotid artery occlusion,92 and one study in which only executive 
function was tested and found to be impaired in 57% of TIA patients.90 Patients evaluated with 
a screening tool were substantially older than those who underwent a full neuropsychological 
assessment (weighted mean age difference 10.9 years).
The highest frequencies of impairment were found shortly (within two weeks) and on the long-
term (more than one year) after the qualifying TIA. Only two studies specifically stated that 
incident stroke between TIA and cognitive testing was an exclusion criterion.42, 98
Severe cognitive impairment was present in 8% to 22% of patients (Table 1). Studies on the 
prevalence of moderate to severe cognitive impairment included older patients than those on 
mild cognitive impairment (weighted mean age difference 6.1 years). Only one study used a test 
battery to determine severe cognitive impairment93 and found a higher prevalence than two other 
studies that applied MMSE.41, 98
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Studies differed considerably in the proportion of patients with a low level of education, ranging 
from 26%-87%. The definitions of a low level of education also differed and could have contributed 
to the between-study heterogeneity (Table 1). Six studies did not provide any information about 
the educational level of TIA patients.89-91, 94-96
3.4 Profile of cognitive function after TIA
Two studies performing a neuropsychological test battery provided information on the cognitive 
profile of TIA patients and found prominent impairment in the domains executive function, working 
memory, attention and information processing speed.42, 92 One study performed a specific test 
battery focused on executive function.90 The other studies either did not describe the cognitive 
profile or performed MMSE or MoCA. These instruments have not been formally validated for 
the assessment of specific cognitive domains in non-demented patients with cerebrovascular 
disease, although the nonamnestic cognitive impairment detected by these tools is consistent 
with the neuropsychological domains reported to be prominently affected in cerebrovascular 
patients.40, 97-100
3.5 Concomitant cerebrovascular disease and structural brain changes
Only five studies reported the presence of vascular risk factors.42, 91, 92, 95, 98 The prevalence of 
hypertension, diabetes mellitus, hypercholesterolemia, and smoking did not differ between 
these studies (Supplementary Table S1). Two studies provided information on brain imaging after 
TIA. In one study, inclusion was restricted to patients with symptomatic ipsilateral internal carotid 
artery occlusion. Signs of prior infarction were found in 56-58% of patients, while white matter 
hyperintensities were present in 8-15%.92 Patients with a previous stroke were not excluded in 
this study and concomitant cerebrovascular disease on brain imaging was unrelated to worse 
cognitive function. Another study excluded patients with previous stroke and performed either 
computed tomography or magnetic resonance imaging within three weeks after the qualifying 
event. The median age-related white matter changes score101 was one and silent brain infarcts 
were present in 18% of TIA patients. The latter was related to worse executive functioning, but 
could not explain the presence of overall cognitive impairment.42
3.6 Concurrent neuropsychiatric symptoms
All but two studies reported that patients with pre-existing dementia were excluded.89, 92 No 
studies specifically investigated the relationship between post-TIA cognitive impairment and 
psychiatric symptoms such as anxiety, depression or delirium. One study excluded patients with 
a current depression,94 one adjusted for possible depression (defined as a Hospital Anxiety and 
Depression Scale, depression subscore ≥8, present in 12%),42 one study reported that 9% of 
patients were treated for depression at the time of cognitive testing,98 and one stated that no TIA 
patients had known pre-existing depression.91
518780-L-bw-van Rooij
Processed on: 30-4-2018 PDF page: 59
Cognitive impairment in tia patients: a systematiC review
59
4
4. DISCuSSIoN
4.1 Main findings
This systematic review shows that post-TIA cognitive impairment is frequent, with mild cognitive 
impairment prevalent in 29% to 68% of patients, and severe cognitive impairment in 8% to 22%. 
Since nearly all the included studies excluded prior dementia and the overall mean age is relatively 
low, the prevalence rate of cognitive impairment is likely higher in the total population with TIA 
and generalizability of our results is limited to the non-demented population.102 Differences in 
reported rates of cognitive impairment after TIA are partly explained by differences in patient 
characteristics, methods, and timing of cognitive testing. Higher frequencies of impairment are 
found with cognitive screening instruments, albeit in a substantially older population, and within 
the first weeks after a TIA or several years later. Based on limited data, deficits in executive 
function, attention, and information processing speed appear to be most common. Between-
study heterogeneity and lack of data impairs the possibilities to determine potential causative 
factors of post-TIA cognitive impairment.
4.2 Methodological considerations
Considerable heterogeneity existed between studies on post-TIA cognitive impairment, limiting 
the possibilities to combine and meta-analyze results in a quantitative manner. First, classification 
of cognitive impairment was not uniform across studies. A variety of cognitive tests were used, 
ranging from short screening instruments to comprehensive neuropsychological test batteries. 
In addition, different cut-offs for impairment were applied. Studies using screening tools included 
patients who were on average substantially older than those in studies applying a test battery. 
Furthermore, information about the level of education was often lacking. Since cut-offs for MoCA 
and MMSE are not age- and education-adjusted, this could at least partly explain the structurally 
reported higher frequencies of cognitive impairment in studies using these tools compared to 
those performing formal neuropsychological testing, which take into account age and education. 
Differences in test selection may not always be a methodological weakness, as long as tests 
are validated and the assessment encompasses the same major cognitive domains (preferably 
those defined by the National Institute of Neurological Disorders and Stroke-Canadian Stroke 
Network vascular cognitive impairment harmonization standards working group, namely 
executive, visuospatial, language, and memory functions).103 However, the use of different cut-
offs for cognitive impairment may be a factor that reduces the combinability of study results.97 
That is, while some studies applied widely used and generally accepted cut-off criteria for 
cognitive impairment, such as 1.5 SD, 1.65 SD, or 2 SD below the age- and education-adjusted 
normative mean on ≥1 cognitive domain (corresponding with percentile scores of 5.9, 5.0, and 
2.3, respectively), other studies defined cognitive impairment as a performance below 1 SD (a 
percentile of 15.8) or failure on only one test, which is typically considered too lenient, increasing 
the risk of false positive results.104
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Second, the small number of eligible studies and lack of data on vascular risk factors, brain 
imaging, and concurrent neuropsychiatric symptoms limited the possibility to identify possible 
causes and associated factors of cognitive dysfunction after TIA. As none of the included studies 
performed DWI and no studies applied the newly proposed tissue-based definition of TIA, we 
were not able to determine the influence of DWI-positivity on cognitive outcome and applied 
the classical time-based TIA definition throughout our study.1, 13 Furthermore, since four studies 
originated from the same population-based cohort (Oxford Vascular Study),105, 106 we cannot 
rule out the possibility that results partly overlap, although demographics differed between the 
individual study populations.40, 41, 97, 98 Next, using only papers written in English could be a bias. 
This is however not very likely since there is no reason why studies published in other languages 
should report systematically different results. Finally, the relatively young mean age of the cohorts 
in some studies limits the generalizability of these results to the overall TIA population, which is 
typically older.
4.3 Prevalence of cognitive impairment after TIA
Compared to the prevalence of cognitive impairment in the general population (7% in a Dutch 
population-based sample of 55-95 year old community-dwelling persons),107 post-TIA cognitive 
impairment is considerably more prevalent. It is, however, less prevalent than cognitive impairment 
after stroke, as reported by all but one study that performed a head-to-head comparison of 
cognitive function after TIA and stroke.40, 89, 94, 96-98 This is to be expected given the presumably 
more widespread brain damage after stroke. Even when cognitive function after minor stroke 
(defined as National Institute of Health Stroke Scale ≤3) is compared to TIA, the prevalence of 
impairment after the latter is lower.40 However, signs of acute infarction are present on DWI in 
up to 30% of TIA patients.4 Whether these patients or those with longer symptom duration have 
worse cognitive performance afterwards is unknown.
Large differences in delay were present between TIA and cognitive testing. Both studies carried 
out in the earliest (first weeks) and the late (after several years) phases found more patients 
to be cognitively impaired. Especially in the early phase, cognitive function can be influenced 
by stress, anxiety, or delirium, leading to falsely high rates of persistent cognitive impairment. 
Transient cognitive impairment in the first month after TIA appears to be a common feature, 
and although its causes remain to be elucidated, patients with transient cognitive impairment 
had worse cognitive outcomes than those without.41 As all other included studies focused 
exclusively on fixed rather than transient cognitive impairment, the concept of dynamic change 
in cognitive function is a topic that merits further research. When tested several years after a TIA, 
incident cerebrovascular events or progressive neurodegenerative pathology may result in a 
larger proportion of patients being cognitively impaired. As most studies did not report whether 
incident strokes were an exclusion criterion, and since new cerebrovascular lesions often pass 
unnoticed,108 these potential causes of the higher rates of cognitive impairment in the late phase 
after TIA need further study.
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4.4 Cognitive profile after TIA
The cognitive profile of TIA patients appears to be consistent with that most often seen in vascular 
cognitive impairment, with prominent deficits in executive function, attention, and information 
processing speed.109 However, this conclusion is based on limited evidence. That is, subscores 
of MoCA and MMSE have not been validated and may also be insensitive to subtle decrements, 
as these tools have been developed to detect cognitive decline due to Alzheimer’s disease99 
and vascular cognitive impairment is often characterized by a nonamnestic profile, driven by 
subcortical vascular damage disrupting subcortical-frontal connections [45].110 Nevertheless, 
the cognitive profiles detected by MoCA and MMSE are generally in line with the results of 
studies using a neuropsychological test battery, which can be considered a form of validation.40, 
97, 98
4.5 Potential causes and underlying mechanisms
Cognitive dysfunction after TIA can be explained in several ways, none of which can be confirmed 
on the basis of the currently reviewed literature. A TIA could, despite the transient nature of 
the focal symptoms, cause permanent brain damage, thereby disrupting networks involved in 
cognitive processes and leading to cognitive impairment.22 This theory is however only partly 
supported by DWI studies, in which signs of recent infarction are found in about 30% of clinically 
defined TIA patients.4 Furthermore, we recently showed that the clinical diagnosis of TIA may 
be inadequate, as more than 20% of patients not fulfilling the clinical criteria for TIA were found 
to have DWI lesions compatible with recent infarction.111 This issue touches on the matter of 
the newly proposed, tissue-based definition of TIA, which discriminates between patients with 
and without signs of recent infarction on brain imaging and states that only the latter category 
truly meets the criteria for TIA. Patients with imaging signs of recent infarction are considered to 
have had brain infarction, regardless of symptom duration.13 The relatively high prevalence of 
cognitive impairment after TIA suggests that some nonfocal symptoms may not be as transient 
as the focal neurological symptoms and as such provides an additional argument for this 
reconsideration of the diagnosis of TIA. Further studies are needed to identify whether there is a 
difference in cognitive outcome between patients with DWI-positive and DWI-negative TIA.
In addition, impaired cognitive function might have been present prior to TIA. Both TIA and 
cognitive impairment can result from the same underlying cerebrovascular disease process. 
Cerebral vascular damage including silent brain infarcts and white-matter hyperintensities of 
presumed vascular origin may lead to cognitive impairment and dementia.19, 20, 112 Moreover, 
anxiety, depressive symptoms, and delirium can occur after TIA and negatively influence 
cognitive function.113 Although partly transient, these psychiatric disturbances may be a major 
cause of cognitive impairment when assessed shortly after TIA.
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5. CoNCluSIoN
Cognitive impairment is remarkably prevalent in TIA patients. This contrasts with the lack of 
regular cognitive evaluation in TIA patients and urges attention to the possibility of persistent 
cognitive problems after seemingly completely subsided neurological symptoms. This systematic 
review shows a lack of available data on factors associated with cognitive impairment after TIA. 
Future studies preferably include brain imaging and evaluate both concomitant vascular risk 
factors and neuropsychiatric disturbances. In addition, to further determine the consequences of 
post-TIA cognitive impairment, assessment of subjective cognitive complaints both by patients 
and caregivers is important, in addition to comprehensive neuropsychological assessment 
using sensitive tests. Cognitive impairment is present in at least one third of TIA patients, which 
justifies scientific ventures to further identify this previously overlooked group at increased risk 
of cognitive decline.
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SuPPleMeNTARy MeThoDS
PRISMA checklist
Section/topic # Checklist item Reported on 
page # 
TITle 
Title 1 Identify the report as a systematic review, meta-analysis, or 
both. 
1
ABSTRACT 
Structured 
summary 
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number. 
2
INTRoDuCTIoN 
Rationale 3 Describe the rationale for the review in the context of what is 
already known. 
3
Objectives 4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
3
MeThoDS 
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
N/A
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale. 
4
Information 
sources 
7 Describe all information sources (e.g., databases with dates 
of coverage, contact with study authors to identify additional 
studies) in the search and date last searched. 
4
Search 8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated. 
Supplemental 
material
Study selection 9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
4
Data collection 
process 
10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators. 
5
Data items 11 List and define all variables for which data were sought 
(e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
5
Risk of bias in 
individual studies 
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used 
in any data synthesis. 
Supplemental 
material, 4-5
Summary 
measures 
13 State the principal summary measures (e.g., risk ratio, 
difference in means). 
5
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Synthesis of results 14 Describe the methods of handling data and combining results 
of studies, if done, including measures of consistency (e.g., I2) 
for each meta-analysis. 
5
Risk of bias across 
studies 
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective reporting 
within studies). 
Supplemental 
material, 4-5
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating which 
were pre-specified. 
N/A
ReSulTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at each 
stage, ideally with a flow diagram. 
6, Figure 1
Study 
characteristics 
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
6-7, Tables 
1, S1
Risk of bias within 
studies 
19 Present data on risk of bias of each study and, if available, any 
outcome level assessment (see item 12).
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individual studies 
20 For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally with 
a forest plot. 
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Synthesis of results 21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency. 
N/A
Risk of bias across 
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22 Present results of any assessment of risk of bias across studies 
(see Item 15). 
6-7, Figure 1
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]). 
N/A
DISCuSSIoN 
Summary of 
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24 Summarize the main findings including the strength of evidence 
for each main outcome; consider their relevance to key groups 
(e.g., healthcare providers, users, and policy makers). 
10
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of identified 
research, reporting bias). 
10-11
Conclusions 26 Provide a general interpretation of the results in the context of 
other evidence, and implications for future research. 
11-13
FuNDING 
Funding 27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
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Search strategies
Medline:
1. Combination of medical subject headings:
   (“Ischemic Attack, Transient”[Mesh]) AND (((((“Cognition”[Mesh]) OR “Cognition 
Disorders”[Mesh]) OR “Dementia”[Mesh]) OR “Dementia, Multi-Infarct”[Mesh]) OR 
“Dementia, Vascular”[Mesh])
2.  Combination of free search terms:
   (cogniti* OR dementia) AND (TIA OR (transient ischemic) OR (transient ischemic) OR 
(transient symptoms) OR transient)
embase:
1. Combination of medical subject headings:
  1. cognition/
  2. cognitive defect/
  3. dementia/
  4. multiinfarct dementia/
  5. transient ischemic attack/
  6. 1 or 2 or 3 or 4
  7. 5 and 6
2. Combination of free search terms:
  1. (cogniti* or dementia).af.
  2. limit 1 to (human and English language)
  3. (tia or transient ischemic or transient ischemic or transient symptoms or transient).af.
  4. limit 3 to (human and English language)
  5. 2 and 4
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Adapted RTI item bank for assessing risk of bias and confounding84, 85
Q1. Are inclusion and exclusion criteria applied uniformly?
Consider patients vs. controls if applicable, otherwise individual patients.
Q2. Is the recruitment strategy the same across individuals or study groups?
Consider patients vs. controls if applicable, otherwise individual patients.
Q3. Is the selection of the comparison group adequate?
Only applicable if control group present.
Consider hospital vs. population based
Q5. Is the outcome assessor blinded to exposure status?
Assessor of cognitive function blinded for clinical status (TIA or not)?
Q6. Are valid and reliable measures implemented?
Reliable and conventional ascertainment of TIA?
Reliable and conventional ascertainment of dementia, prior stroke status, cardiovascular risk 
factors, depression?
Q7. Is the length of follow-up the same across individuals or study groups?
Delay from TIA to cognitive testing uniform for all individuals or study groups?
Q8. Is the impact of loss to follow-up assessed?
Only applicable if follow-up study.
Q9. Are important primary outcomes reported?
Cognitive impairment
Timing of cognitive testing
Q11. Are the results believable?
Q12. Has an attempt been made to balance to allocation between groups or to match groups?
Only applicable if control group present.
518780-L-bw-van Rooij
Processed on: 30-4-2018 PDF page: 67
Cognitive impairment in tia patients: a systematiC review
67
4
Q13. Are important confounding variables taken into account in the design and/or 
analysis?
Stratified by level of importance:
1. Age, level of education, prior stroke, pre-existing dementia.
2. Vascular risk factors, vascular brain damage, concurrent neuropsychiatric disturbances.
Q4 and Q10 of the RTI item bank not relevant to the included studies.
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SuPPleMeNTARy FIGuRe
Figure S1. Risk of bias by item in all studies (n=13) using an adaptation of the RTI item bank. 
Numbers and percentages represent the studies with low risk of bias (green), unclear risk of bias (yellow), 
or high risk of bias (red) over the number of studies for which the item was applicable. Due to limited space, 
not all numbers were included.
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ABSTRACT
Background and purpose
By definition the symptoms of a transient ischemic attack (TIA) subside completely within 
24 hours. Imaging studies show signs of persistent ischemic tissue damage in a substantial 
amount of TIA patients. Cerebral infarction can cause permanent cognitive impairment. Whether 
permanent cognitive impairment occurs after TIA is unclear, as is its profile. 
Methods
TIA patients aged 45-65 years without prior stroke or dementia underwent comprehensive 
neuropsychological testing within three months. Z-scores per cognitive domain were obtained, 
based upon the mean of a control group within the same age range. Cognitive impairment was 
defined as a domain z-score <-1.65. Patients underwent either CT or MRI brain imaging.
Results
One hundred seven TIA patients (63% women, mean age 56.6 years) were included and 
compared with 81 controls (56% women, mean age 52.9 years). Patients performed worse on 
all cognitive domains except episodic memory. Working memory (25%), attention (22%), and 
information processing speed (16%) were most frequently impaired, and more often than in the 
control group (age- and sex-adjusted OR respectively 22.5 (95%-CI 2.9-174.3), 6.8 (1.9-24.3), 
7.1 (1.5-32.5)). More than 35% of TIA patients had impairment of at least one cognitive domain. 
Presence of silent brain infarcts was related to worse executive functioning, but did not explain 
the whole relationship between TIA and cognitive impairment.  
Conclusions
More than a third of TIA patients have impairment of at least one cognitive domain within three 
months after their TIA. The affected domains fit in the vascular cognitive impairment profile.
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INTRoDuCTIoN
By definition symptoms of a transient ischemic attack (TIA) subside completely within 24 hours.1 
Studies using diffusion-weighted imaging (DWI) found signs of cytotoxic edema beyond the 
point of symptom resolution in more than 30% of TIA patients.4
Permanent cerebrovascular damage, both with and without clinical signs of brain infarction, 
may lead to cognitive decline.18-20 This cognitive impairment is referred to as vascular cognitive 
impairment (VCI) and has a profile characterized by executive and attention deficits with a 
relatively intact memory function.109
A TIA could give rise to transient cognitive defects, although studies examining the persistency 
of this cognitive impairment beyond one month after the TIA are scarce and often include elderly 
patients.12, 40, 41, 91, 92 Any cognitive impairment potentially due to a TIA might be obscured by 
age or Alzheimer’s pathology related cognitive decline. Furthermore, the profile of cognitive 
impairment after TIA is unknown.
We therefore determined the cognitive performance of patients within three months after a TIA in 
a single center cross-sectional study. We aimed to minimize the effects of aging and concomitant 
cognitive disorders by restricting our research population to an age-range of 45-65 years. We 
hypothesized that cognitive function after TIA would be impaired and have a ‘vascular profile’.
MeThoDS
Participants
Patients aged 45-65 years attending the stroke unit or TIA outpatient clinic of the Radboud 
university medical center after a TIA between 2004 and 2010 were consecutively recorded. Our 
guidelines state that patients referred to the TIA clinic should be seen within 24-48 hours. As part 
of clinical care a comprehensive neuropsychological assessment was performed within three 
months after the qualifying event. The number of available slots for these assessments was 
restricted. However, no selection for neuropsychological assessments was used.
TIA was defined as a sudden onset focal neurological deficit of vascular origin with complete 
resolution of focal symptoms within 24 hours.1 Patients with prior stroke or dementia were 
excluded, whereas those with prior TIA were not. In addition, patients with incident stroke or 
carotid endarterectomy between TIA and cognitive testing were excluded, as were those with 
a Mini-Mental State Examination (MMSE) score <24 since this was considered indicative for 
possible pre-existing dementia and would prevent a reliable cognitive assessment.46
All data were acquired as part of clinical care and both storage and processing were conducted 
anonymously, in agreement with the local ethical committee rules.
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Control group
Patients’ performances on all individual tests were compared to a control group, recruited 
among spouses, relatives or social environment of patients attending our outpatient department. 
All participants were free from TIA and the same exclusion criteria as for patients were applied. 
The stroke-free status was verified through a standardized, structured questionnaire. When a 
possible cerebrovascular event was reported, the general practitioner was contacted for further 
information.
Only for the California Verbal Learning Test (CVLT), performance was not compared with the 
control group, but with a normative sample described in the test manual (n=164, age 45-64 
years). None of the subjects in the normative sample had a history of psychiatric or neurological 
disease.116
Clinical characteristics
Hypertension was considered present when (1) systolic blood pressure was >140 mmHg and/
or diastolic blood pressure was >90 mmHg at both time of presentation and at 90 days follow-
up, or (2) antihypertensive medication was used, or (3) a previous diagnosis by a physician 
was recorded. Hypercholesterolemia was considered present when (1) fasting total cholesterol 
level was >6.5 mmol/L, or (2) lipid lowering drugs were used, or (3) a physician had previously 
made the diagnosis. Diabetes mellitus was defined as (1) the use of anti-diabetic medication or 
(2) a previous diagnosis by a physician. Smoking status was determined current when a patient 
smoked or had stopped within the past 6 months, and former when smoking was stopped 
earlier. Any prior myocardial infarction was noted, and the body mass index was calculated.
Brain imaging
Brain imaging, either CT or MRI, performed within three weeks after the qualifying event was 
evaluated for the presence and severity of age-related white matter changes (ARWMC) using a 
semi-quantitative scale, as well as the presence of silent brain infarct (SBI).101 SBI was defined 
as an infarct on CT or MRI at a location that did not correspond with the symptoms of the 
qualifying or any previous TIA, and was classified as lacunar or nonlacunar.29 Two experienced 
raters (F.G.v.R. and E.J.v.D.) separately performed assessment of brain imaging. In case of 
disagreement, a consensus meeting was held.
Neuropsychological assessment
A trained examiner administered the neuropsychological tests in a quiet, well-lit room and under 
standard circumstances. Executive functioning was assessed with a verbal fluency task (naming 
as many animals as possible within 60 seconds; response generation) and the interference score 
of the Abbreviated Stroop Color Word Test (response inhibition).49 Information processing speed 
was tested with Cards I and II of the Abbreviated Stroop Color Word Test and the Symbol-Digit 
Modalities Test.49, 51 The Paper and Pencil Memory Scanning Test (PPMST; four subtasks) was 
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used to measure working memory and attention was evaluated by the Verbal Series Attention 
Test (VSAT).53, 117 Finally, verbal episodic memory was tested with the Dutch version of the CVLT, 
using both the total correct answers of five immediate recall trials and the difference between trial 
five and long-term recall (consolidation).116 For tests requiring both speed and precision a speed 
accuracy trade-off (SAT) score was calculated by dividing the percentage of correct answers 
by the time taken to complete the test.118 This applied to the VSAT, Cards I and II of the Stroop 
Color Word Test, and all subtasks of the PPMST. The Stroop interference score was computed by 
dividing the SAT-score of Card III by the mean of the SAT-scores of Cards I and II.49
Subjective cognitive failures
Additionally, a 15-item semi-structured interview based on the Cognitive Failures Questionnaire 
(CFQ) was administered to identify subjective cognitive failures (SCF) experienced the month 
before.54 Responses were added to provide a sum score with a maximum of 25. SCF reported 
in remembering, word finding, planning, concentration, and slowness in thought were given a 
higher weight in the sum scores (range 0-3: none, mild, moderate, severe) than the other items 
(0-1). If at least one moderate problem (score 2 or higher) on an item with a score range of 0-3 
or a score of 1 on a dichotomous item was reported, SCF was considered present.
other measurements
Age, sex, and level of education were recorded. The presence of depressive symptoms was 
defined as a Hospital Anxiety and Depression Scale depression subscale (HADS-D) score ≥8.56, 
119
Statistical analysis
All analyses were done with IBM SPSS Statistics version 20.0 (IBM Corp., Armonk, NY). 
Differences in characteristics between patients and controls were compared using Student’s 
t-test, Pearson’s Chi-square, and age- and sex-adjusted analysis of covariance (ANCOVA), 
when appropriate. Bonferroni correction for multiple testing was applied with alpha set at 0.01.
Individual z-scores were computed for each neuropsychological test using the mean and 
standard deviation (SD) of the control group, and domain z-scores were calculated by averaging 
z-scores of individual tests. Per cognitive domain a z-score <-1.65 of the control group was 
used as a cut-off to determine domain-specific impairment (i.e. corresponding to a performance 
below the lower 5th percentile).104 Domain-specific age- en sex-adjusted odds ratios (OR) of 
cognitive impairment after TIA were obtained by logistic regression. No OR of episodic memory 
impairment was calculated, since CVLT test results were not compared with the same control 
group.
In case of missing neuropsychological test results (maximum 12.2%), the domain score was 
based on the remaining tests, or if no tests were performed within a cognitive domain, the 
domain z-score was not used in further analyses.
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ReSulTS
Between September 2004 and December 2010 246 TIA patients aged 45-65 years were 
registered, of whom 114 underwent neuropsychological testing within three months after the 
qualifying event (mean (SD) 56 (14.7) days, range 26-91 days). Patients with and without 
neuropsychological assessment did not differ on age and sex (Student’s t-test and Pearson’s 
Chi-square, p=0.92 and 0.43 respectively). Subsequently, five patients were excluded because 
of a history of stroke and two because of a MMSE score <24. Characteristics of included patients 
(n=107) are summarized in Table 1. The control group included 81 individuals. No differences 
were present between patients and controls for sex, low level of education, HADS-D mean score, 
HADS-D score ≥8, or the presence of vascular risk factors. Patients were on average older than 
controls (56.6 and 52.9 years respectively, p<0.001).
Table 1. Characteristics of TIA patients and controls.
TIA patients
(N=107)
Controls
(N=81)
p-value*
Women 67 (62.6) 45 (55.6) 0.41
Age, mean (SD) 56.6 (6.3) 52.9 (6.2) <0.001
Low level of education 28 (26.2) 17 (21.0) 0.52
HADS-D, mean (SD) 3.2 (3.9) 2.6 (2.7) 0.22
HADS-D score ≥8 13 (12.1) 6 (7.4) 0.35
Body Mass Index, mean (SD) 26.8 (4.0) 27.4 (4.9) 0.36
Hypertension 52 (48.6) 27 (33.3) 0.05
Dyslipidemia 31 (29.0) 15 (18.5) 0.14
Diabetes mellitus 5 (4.7) 1 (1.2) 0.36
Prior myocardial infarction 8 (7.5) 1 (1.2) 0.10
Smoking status 0.32
Current 19 (17.8) 22 (27.2)
Former 53 (49.5) 35 (43.2)
ARWMC score, median (IQR) 1 (3) N/A
Silent brain infarct 18 (18.2) N/A
Single 17 (94.4) N/A
Lacunar 14 (77.8) N/A
DWI lesion (only MRI) 16 (27.1) N/A
Numbers are N (%) unless stated otherwise.
*for difference using Student’s t-test and Pearson’s Chi-square (continuity correction) when appropriate.
SD Indicates standard deviation; HADS-D, Hospital Anxiety and Depression Scale, depression subscale; 
ARWMC, age-related white matter changes; IQR, interquartile range; N/A, not applicable; DWI, diffusion-
weighted imaging.
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TIA patients performed worse than controls on each individual cognitive test and all cognitive 
domains, except episodic memory (Table 2). The highest impairment rates were present in the 
domains of working memory and attention, while episodic memory was relatively preserved. 
Age- and sex-adjusted ORs for domain-specific cognitive impairment after TIA ranged from 3.5 
(executive function, 95%-confidence interval (CI) 0.7-16.7) to 22.5 (working memory, 95%-CI 2.9-
174.3). Impairment of at least one cognitive domain (excluding episodic memory) was present 
in 38.3% of TIA patients, with an associated age- and sex-adjusted OR of 5.9 (95%-CI 2.4-14.5) 
(Table 3). 
Table 2. Mean difference in z-scores per cognitive domain and cognitive test between TIA patients 
(N=107) and controls (N=81). Percentage of patients with domain-specific cognitive impairment.
Cognitive test and domain Difference in 
z-score, mean
p-value* % impaired†
Executive function -0.59 <0.001 10.3
Verbal fluency -0.69 <0.001
Stroop interference task -0.48 0.02
Information processing speed -0.66 <0.001 16.1
Stroop task 1 -0.64 0.001
Stroop task 2 -0.74 <0.001
SDMT -0.55 0.01
Working memory -0.87 <0.001 24.5
PPMST % -1.47 <0.001
PPMST 1 letter -0.80 <0.001
PPMST 2 letters -0.68 0.002
PPMST 3 letters -0.55 0.03
Attention -0.51 0.01 21.7
VSAT -0.51 0.01
Episodic memory 0.01‡ 0.96 8.4
CVLT; immediate recall -0.02‡ 0.91
CVLT; consolidation 0.03‡ 0.87
*for difference using age- and sex-adjusted ANCOVA.
†defined as z-score <-1.65; ‡compared with normative data based on 164 individuals aged 45-64 years.13
SDMT Indicates Symbol-Digit Modalities Test; PPMST, Paper and Pencil Memory Scanning Test; VSAT, Verbal 
Series Attention Test; CVLT, California Verbal Learning Test.
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Table 3. Odds ratios for cognitive impairment within three months after TIA compared to controls without 
TIA (N=81).
Cognitive domain Cognitive impairment, oR (95%-CI)*
All TIA patients  
(N=107)
TIA patients without SBI only 
(N=89)
Executive function 3.5 (0.7-16.7) 1.5 (0.3-8.7)
Information processing speed 7.1 (1.5-32.5) 4.8 (1.0-23.4)
Working memory 22.5 (2.9-174.3)† 16.2 (2.0-128.7)†
Attention 6.8 (1.9-24.3)† 1.7 (1.5-20.9)†
≥1 cognitive domain 5.9 (2.4-14.5)‡ 5.4 (2.1-13.3)‡
Cognitive impairment defined as domain z-score <-1.65.
*age- and sex-adjusted logistic regression; †p-value <0.01; ‡p-value <0.001.
OR Indicates odds ratio; CI, confidence interval; SBI, silent brain infarct.
Brain imaging was performed within three weeks after the qualifying event in 99 TIA patients 
(59% MRI). Within the patient group SBI, but not ARWMC, was associated with worse executive 
functioning (Supplementary Table I). SBI were almost exclusively single lacunar infarcts (four 
nonlacunar infarcts, three of which were subcortical). TIA patients with signs of cytotoxic edema 
on DWI were not more frequently impaired (age- and sex-adjusted OR for any domain-specific 
cognitive impairment 0.7 (95%-CI 0.3-2.0)). After excluding patients with SBI, TIA was still 
associated with impairment of cognition within three months (Table 3).
We found no difference between patients and controls with respect to mean CFQ sum score. 
SCF were reported by 59% of TIA patients, which did not differ from the control group. SCF were 
associated with lower z-scores in all cognitive domains for TIA patients (age- and sex-adjusted 
ANCOVA, p<0.01).
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DISCuSSIoN
The main findings of our study are that (1) more than a third of patients aged 45-65 years who 
had a TIA in the previous three months has impairment of function in at least one cognitive 
domain, (2) working memory, attention, and information processing speed are the most affected 
cognitive domains while global memory functions remain relatively intact, (3) this cognitive 
impairment is only partly related to cerebrovascular damage on conventional neuroimaging, 
and (4) subjective cognitive complaints are not more frequently reported by TIA patients than by 
healthy individuals.
This study was not without limitations. Given the cross-sectional design of the study without 
information on cognitive performance before the qualifying event, neither definite causal relations 
between cognitive function and TIA nor its time course could be established. Not all TIA patients 
seen during the study period underwent cognitive assessment because of restricted availability 
of slots. In order to prevent selection bias, patients were assigned to cognitive assessment 
irrespective of clinical data. Furthermore, CVLT was not performed in the control group, and 
patients’ results for this test were compared with normative data derived from a different age-
adjusted reference group published in the test manual. Although this prevented calculation of 
ORs for overall cognitive impairment, the composition of the cognitive profile of TIA patients 
separately could be described. In addition, not all patients completed the neuropsychological 
test battery. By computing a domain-specific compound z-score based on less than all 
associated tests when necessary, and by not using missing values in further analyses, we might 
have reduced statistical power of our results. Despite swift analysis after referral, patient delay 
caused initial brain imaging to take place up to three weeks after the qualifying event, which 
could have influenced DWI lesion prevalence.120 Also, controls were on average slightly younger 
than the patients. However, they were all from the same relatively narrow age range, and although 
statically significant the mean difference was small and analyses were adjusted for differences in 
age. Therefore we feel that this potential factor has been adequately accounted for and cannot 
entirely explain our findings. Finally, to reduce the influence of concomitant cognitive disorders, 
we excluded older patients and those with low MMSE performance. This limits the generalizability 
of our results to the whole TIA population and might have excluded representatives of the more 
severe spectrum of cognitive impairment after TIA.
Previous data on cognitive function after TIA are scarce and heterogeneous.12, 17, 40, 41, 91, 92 Patient 
characteristics, definition of cognitive impairment, and delay from TIA to assessment of cognition 
differ widely between studies. Furthermore, cognitive assessment is mostly limited to screening 
tools such as Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment 
(MoCA), which are not sensitive to mild cognitive deficits after stroke and do not assess specific 
cognitive domains.99, 100 Previously reported prevalence of cognitive impairment after TIA varies 
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from 30-57%.40, 91, 92 Compared to our study, these studies included substantially older patients, 
performed cognitive assessment much later after TIA, and did not exclude patients with previous 
stroke. In contrast, we aimed to minimize the effect of possible concomitant causes of cognitive 
impairment by performing cognitive testing within three months after the qualifying event in 
patients aged <65 years and excluding those with a history of stroke. Despite our rigorous 
measures to minimize the effects of neurodegenerative or previous vascular cognitive disorders, 
we found a prevalence of 38% of cognitive impairment in a relative young cohort of patients with 
a recent TIA.
The cognitive profile after TIA showed prominent impairment in the domains of working memory, 
attention, and information processing speed, while global memory functions remained within 
normal ranges. This nonamnestic cognitive impairment is compatible with the VCI profile, 
and mainly driven by subcortical brain damage disrupting subcortical-frontal connections.110 
Only a few studies have previously described the cognitive profile of TIA patients and found 
prominent deficits in executive functioning, visuoconstruction and attention.40, 91, 92 However, one 
of these studies included only patients with internal carotid artery occlusion and did not exclude 
patients with prior stroke, while the others performed MoCA instead of a more comprehensive 
neuropsychological evaluation.
Presence of SBI was related only to worse executive functioning, whereas ARWMC were 
not related to any cognitive impairment after TIA. Due to limited numbers we were unable to 
assess the relationship of different types of SBI with cognitive function. The prevalence of SBI 
and the severity of ARWMC were low compared to population based studies, probably related 
to our relatively young study population.29, 121 Both SBI and ARWMC are markers for cerebral 
small vessel disease (SVD), indicating that in our study population the role of SVD in cognitive 
impairment after TIA seems limited. This is further strengthened by the robust association of 
TIA with cognitive impairment after excluding patients with SBI. The influence of concomitant 
neurodegeneration on cognitive function was minimized through a rigorous age restriction. 
This suggests a role for TIA itself in cognitive impairment afterwards, the mechanism of which 
remains to be elucidated. Transient ischemia might lead to microstructural damage and loss 
of white matter structural integrity, giving rise to subcortical-frontal disconnection in a similar 
fashion as the VCI construct. Verification of this potential pathway was not possible in our study, 
since imaging modalities assessing the structural integrity of white matter were not performed.
In contrast to the high prevalence of objective cognitive dysfunction, TIA patients did not report 
more SCF than controls. The prevalence of SCF among TIA patients is remarkably lower than 
in elderly persons with white matter lesions, and is comparable to the one study that previously 
reported cognitive complaints in TIA patients.16, 122 However, those results were not separately 
reported for TIA and minor stroke patients, and assessment of SCF was limited. The discrepancy 
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between prevalence of objective and subjective cognitive dysfunction in TIA might mean that 
only relatively minor difficulties in everyday life are perceived. Still, since TIA patients in our study 
were relatively young, a large proportion would still be working and be socially active. Even minor 
cognitive decline might therefore have impact.
The causes of cognitive impairment after TIA remain unknown. Future studies should include 
advanced brain imaging techniques to identify microstructural and functional cerebrovascular 
damage and perform longitudinal assessment of cognitive function after TIA to observe whether 
cognitive impairment is transient, stationary or progresses over time. Nevertheless, our results 
show the extent of cognitive impairment after TIA in relatively young adults and warrant the need 
for more clinical awareness of this problem.
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SuPPleMeNTARy TABle
Supplementary Table I. Associations of silent brain infarct and age-related white matter changes with 
cognitive impairment within three months after TIA.
Cognitive impairment, oR (95%-CI)*
Cognitive domain
SBI
(yes/no)
ARWMC
(per 1 point increase)
Executive function 10.7 (2.5-44.8)† 1.0 (0.8-1.3)
Information processing speed 4.8 (1.3-17.5) 0.7 (0.5-1.0)
Working memory 3.5 (1.0-11.9) 0.7 (0.5-1.0)
Attention 3.4 (1.0-11.4) 0.8 (0.6-1.0)
≥1 cognitive domain 2.4 (0.8-7.2) 0.8 (0.7-1.0)
Cognitive impairment defined as z-score <-1.65.
*age- and sex-adjusted logistic regression; †p-value <0.01.
OR Indicates odds ratio; CI, confidence interval; SBI, silent brain infarct29; ARWMC, age-related white matter 
changes.101
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ABSTRACT
Background and purpose
Although by definition transient, both transient ischemic attack (TIA) and transient neurological 
attack (TNA) are associated with cognitive impairment. Determinants and course of cognitive 
function afterwards are however unclear. We prospectively determined cognitive performance 
after TIA and TNA in relation to clinical diagnosis and diffusion-weighted imaging (DWI) results.
Methods
TIA and TNA patients aged ≥45 years without prior stroke or dementia underwent comprehensive 
cognitive assessment and magnetic resonance imaging within 7 days after the qualifying event. 
Cognitive tests were repeated after 6 months. Domain-specific compound z scores based on 
the baseline mean and SD were calculated. Repeated measures analysis was used to test for 
differences in domain-specific cognitive performance over time between DWI-positive and DWI-
negative patients, as well as between TIA and TNA patients.
Results
One hundred twenty-one patients were included (mean age (SD) 64.6 years (9.2 years), 60% TIA 
and 40% TNA) of whom 32 (26%) had a DWI lesion. Executive function performance decreased 
over time (mean change in compound score -0.23; P=0.01 adjusted for age, sex, education), 
whereas attention improved (0.11; P=0.02), and information processing speed and episodic 
memory remained unchanged. Patients with a DWI lesion had worse executive function at 
baseline than those without a DWI lesion (compound scores -0.26 vs. 0.08, P=0.048), which 
persisted throughout the study period (P=0.04). Clinical diagnosis (TIA or TNA) was not related 
to cognitive function over time.
Conclusions
Executive function declines during the first 6 months after TIA or TNA. Patients with an initial DWI 
lesion have persisting worse executive function than those without.
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INTRoDuCTIoN
A transient ischemic attack (TIA) is characterized by acute focal neurological symptoms 
of presumed vascular origin that subside completely within 24 hours.1 Often patients are 
encountered with acute nonfocal symptoms that are atypical for the clinical diagnosis of TIA, like 
acute onset short lasting confusion. In the absence of an alternative diagnosis, this is referred 
to as a transient neurological attack (TNA).5, 12 Diffusion-weighted imaging (DWI) shows signs of 
acute infarction beyond the point of symptom resolution in more than a third of clinically defined 
TIA patients,4 but also in over 20% of TNA patients.111 Although by definition a TIA leaves no 
persistent deficits, there is growing evidence for cognitive sequelae afterwards.16, 42 Patients with 
a TNA are at increased risk of cognitive decline as well.12 After TIA and minor stroke, infarct on 
brain imaging is associated with transient cognitive impairment, which is in turn associated with 
cognitive decline in the following years.41 The determinants and course of cognitive dysfunction 
after TIA or TNA are, however, unclear, as previous studies were mainly cross-sectional, rarely 
performed brain imaging, and were restricted to clinically defined TIA patients.123
We conducted a prospective cohort study on cognitive function after TIA and TNA to provide 
insight into the determinants and course of cognitive function in the full clinical spectrum of 
short-lasting episodes of possible acute cerebral ischemia. We hypothesized that the presence 
of a DWI lesion would be associated with worse cognitive function at baseline and deterioration 
in the following 6 months. Since DWI lesions occur in both TIA and TNA patients,111 we expected 
to find similar results in these 2 patient categories.
MeThoDS
Study design and patients
This study was part of CONNECT (Cohort study ON Neuroimaging, Etiology and Cognitive 
Consequences of Transient neurological attacks), the details of which have been previously 
described.65 In short, consecutive patients aged ≥45 years were included at a specialized TIA 
clinic within 7 days after an event of neurological symptoms lasting <24 hours. Exclusion criteria 
were clinical diagnosis other than TIA or TNA, magnetic resonance imaging contraindication, prior 
stroke, preexisting dementia, Mini Mental State Examination46 score <24, intracerebral space-
occupying lesion, and other neurological diseases which could influence cognitive function (e.g. 
Parkinson’s disease, multiple sclerosis). Baseline assessments took place within 7 days after 
the qualifying event and follow-up assessments were performed 6 months later. The Medical 
Review Ethics Committee region Arnhem-Nijmegen approved the study and written informed 
consent was obtained from all participants. Study data will at request be made available to other 
researchers for purposes of reproducing the results.
518780-L-bw-van Rooij
Processed on: 30-4-2018 PDF page: 92
Chapter 6
92
Classification of qualifying event
TIA was defined as an acute onset focal loss of brain function of presumed vascular origin 
with complete symptom resolution within 24 hours.1 TNA was defined as an attack of nonfocal 
neurological symptoms with complete recovery within 24 hours, without clinical evidence 
for other diagnoses such as migraine, epilepsy, Ménière disease, hyperventilation, cardiac 
syncope, orthostatic hypotension, drug intoxication, hypoglycemia, or electrolyte imbalances.12 
Detailed descriptions of the signs and symptoms of the transient neurological events were 
obtained, including a structured interview of 18 questions concerning the presence or absence 
of specific neurological symptoms (Table 1). This information was provided to 3 specialized 
stroke neurologists who classified each event as TIA, TNA, or as a specific alternative diagnosis. 
Patients in the latter category were excluded from further analyses. Raters were blinded to results 
of ancillary investigations and a consensus meeting was held in case of disagreement. 
Table 1. Predefined focal and nonfocal neurological symptoms.
Focal Nonfocal
Hemiparesis Decreased consciousness or unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular blindness Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelings*
All symptoms should have a sudden onset, rapid clearance, and duration of <24 h.
*Considered referable to the central nervous system if the referring physician included transient ischemic 
attack in the differential diagnosis but patients were unable to specify what had been wrong.
Brain imaging
Within 7 days after the TIA or TNA, brain MRI was performed on a 1.5-T Magnetom Scanner 
(Siemens, Erlangen, Germany). The protocol included transversal T1-, T2-, and T2*-weighted, 
fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted sequences with 5 mm coupes. 
Two raters, blinded to clinical information, independently evaluated all baseline magnetic 
resonance imaging scans for the following items: lacunes of presumed vascular origin, defined 
as a hypo-intensity on T1-weighted and FLAIR images >2 mm and ≤15 mm; territorial infarcts, 
defined as hypo-intense lesions ≥15 mm on T1-weighted images, with a corresponding 
hyperintensity on FLAIR images; microbleeds, defined as small, homogeneous, round or ovoid, 
hypo-intense foci on T2*-weighted images, measuring 2-10 mm in diameter; and white matter 
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hyperintensities (WMH) of presumed vascular origin, defined as FLAIR hyperintense lesions in 
the white matter with no or only slightly hypo-intense signal on T1-weighted images.28 Finally, 
DWI was visually assessed for signs of acute infarction, defined as a hyperintense lesion on 
DWI with corresponding hypo-intensity on the apparent diffusion coefficient map. Only for DWI 
lesions with a diameter <5 mm absence of a corresponding hypo-intense signal on apparent 
diffusion coefficient was accepted, given the lower resolution of apparent diffusion coefficient 
images.66 WMH on baseline imaging were semi-quantified using the Fazekas scale.124
Neuropsychological assessment
Baseline neuropsychological assessment covering the main cognitive domains was performed 
within 7 days after the qualifying TIA or TNA. Executive function was tested with a verbal fluency 
test (naming as many animals and professions within 60 s; response generation), the interference 
score of the abbreviated Stroop Color Word Test (response inhibition),49 and the Brixton Spatial 
Anticipation Test (rule detection and shifting).50 The Symbol-Digit Modalities Test and Cards I 
and II of the abbreviated Stroop Color Word Test were used to assess information processing 
speed.51, 52 Attention was tested with the Verbal Series Attention Test53 and episodic memory 
with the 3-trial version of the Rey Auditory Verbal Learning Test, including delayed free-recall 
and recognition trials.48 Depressive symptoms were assessed with the Hospital Anxiety and 
Depression Scale.56 Neuropsychological assessment at follow-up took place after 6 months and 
consisted of identical tests, except for the verbal fluency test and Rey Auditory Verbal Learning 
Test, for which parallel versions were used to minimize material-specific learning effects.
other measurements
Level of education was recorded in accordance with the Dutch educational system (7 categories 
ranging from less than primary school to an academic degree).44 Standardized assessment 
of vascular risk factors (hypertension, dyslipidemia, diabetes mellitus, atrial fibrillation, and 
smoking status) was performed at baseline. Incident vascular events (stroke, TIA, and myocardial 
infarction) between baseline and follow-up were assessed with a standardized, structured 
questionnaire and when an event was reported verification of medical records took place.
Statistical analysis
For cognitive tests requiring both speed and precision (Verbal Series Attention Test and abbreviated 
Stroop Color Word Test) speed accuracy trade-off scores were calculated (percentage of 
correct answers/time taken to complete test).118 For purposes of longitudinal and interdomain 
comparison, results of each cognitive test were transferred into a z score derived from the 
baseline mean and SD. Next, compound cognitive domain scores were calculated by averaging z 
scores of the individual tests within that domain. Patients were grouped according to radiological 
results (DWI-positive or DWI-negative) as well as clinical diagnosis (TIA or TNA). Student’s t test, 
Pearson χ2, and Mann-Whitney U test were used to compare baseline characteristics. ANCOVA 
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and repeated measures analysis with a Bonferroni adjustment for multiple comparisons were 
performed to test for differences in domain-specific cognitive performance at baseline and over 
time by adding the clinical category (either DWI-status or clinical diagnosis) to the regression 
model. For those cognitive domains in which differences between patient groups were present, 
the relationship with prevalent silent brain infarcts, lacunes, WMH severity, and microbleeds was 
determined by adding these factors to the regression model. All analyses were adjusted for age, 
sex, and education. 
In case of missing cognitive test results the cognitive domain score was based on the remaining 
tests within that domain (2%), or if no results were available within a domain the compound score 
was labeled missing and not used in further analyses (1%). Alpha was set at 0.05 and IBM SPSS 
Statistics version 24 (IBM Corp, Armonk, NY) was used for all statistical analyses.
ReSulTS
In total, 150 patients were included in CONNECT. For the current study, patients with a diagnosis 
other than TIA or TNA were excluded, as were those with invalid baseline or follow-up cognitive 
assessments, leaving 121 patients for analysis (mean age (SD) 64.6 years (9.2 years), 39% 
women; Figure 1). 
Figure 1. Flowchart of patient inclusion.
TIA indicates transient ischemic attack; and TNA, transient neurological attack.
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Patients who were excluded were more often women (62% vs. 39%; P=0.04) but otherwise 
did not differ from those included concerning age, level of education, and prevalence of DWI 
lesions. Baseline cognitive tests and imaging were performed a mean 3.7 days (median, 3 
days; interquartile range, 0-6 days) after the qualifying event. TIA and TNA were diagnosed 
in, respectively, 73 (60%) and 48 (40%) patients. Thirty-two patients (26%) had signs of recent 
ischemia on baseline DWI, of whom 23 (72%) were clinically diagnosed as TIA (Table 2). 
Table 2. Clinical diagnosis by diffusion-weighted imaging result of included patients (n=121).
Clinical diagnosis DWI result
DWI+ DWI-
TIA 23 50
TNA 9 39
DWI indicates diffusion-weighted imaging; TIA, transient ischemic attack, and TNA, transient neurological 
attack.
Table 3. Characteristics of the study population by DWI result.
Characteristic DWI+ (n=32) DWI- (n=89) P*
Mean age, years (SD) 66.1 (8.8) 64.1 (9.3) 0.30
Women 10 (31) 37 (42) 0.41
Education, median (Q1-Q3) 5 (2-7) 5 (3-7) 0.49
Baseline HADS depressive symptoms, median (Q1-Q3)† 2 (0-6) 2 (0-6) 0.26
TIA as qualifying event 23 (72) 50 (56) 0.18
Hypertension 27 (84) 72 (81) 0.87
Dyslipidemia 21 (66) 64 (72) 0.66
Diabetes mellitus 2 (6) 9 (10) 0.77
Atrial fibrillation 2 (6) 12 (13) 0.44
Smoking‡ 15 (47) 21 (24) 0.03
Fazekas score, median (Q1-Q3) 1 (0-2) 1 (0-2) 0.11
≥1 lacune 5 (16) 12 (13) 0.99
≥1 territorial infarct 3 (9) 10 (11) 0.99
≥1 microbleed§ 1 (5) 8 (12) 0.56
Numbers are n (%) unless stated otherwise. DWI indicates diffusion-weighted imaging; HADS-D, Hospital 
Anxiety and Depression Scale depression subscore; Q1-Q3, interquartile range; and TIA, transient ischemic 
attack.
*For difference using Pearson χ2 (continuity correction), Student t test, or Mann-Whitney U test as appropriate, 
unadjusted.
†HADS was not performed in 4 of 32 DWI-positive and in 13 of 89 DWI-negative patients.
‡Currently smoking or stopped smoking <6 months before.
§T2*-weighted imaging was not performed in 10 of 32 DWI-positive patients and in 22 of 89 DWI-negative 
patients.
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In DWI-positive patients, lesion multiplicity was more frequent in TIA patients than in those 
diagnosed with TNA (26% vs. 22%; P=0.05). Clinical characteristics stratified by DWI result are 
presented in Table 3. Except for smoking, which was more prevalent in patients with a DWI 
lesion, there were no differences between DWI-positive and DWI-negative patient groups. During 
6 months follow-up no incident strokes or myocardial infarctions occurred and 6 patients had a 
TIA. Excluding patients with incident TIA from the analyses did not change the results. 
At baseline, patients with a DWI lesion performed worse in every cognitive domain compared to 
DWI-negative patients, although after adjusting for age, sex, and education only differences in 
the domain of executive function remained significant (Table 4). Additional adjustment for WMH 
severity did not change these results. Overall, test results in the cognitive domain of executive 
function decreased over 6 months, whereas the other cognitive domains improved. After 
adjusting for age, sex, and education, only decrease in executive function and improvement 
in attention remained significant (Table 5). Silent brain infarcts, lacunes, microbleeds, and 
WMH severity on baseline imaging were not associated with executive function or attention 
performance at baseline or follow-up. DWI-positive patients persistently performed worse in 
executive function over time than DWI-negative patients (repeated measures analysis adjusted 
for age, sex, and education; P=0.04), whereas there were no differences in performance over 
time in other cognitive domains. Clinical diagnosis of the qualifying event (TIA or TNA) was not 
associated with cognitive function at baseline or over time. 
Table 4. Cognitive domain compound scores <7 days after transient ischemic attack or transient 
neurological attack, stratified by DWI result.
Cognitive domain DWI+ (n=32) DWI- (n=89) P*
Executive function -0.26 (-0.51 to -0.01) 0.08 (-0.07 to 0.23) 0.048
Attention -0.23 (-0.53 to 0.08) 0.08 (-0.14 to 0.30) 0.23
Info processing speed -0.08 (-0.33 to 0.19) 0.01 (-0.19 to 0.21) 0.80
Episodic memory -0.02 (-0.22 to 0.19) 0.01 (-0.14 to 0.17) 0.69
Data are mean (95% CI). Cognitive domain compound scores represent the mean of individual test z-scores 
within a cognitive domain. DWI indicates diffusion-weighted imaging.
*For difference in cognitive function at baseline using analysis of covariance, adjusted for age, sex, and 
education.
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Table 5. Mean change in cognitive domain compound scores 6 months after transient ischemic attack or 
transient neurological attack, specified by DWI result.
Cognitive domain All patients P* DWI+ (n=32) DWI- (n=89)
Executive function -0.23 (-0.33 to -0.13) 0.01 -0.20 (-0.39 to -0.02) -0.23 (-0.35 to -0.10)
Attention 0.11 (0.02 to 0.20) 0.02 0.21 (0.02 to 0.40) 0.07 (-0.03 to 0.18)
Info processing speed 0.15 (0.02 to 0.28) 0.08 0.07 (-0.12 to 0.27) 0.16 (0.08 to 0.24)
Episodic memory 0.27 (0.17 to 0.38) 0.20 0.35 (0.16 to 0.55) 0.24 (0.11 to 0.37)
Data are mean (95% CI). Cognitive domain compound scores represent the mean of individual test z scores 
(based on the mean and SD of baseline test results) within a cognitive domain. DWI indicates diffusion-
weighted imaging.
*For change in cognitive function between baseline and follow-up using repeated measures analysis, 
adjusted for age, sex, and education.
DISCuSSIoN
In this prospective study, we found a decline in executive function in the first 6 months after TIA or 
TNA, whereas cognitive function in other domains remained stable or improved slightly. Decline 
in executive function was independent of the presence or severity of silent brain infarcts, lacunes, 
microbleeds, and WMH. Patients with signs of recent ischemia on brain DWI at baseline showed 
persistently worse executive function compared to patients without a DWI lesion, while initial 
clinical diagnosis (TIA or TNA) was not associated with cognitive function afterwards.
When interpreting our results some methodological considerations need to be addressed. First, 
we studied cognitive function over time, not cognitive impairment as a clinical entity. To establish 
whether group differences reflect clinically relevant effects, a functional measure should be 
assessed and ideally a stroke-free control group included. Clearly, our findings show that cognitive 
function after a TIA or TNA is not static but a dynamic process in which both improvement and 
decline can occur. Dynamic change in cognitive function after TIA has been subject of a previous 
study in which improvement was found in >30% of TIA patients within the first month after the 
event, determined by repeated Mini-Mental State Examination assessments.41 We found only 
minor cognitive improvements solely on the attention domain. However, since we performed 
follow-up 6 months after TIA or TNA, any initial improvement may have been concealed by an 
overall cognitive decline. Perhaps the low test-retest reliability and possible learning effects of 
Mini-Mental State Examination resulted in an overestimation of cognitive improvement in the 
previous study.125 Secondly, our follow-up duration of 6 months is relatively short for monitoring 
cognitive changes. This may partly explain the lack of significant changes in half of the cognitive 
domains, but also makes the observed decline in executive function remarkable. Next, 21 patients 
(15% of initially included participants) were lost to follow-up, possibly introducing selective 
follow-up.126 Since these patients did not differ from included participants with respect to age, 
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education, or DWI lesion presence we infer that possible selection has not greatly influenced our 
results. Selective follow-up may however explain the absence of incident stroke and myocardial 
infarction, as well as the relatively low incidence of TIA between baseline and follow-up (5%).8 In 
turn, this may also be a reflection of the relatively young and healthy patient sample in our study, 
since we excluded patients with previous stroke. This may have resulted in an underestimation 
of cognitive consequences of TIA and TNA in the group of patients as a whole.102 Therefore, our 
findings are not directly generalizable to the wider group of TIA and TNA patients, and must be 
replicated in larger and demographically different samples. 
A strength and novelty of our study is the inclusion of both TIA and TNA patients who were 
referred to a specialized outpatient TIA clinic. The clinical diagnosis of TIA is notoriously difficult 
and the correlation with evidence of cerebral ischemia is far from perfect.64, 111 The term TNA 
is nonspecific and by no means a distinct pathological entity. It is a concept used to describe 
those patients that very often are not diagnosed as having had a TIA, based solely on clinical 
symptoms. Including both TIA and TNA patients provides a more accurate reflection of the 
normal referral population than by selecting only on the basis of a clinical TIA diagnosis.64 We 
deliberately separated the clinical from the radiological diagnosis. This was done to determine 
any differences in cognitive outcome between TIA and TNA, without interference from radiological 
findings. Although this may deviate from the usual integrated diagnostic workup, many patients 
whose symptoms are vague and nonfocal are never referred for analysis of possible TIA, and 
others are radiologically screened with computed tomography. Both categories of patients may 
never be diagnosed as having had cerebral ischemia. By separating clinical and radiological 
results, we have shown that a distinction based solely on an interpretation of clinical symptoms 
does not adequately identify those patients at risk of lower cognitive functioning. Rather, we 
found that signs of recent ischemia on DWI do differentiate with regard to cognitive status. 
As such, the tissue-based definition of TIA more accurately predicts cognitive status than the 
classical definition of TIA, at least when DWI is performed.1, 13
Furthermore, we conducted a comprehensive and sensitive neuropsychological test battery 
composed of tests with which local experience was high, covering the major cognitive domains 
determined in international standards.103 We were therefore able to draw conclusions on domain-
specific cognitive function. Patients with signs of recent infarction on DWI had significantly worse 
executive function than those without a DWI lesion, persisting throughout the study period. 
Nonamnestic cognitive decline is often seen in vascular cognitive impairment, a profile that 
has been found in cross-sectional studies with TIA patients before.109, 123 Possibly, the acute 
ischemic lesion caused disruption of networks involved in cognitive processing, leading to 
reduced executive function.110 Perhaps worse executive function was already present in DWI-
positive patients before the qualifying event, driven by a potentially higher vascular lesion load. 
In contrast to DWI-positive patients who by definition suffered a cerebrovascular event, the DWI-
negative group possibly included patients with a non-cerebrovascular cause of their transient 
symptoms. However, there were no differences between the DWI-positive and negative groups 
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considering several other imaging markers for cerebrovascular disease. From an etiologic 
point of view, changes in cognitive performance within 6 months are less likely to result from 
widespread increase of macrostructural cerebrovascular damage, as this generally changes 
at a lower pace.127 Another notable finding is the improvement of performance in the cognitive 
domain of attention found in all patients, independent of DWI status. This may be related to 
the timing of cognitive testing, as the baseline measurements took place during the process 
of clinical investigations of a possible TIA, which may introduce stress and therefore reduced 
attention. However, no comparable effects were seen in other cognitive domains. As the domain 
of attention was determined by a single test, results may be less stable and learning effects more 
relevant than for other domains, which were determined by multiple test results. Interestingly, 
however, there is prior evidence for specific improvement of attention after TIA.41
The presence of a DWI lesion in TIA patients is associated with a considerably higher risk of 
subsequent stroke.24 Although the determinants of DWI-positivity in clinically defined TIA patients 
are not yet completely understood, this difference in prognosis is one reason for the American 
Heart Association to consider DWI-positive TIAs to be infarcts.4, 13 Our finding of persisting worse 
executive function in DWI-positive compared to DWI-negative TIA and TNA patients provides 
evidence for cognitive differences in addition to the established vascular prognostic differences.
In conclusion, cognitive function in TIA and TNA patients is a dynamic process in which especially 
executive function declines in the first 6 months after the initial event. Signs of recent ischemia 
on DWI, but not other radiological markers of cerebrovascular damage, are associated with 
persistently worse executive function after TIA and TNA. Our results suggest that the commonly 
used, classical definition of TIA may not suffice in detecting those patients at risk of cognitive 
impairment, as imaging results are not incorporated.1 Further studies, preferably including larger 
patient numbers, employing a longer follow-up duration, and measuring functional outcomes 
are needed to provide more insight into cognitive function after TIA and TNA and its relationship 
with DWI lesion presence.
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ABSTRACT
Introduction
Subjective cognitive impairment, depressive symptoms, and fatigue are common after stroke 
and are associated with reduced quality of life. We prospectively investigated their prevalence 
and course after a transient ischemic attack (TIA) or non-focal transient neurological attack (TNA) 
and the association with diffusion-weighted imaging (DWI) lesions.
Methods
The Cognitive Failures Questionnaire, Hospital Anxiety and Depression Scale, and Subjective 
Fatigue subscale from the Checklist Individual Strength were used to assess subjective 
complaints shortly after TIA or TNA and six months later. With repeated measure analysis the 
associations between DWI lesion presence or clinical diagnosis (TIA or TNA) and subjective 
complaints over time was determined.
Results
We included 103 patients (28 DWI-positive). At baseline, subjective cognitive impairment and 
fatigue were less severe in DWI-positive than in DWI-negative patients, whereas at follow-up there 
were no differences. Subjective cognitive impairment (p=0.02) and fatigue (p=0.01) increased 
in severity only in DWI-positive patients. There were no differences between TIA and TNA.
Conclusions
Subjective complaints are highly prevalent in TIA and TNA patients. The short-term prognosis 
is not different between DWI-positive and DWI-negative patients, but subjective cognitive 
impairment and fatigue increase in severity within six months after the event when an initial DWI 
lesion is present.
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INTRoDuCTIoN
Subjective cognitive impairment (SCI), depressive symptoms, and fatigue are highly prevalent 
after stroke and are related to stroke severity.128-131 Although by definition the symptoms of a 
transient ischemic attack (TIA) subside completely within 24 hours,1 subjective cognitive 
complaints, depressive symptoms, and fatigue often persist in these patients as well.16, 113, 132
Diagnosing TIA is notoriously difficult.64 Patients often report attacks of atypical or nonfocal 
neurological symptoms. In the absence of an alternative diagnosis, these episodes are referred 
to as transient neurological attack (TNA).12 In one third of TIA patients diffusion-weighted imaging 
(DWI) shows signs of acute ischemia beyond the point of symptom resolution, ascertaining a 
cerebrovascular etiology of the attack.4 Acute DWI lesions are however also present in more than 
20% of clinically diagnosed TNA patients.111
Previous studies on subjective complaints after short lasting attacks of neurological symptoms 
have focused solely on TIA, did not take DWI findings into account, and were cross-sectional 
in nature.16, 113, 132 Since subjective complaints are associated with a reduced quality of life and 
are possible harbingers of forthcoming cognitive decline, it is important to understand their 
prevalence and determinants.133, 134
We prospectively investigated the prevalence, severity, and course of SCI, depressive symptoms, 
anxiety, and fatigue in a cohort of TIA and TNA patients, and determined the relation with event 
type and DWI results. We hypothesized that patients with acute DWI lesions would report an 
increase in severity of complaints in the months after the initial event. Since TIA and TNA have 
a comparable prevalence of DWI positivity, we expected to find no differences between these 
patient categories.111
MeThoDS
Study design and patients
This study was part of the prospective Cohort study ON Neuroimaging, Etiology, and Cognitive 
consequences of Transient neurological attacks (CONNECT), the details of which have been 
previously reported.65 Consecutive stroke-free patients aged ≥45 years referred to a specialized 
outpatient TIA clinic within 7 days after an event of acute onset neurological symptoms lasting 
<24 hours were included. Baseline measurements took place within seven days after the 
qualifying event and follow-up was performed six months later. All baseline assessments were 
performed before the final diagnosis was discussed with the patient. The Medical Review Ethics 
Committee region Arnhem-Nijmegen approved the study and written informed consent was 
obtained from all participants.
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Classification of qualifying event
Based on a detailed description of the signs and symptoms of the event including a structured 
assessment of the presence or absence of eighteen specific predefined symptoms (Table 1), 
three specialized stroke neurologists adjudicated each event as TIA, TNA, or a specified other 
diagnosis, using previously determined definitions of TIA and TNA.1, 12 Events with both focal and 
nonfocal symptoms were classified as TIA. Qualifying neurologists were blinded to results from 
MRI and in case of disagreement a consensus meeting was held.
Table 1. Predefined focal and nonfocal neurological symptoms.
Focal Nonfocal
Hemiparesis Decreased consciousness or unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular blindness Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelings*
Symptoms should have sudden onset, rapid clearance, and duration of <24 hours.
*Referable to the nervous system if the referring physician considered TIA but patients were unable to specify 
further.
Brain imaging
Brain MRI was performed within seven days after the qualifying event on a 1.5 Tesla Magnetom 
Scanner (Siemens, Erlangen, Germany), and included DWI, FLAIR, T1-, T2-, and T2*-
weighted sequences. Two experienced raters individually evaluated the severity of white matter 
hyperintensities, the presence of (silent) territorial infarcts, lacunes, and microbleeds.28, 124 DWI 
was visually assessed for signs of acute infarction. Raters were unaware of clinical information 
and a consensus meeting was held in case of disagreement.
Subjective cognitive impairment
At baseline and follow-up, the presence and severity of SCI in the previous month was assessed 
with a 15-item semi-structured interview based on the Cognitive Failures Questionnaire (CFQ).54 
Items concerning remembering, word finding, planning, concentration, and slowness of thought 
were given a wider score range (0-3) than other items (0-1). SCI was considered present if 
≥1 moderate problem (score ≥2) on an item with a score range of 0 to 3, or a score of 1 on a 
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dichotomous item was reported.59 Trained examiners, unaware of clinical diagnosis and DWI 
status, administered all semi-structured interviews.
other measurements
At both baseline and follow-up, the Hospital Anxiety and Depression Scale (HADS) was 
administered to measure the severity of symptoms of depression and anxiety.56 Relevant 
symptoms of depression or anxiety were defined as a value of >7 on the subscales.119 Fatigue 
was assessed with the subscale Subjective Fatigue of the Checklist Individual Strength (CIS20R-
fatigue) with a score >35 considered indicative for severe fatigue.57 Level of education was 
classified using seven categories (1=less than primary school; 7=academic degree).44 Vascular 
risk factors were assessed at baseline. Incident vascular events (stroke, TIA, myocardial 
infarction) between baseline and follow-up were assessed with a standardized, structured 
questionnaire. All questionnaires were handed out at the baseline or follow-up visit. In case of 
limited time, these were filled in at home and returned within one week.
Statistical analysis
Only patients who completed follow-up were included. Baseline characteristics were compared 
between patients with complete and incomplete follow-up, TIA and TNA patients, and patients 
with and without DWI lesion, using Student’s t test, χ2 test, or Mann-Whitney U test as appropriate.
Differences in prevalence of SCI, symptoms of depression, or anxiety, and severe fatigue between 
groups (clinical diagnosis and DWI-status) and time points were analyzed with McNemar’s test. 
Subsequently, the effect of DWI lesion and clinical diagnosis on change in subjective outcomes 
over time was determined with repeated measures analyses of variance. Associations between 
SCI, fatigue, depressive and anxiety symptoms were assessed with multivariate regression 
analysis.
Age, sex, and level of education were regarded as potential confounders and adjusted for in all 
repeated measures analyses. Alpha was set at 0.05 and statistical analyses were performed with 
IBM SPSS Statistics version 24.0 (IBM Corp, Armonk, NY).
ReSulTS
CONNECT included 150 patients, 87 of whom were diagnosed as TIA, 56 as TNA, and 7 with a 
specific other diagnosis. Patients in the last category were excluded from further analyses, as 
were those with incomplete baseline or follow-up assessments, leading to 103 included patients 
(Figure 1). Reasons for incomplete assessment were failure to return questionnaires (>95%) 
and refusal (<5%). Patients with incomplete HADS or CIS20R-fatigue were slightly younger 
(mean 61.8 [SD 10.7] years versus 65.8 [SD 9.1] years, p=0.04) than those with complete 
evaluations. There were no differences concerning clinical diagnosis, DWI lesion presence, level 
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of education, or presence of vascular risk factors between patients with complete and incomplete 
assessments. Baseline characteristics of participants with complete assessments are presented 
by DWI results in Table 2. DWI lesions were more often present in clinically defined TIA patients, 
although 13% of included TNA patients also had a DWI lesion. Most DWI lesions were small 
cortical or subcortical lesions. There were no incident strokes or myocardial infarctions between 
baseline and follow-up and five patients had an incident TIA. Excluding patients with incident TIA 
from the analyses did not change the results. 
Table 2. Baseline patient characteristics stratified by DWI result (n=103).
DWI+
(n=28)
DWI-
(n=75)
p*
Women 8 (29) 29 (39) 0.34
Age, mean (SD) 66.7 (8.5) 65.6 (9.3) 0.60
Level of education, median (IQR) 5 (3) 5 (2) 0.10
TIA 23 (82) 42 (56) 0.01
Hypertension 25 (89) 60 (80) 0.27
Dyslipidemia 18 (64) 53 (71) 0.53
Diabetes mellitus 2 (7) 7 (9) 0.73
Atrial fibrillation 3 (11) 10 (13) 0.72
Smoking 13 (46) 17 (23) 0.02
Diffusion-weighted imaging lesions, total n 45 N/A N/A
Lesion type
Small cortical 26 (58)
Small subcortical 14 (31)
Territorial 5 (11)
Fazekas score, median (IQR) 1 (1) 1 (1) 0.30
Lacunes 5 (18) 12 (16) 0.82
Territorial infarcts 2 (7) 8 (11) 0.59
Microbleeds (available for 72 patients) 1 (6) 6 (11) 0.49
Values are n (%) unless stated otherwise.
*For difference using Student’s t test, χ2 test, or Mann-Whitney U test as appropriate.
DWI, diffusion-weighted imaging; IQR, interquartile range; N/A, not applicable.
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Figure 1. Study population.
CFQ, Cognitive Failures Questionnaire; CIS20R-fatigue, Checklist Individual Strength, fatigue subscale; DWI, 
diffusion-weighted imaging; HADS, Hospital Anxiety and Depression Scale; TNA, transient neurological 
attack.
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Subjective cognitive impairment (n = 87)
The overall prevalence of SCI in TIA and TNA patients was 82% at baseline and 77% at follow-
up and was not significantly different between time points, DWI status, or clinical diagnosis. At 
baseline the mean number of subjective cognitive failures was lower in patients with a DWI lesion 
than in those without (mean (SD) 1.83 (1.75) versus 3.77 (3.27), p=0.01), while at follow-up 
this increased to 3.00 (2.70) in the first group and decreased slightly to 3.14 (3.17) in the latter 
(p=0.73) (Figure 2, panel a). Repeated measures analysis (adjusted for age, sex, and level of 
education) showed that change over time in the number of subjective cognitive failures was 
significantly different between DWI positive and DWI negative patients (p=0.01). There was no 
difference in SCI between TIA and TNA patients.
Depressive symptoms and anxiety (n = 103)
Relevant depressive symptoms (HADS-depression subscore >7) were present in 8% of all 
patients at baseline and 9% at follow-up. The prevalence of relevant anxiety symptoms (HADS-
anxiety subscore >7) was 15% at baseline and 11% at follow-up. Depressive and anxiety 
symptoms did not differ between DWI negative and DWI positive patients or between TIA and 
TNA patient groups (Figure 2, panels b and c).
Fatigue (n = 101)
Severe fatigue (CIS20R-fatigue score >35) was present in 23% of patients at baseline and in 
19% six months later. Prevalence of severe fatigue did not differ between DWI positive and DWI 
negative patients, or between TIA and TNA patients.
Mean (SD) CIS20R-fatigue score was 25.0 (12.7) at baseline and 24.8 (11.5) at follow-up. 
Baseline scores were lower in DWI-positive patients (21.0 (12.7) compared to 26.6 (12.4) for 
those without; p=0.07), but equal at follow-up (24.9 (11.6) in the DWI positive group versus 24.7 
(11.6) in the DWI negative group; p=0.86). Patients with and without DWI lesions differed with 
respect to change in CIS20R-fatigue scores (p=0.01) (Figure 2, panel d). The clinical diagnosis 
was unrelated to severity or change over time of fatigue.
At both baseline and follow-up, SCI was associated with higher CIS20R-fatigue scores (p=0.001), 
but not with symptoms of depression or anxiety. 
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Figure 2. Subjective cognitive impairment, depressive symptoms, anxiety symptoms, and fatigue at 
baseline and follow-up in transient neurological attack patients with and without diffusion-weighted imaging 
lesions.
CFQ, Cognitive Failures Questionnaire; CIS20R-fatigue, Checklist Individual Strength, fatigue subscale; DWI, 
diffusion-weighted imaging; HADS-a, Hospital Anxiety and Depression Scale, anxiety; HADS-d, Hospital 
Anxiety and Depression Scale, depression.
*p=0.02, analysis of covariance, adjusted for age, sex, and level of education.
†p=0.02, ‡p=0.01, repeated measures analysis for difference in change over time between DWI-negative 
and DWI-positive patients, adjusted for age, sex, and level of education.
DISCuSSIoN
Subjective complaints, especially SCI and fatigue, are highly prevalent in TIA and TNA patients 
both directly before the event and after six months. The initial qualifying diagnosis was unrelated 
to the presence, severity, and course of subjective complaints. Patients with signs of acute 
ischemia on DWI reported less severe SCI and fatigue in the month before the TIA or TNA than 
those without such a lesion. In this group of patients, severity subsequently increased in the six 
months after the event to a level equal to that of DWI-negative patients.
Some methodological issues need to be considered when interpreting these results. First, due to 
loss to follow-up, selection bias might have occurred. Patients with missing follow-up HADS and 
CIS20R-fatigue assessments were on average slightly younger than participants. Since especially 
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fatigue is more often reported in older patients, this might have resulted in an overestimation of 
its prevalence.135 Alternatively, patients with incomplete assessments might have dropped out 
because of complaints, resulting in an underestimation. Other demographic variables however 
did not differ between patients with and without complete assessments and we adjusted for 
age in our analyses. Therefore, we feel that selection bias has not largely influenced our results. 
The relatively small patient numbers in our study however limits statistical power, and our results 
need to be replicated in a larger cohort. Secondly, we used questionnaires to obtain information 
on the presence of SCI, depression, anxiety and fatigue. These screening instruments, although 
validated, indicate whether patients experience dysfunction when actively asked about it. This 
differs from spontaneously reported complaints and may explain the high frequency of SCI 
observed in our cohort. The CFQ handles a strict cut-off for SCI, making it a sensitive but perhaps 
not very specific screening instrument. Thirdly, our study did not include a control group, limiting 
the interpretation of an added effect of TIA or TNA on subjective complaints.
The prevalence of SCI in our study is comparable to that in both stroke patients and those with 
evidence of small vessel disease on neuroimaging, using the same screening instrument.59, 122, 129 
Patients in those studies were on average older, had more often suffered stroke instead of TIA, 
and were tested several years after the initial event. Also, vascular lesions on neuroimaging were 
relatively sparse in our cohort, as compared to these studies.59, 122 The high prevalence of SCI in 
TIA and TNA patients is therefore remarkable. Severe fatigue was less prevalent in our patients 
than in other stroke cohorts, as were depressive symptoms.131, 136, 137
Interestingly, DWI-positive patients reported less subjective cognitive failures and fatigue in 
the month before the event than those without a lesion. The DWI-positive group by definition 
consisted of patients with a recent cerebrovascular event, independent of the clinical diagnosis. 
The DWI-negative group possibly included some patients whose transient complaints have non-
cerebrovascular causes such as somatization, depression, or anxiety. Although this may explain 
the higher prevalence of premorbid SCI and fatigue, the lack of observed higher frequencies of 
depressive or anxiety symptoms does not support this hypothesis. Furthermore, we found no 
changes in subjective complaints in the DWI-negative group, although one could expect these 
to increase after a disturbing event such as a TIA or TNA. 
Within six months after TIA or TNA, severity of SCI and fatigue increased significantly in DWI-
positive patients. These findings can be explained in several ways. First, DWI hyperintensities are 
associated with permanent brain damage, which in turn is associated with cognitive decline, SCI, 
mood disorders, and fatigue in stroke patients.18, 128, 130, 131, 138 Although the exact etiology remains 
to be established, a relationship between minor cognitive decline and recent lacunar infarct 
has been suggested.139 Since the DWI lesions in our cohort were predominantly small cortical 
and subcortical lesions, a similar relationship may exist between these lesions and increasing 
subjective complaints over time. Second, the knowledge of having a DWI lesion could have 
influenced the perception of cognitive performance and have lead to more subjective cognitive 
complaints. Thirdly, secondary preventive medications including statins will more often have 
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been started in the DWI-positive patient group. Statins have been associated with cognitive 
complaints and fatigue. However, there are no consistent negative effects of statins on these 
outcome measures.140 Finally, the increase in severity of SCI and fatigue observed in the DWI-
positive patient group could be merely a correction of an unexplained baseline difference, i.e. 
regression towards the mean. However, no changes in prevalence or severity of these complaints 
were found in the DWI-negative group, countering this explanation.
Fatigue was associated with subjective cognitive function. Possibly both fatigue and SCI, as 
measured in our study, are expressions of the same underlying sense of unwell being. We found 
no association between depressive symptoms and subjective cognitive function, suggesting 
that the increased severity of SCI observed in DWI-positive patients was not influenced by mood 
changes.
CoNCluSIoNS
Subjective complaints are highly prevalent in TIA and TNA patients. Larger sampled studies with 
longer follow-up need to determine whether subjective complaints last beyond six months after 
TIA or TNA, assess the course over time with respect to DWI lesion presence, and the association 
with cognitive performance. Furthermore, the etiology of subjective cognitive impairment and 
fatigue after short-lasting cerebral ischemia, and the association with radiological markers of 
cerebrovascular damage such as lacunes and cerebral atrophy should be subject to further 
research. Our results nevertheless add to the growing notion that TIA and TNA are more than 
just transient attacks but are associated with ongoing deficits and problems. This can be used 
to inform patients on the potential long-term prognosis of their TIA or TNA. 
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ABSTRACT
Introduction
Diffusion-weighted imaging (DWI) shows signs of recent ischemia beyond symptom resolution 
in 20-30% of patients with a transient ischemic attack (TIA) or transient attack with non-focal 
symptoms (transient neurological attack; TNA). DWI-positivity has an unfavorable prognosis 
regarding recurrent stroke. TIA and TNA are associated with cognitive decline unexplained by 
conventional neuroimaging. We therefore investigated white matter integrity with diffusion tensor 
imaging (DTI) after TIA or TNA in relation to DWI-positivity.
Methods
We performed DTI in 56 TIA and 34 TNA patients six months after the qualifying event. Fractional 
anisotropy (FA) and axial, radial (RD), and mean diffusivity of the white matter were determined. 
Differences in DTI metrics between TIA and TNA patients, as well as DWI-positive and DWI-
negative patients, were evaluated using tract-based spatial statistics (TBSS).
Results
DWI-positive TIA and TNA patients had lower FA and higher RD than DWI-negative patients, 
especially in the frontoparietal white matter and to a lesser extent the corpus callosum, after 
adjusting for concurrent vascular brain damage. There were no differences between TIA and 
TNA patients.
Discussion
In TIA and TNA patients, signs of recent ischemia on initial DWI were marginally associated 
with lower white matter integrity at least six months later. This association was independent of 
macrostructural cerebrovascular damage.
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INTRoDuCTIoN
A transient ischemic attack (TIA) results from temporary focal brain ischemia leading to 
neurological deficits that by definition resolve within 24 hours.1 Contrary to this definition, many 
patients report persistent cognitive problems, fatigue, and mood disorders beyond the point of 
focal symptom resolution.16, 113, 132 However, the causes of these ongoing symptoms are unclear, 
as markers of cerebrovascular damage on conventional neuroimaging are not, or only weakly 
related to the presence of cognitive impairment and subjective complaints after TIA.42
The diagnosis of TIA is notoriously difficult, as signs and symptoms have often resolved before 
medical attention is sought.64 Frequently patients are encountered after an episode of nonfocal 
or atypical neurological symptoms that do not match with the clinical definition of TIA. In the 
absence of an alternative diagnosis, this is referred to as a transient neurological attack (TNA).5 
TNAs are associated with an increased risk of cardiovascular events and dementia.12
In about one third of TIA patients diffusion-weighted imaging (DWI) performed within days after 
the event shows signs of acute infarction.4 TIA patients with a DWI lesion have a higher risk of 
subsequent stroke than those with normal DWI.24 Because of their prognostic differences DWI-
positive and DWI-negative TIAs are increasingly recognized as separate entities, although both 
are considered to be the consequence of focal brain ischemia.25 Interestingly, although their 
etiology is unknown, more than 20% of TNA patients have signs of recent ischemia on DWI.111
Loss of white matter microstructural integrity is considered an early sign of cerebral small vessel 
disease (SVD) and is not visible on conventional MRI sequences. Diffusion tensor imaging 
(DTI) is a MRI technique that measures local molecular diffusion of water to provide quantitative 
information about the structural integrity of the white matter.32, 35 Previous studies have found an 
association between lower fractional anisotropy (FA) and higher mean diffusivity (MD), indicative 
for lower microstructural integrity of the white matter, and cognitive impairment in the general 
elderly population and in patients with SVD.39, 141 Only one small sampled study previously 
assessed microstructural integrity after TIA, and was restricted to patients with ipsilateral 
carotid artery disease.142 White matter integrity has never been studied in TNA patients and the 
relationship with DWI-positivity has not been previously investigated.
We aimed to determine white matter microstructural integrity in a cohort of TIA and TNA patients, 
and investigate the association with DWI lesion presence. We included TIA and TNA as both are 
associated with cognitive impairment and DWI lesions are almost equally frequent in both patient 
categories. We hypothesized that DWI-positivity would be associated with lower microstructural 
integrity in both TIA and TNA patients.
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MATeRIAlS AND MeThoDS
Study population
This study was embedded within the prospective Cohort study on Neuroimaging, Etiology, and 
Cognitive Consequences of Transient Neurological Attacks (CONNECT), which was designed 
to investigate the possible cognitive and neuropsychological sequelae of TIA and TNA, as well 
as to unravel the diagnostic uncertainty associated with TIA and TNA by means of conventional 
and advanced MRI. The study protocol has been described in detail.65 In short, consecutive 
patients ≥45 years that were referred to a specialized TIA clinic within seven days after an 
event of acute neurological symptoms that lasted less than 24 hours were included. Exclusion 
criteria were prior stroke, inability to undergo MRI, a clinical diagnosis other than TIA or TNA, 
intracerebral space-occupying lesion, Mini-Mental State Examination46 score <24, and prior 
neurological disease interfering with cognitive function (e.g. Parkinson’s disease, multiple 
sclerosis, dementia). All patients were seen within seven days of the qualifying event, at which 
point all baseline assessments took place. After at least six months, patients returned for follow-
up measurements. The Medical Review Ethics Commission Region Arnhem-Nijmegen approved 
the study and written informed consent was obtained from all participants.
Three experienced stroke neurologists classified each qualifying event as TIA, TNA, or a 
specified alternative diagnosis (e.g. migraine aura, peripheral vestibulopathy, epilepsy) based 
on a narrative of the events as provided by the patient or a witness and a structured assessment 
of the presence or absence of 18 predefined focal and nonfocal neurological symptoms (Table 
1). TIA was defined as a sudden loss of focal brain function of presumed vascular origin and 
complete resolution of symptoms within 24 hours.1 TNA was defined as an event of acute onset 
nonfocal neurological symptoms with complete recovery within 24 hours, without evidence 
for an alternative diagnosis such as migraine, epilepsy, Ménière disease, benign paroxysmal 
positional vertigo, hyperventilation, cardiac syncope, orthostatic hypotension, drug intoxication, 
hypoglycemia, or electrolyte imbalances.12 Classifying neurologists were blinded to MRI results 
and in case of disagreement, a consensus meeting was held. Events with both focal and 
nonfocal symptoms were classified as TIA. Only patients with a TIA or TNA as qualifying event 
were eligible for the current study. 
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Table 1. Predefined focal and nonfocal neurological symptoms.
Focal Nonfocal
Hemiparesis Decreased consciousness or unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular blindness Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelings*
All symptoms should have a sudden onset, rapid clearance, and duration of <24 hours.
*Considered referable to the nervous system if the referring physician included transient ischemic attack in 
the differential diagnosis but patients were unable to specify what had been wrong. 
MRI protocol
Baseline and follow-up MRI scans of all participants were acquired on a 1.5 Tesla scanner 
(Magnetom, Siemens, Erlangen, Germany). Baseline scanning included a single-shot echo planar 
diffusion-weighted sequence: time repetition/time echo 6300/134 ms, echo planar imaging factor 
192, voxel size 1.2 x 1.2 x 5.0 mm, with diffusion weighting applied in three directions and b-value 
of 1000 s/mm2. The follow-up protocol included a 3D T1-weighted magnetization-prepared rapid 
gradient-echo sequence: time repetition/time echo/time interval 2730/2.95/1000 ms, flip angle 
7°, voxel size 1.0 x 1.0 x 1.0 mm; a transversal FLAIR pulse sequence: time repetition/time echo/
time interval 12220/85/2200 ms, voxel size 1.2 x 1.0 x 3.0 mm, plus an interslice gap of 0.6 mm; a 
transversal T2*-weighted gradient echo sequence: time repetition/time echo 727/19.1 ms, voxel 
size 1.0 x 0.7 x 5.0 mm; and a DTI sequence: time repetition/time echo 9100/98 ms, voxel size 
2.2 x 2.2 x 2.2 mm, seven unweighted scans, 61 diffusion-weighted scans, with non co-linear 
orientation of the diffusion weighting gradient and b-value of 1000 s/mm2. Due to limited time, 
not all patients underwent DTI and T2*-weighted imaging at follow-up. No selection criteria were 
applied.
Conventional MRI analysis
Two experienced raters, blinded for any clinical information, evaluated all MRI scans. In case of 
disagreement a consensus meeting was held. Baseline DWI was evaluated for the presence 
of signs of acute infarction, defined as a hyperintense lesion on DWI with a corresponding 
hypointensity on the apparent diffusion coefficient map. Each DWI lesion was classified as 
small cortical, small subcortical, or territorial and the vascular territory involved was recorded 
(left anterior, right anterior, or posterior circulation). White matter hyperintensities (WMH) 
were defined as white matter signal hyperintensities on FLAIR images, with no or only minor 
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corresponding hypointensities on T1-weighted images, excluding gliosis surrounding infarcts.28 
WMH were segmented on the FLAIR images and total WMH volume was determined by an 
in-house developed, semi-automatic technique.143 Lacunes of presumed vascular origin were 
rated as a hypo-intense lesion on T1-weighted and FLAIR images with a diameter >2 mm and 
≤15 mm, ruling out enlarged perivascular spaces and infraputaminal pseudolacunes.28 Territorial 
infarcts were defined as hypo-intense lesions >15 mm in diameter with low signal intensity on 
T1-weighted images and a corresponding hyperintensity on FLAIR. Microbleeds were assessed 
on T2*-images and defined as small (2-10 mm), homogeneous, round or ovoid, hypo-intense 
lesions. Probability maps for grey matter, white matter, and cerebrospinal fluid were computed 
using a six-class segmentation tool in Statistical Parametric Mapping 8 (http://fil.ion.ucl.ac.uk/
spm) on the T1 images. Total grey and white matter volumes were determined by summing all 
voxel volumes belonging to that tissue class. Total brain volume (TBV) was calculated as the 
sum of total grey and total white matter volume and normalized by dividing the TBV by the total 
intracranial volume to account for the head size.
DTI analysis
The diffusion tensor has three eigenvalues. The first is termed axial diffusivity (AD) and typically 
represents the diffusivity parallel to the white matter tracts. Radial diffusivity (RD) is composed 
of the average of the second and third eigenvalues and represents the diffusivity perpendicular 
to the white matter tracts. These eigenvalues can be used to calculate two complementary DTI 
metrics: mean diffusivity (MD) and fractional anisotropy (FA). MD is the average value of the 
three eigenvalues and therefore measures the overall magnitude of water diffusion, whereas 
FA is a normalized ratio of diffusion directionality.36 Loss of microstructural integrity is typically 
characterized by a reduction in FA and/or an increase in MD, resulting from different combinations 
of changes in AD and RD.37
First, denoising of the raw diffusion data was performed according to the local Principal 
Components Analysis method.144 Next, an in-house developed algorithm for patching artifacts 
from cardiac and head motion was applied.61 Misalignments from eddy currents were corrected 
and unwarping (non-linear registration) was performed only in the phase-encoding direction. 
AD, RD, FA and MD images were constructed using DTIFit within the Functional MRI of the 
Brain diffusion toolbox, which were then fed into the TBSS pipeline.145 By thinning the mean FA 
image based on the FA values, a skeleton representing the core structure of the white matter 
was created. A threshold of 0.3 was applied to this skeleton in order to include the major white 
matter tracts and to account for inter-subject variability. Subsequently, all normalized FA data 
were projected onto the skeleton, after which these projection factors were applied to the AD, 
RD, and MD images. Finally, these data were fed into voxel-wise cross-subject statistics.
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other measurements
Age, sex, and time from event to DTI were recorded. Vascular risk factors were assessed at 
baseline with standardized, structured questionnaires, together with the mean of three consecutive 
blood pressure measurements as well as ECG results. Risk factors included hypertension (mean 
systolic blood pressure ≥135/85 mmHg and/or use of antihypertensive medication), dyslipidemia 
(treatment with lipid-lowering medication), diabetes mellitus (treatment with antidiabetic drugs), 
and atrial fibrillation (detected on ECG and/or previously confirmed by a specialist). Incident 
stroke or TIA between baseline and follow-up was recorded.
Statistical analysis
Differences in clinical characteristics between DWI-positive and DWI-negative patients, as well 
as between TIA and TNA patients, were compared using Student’s t test, χ2 test, or Mann-Whitney 
U test as appropriate.
Mean FA and MD of the TBSS skeleton were calculated and the associations with DWI-positivity 
and clinical diagnosis (TIA or TNA) were determined using linear regression analysis adjusted 
for age, sex, time from qualifying event to DTI, and normalized TBV. Next, a voxel-wise analysis 
was performed to identify the locations in which correlations were most profound. These 
analyses were adjusted for age, sex, time from event to DTI, and normalized TBV. To test whether 
associations were independent of concurrent vascular brain damage, we additionally adjusted 
for WMH volume, number of lacunes, microbleeds, and territorial infarcts. A permutation-based 
statistical interference tool for non-parametric approach was used for all voxel-based analyses, 
with the number of permutation tests set to 5000.146 Significant clusters were identified with the 
threshold-free cluster enhancement with a p-value <0.05, corrected for multiple comparisons.147
ReSulTS
In total, 150 patients participated in the CONNECT study, of whom seven received a diagnosis 
other than TIA or TNA (migraine aura (n=2), peripheral vestibulopathy (n=2), orthostatic 
hypotension (n=2), and peripheral nerve compression (n=1)) and were excluded. Of the 
remaining 143 patients, 90 underwent DTI a median 7.7 months (interquartile range 5.1 months) 
after the qualifying event and were included for further analyses. There were no differences 
between patients with and without DTI at follow-up regarding age, sex, clinical diagnosis (TIA or 
TNA), duration of symptoms, vascular risk factors, WMH volume, the presence of DWI lesions, 
lacunes, territorial infarcts, or microbleeds.
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Table 2. Patient characteristics stratified by diffusion-weighted imaging results (n=90).
DWI+ (n=22) DWI- (n=68) P value*
Women 8 (36) 28 (41) 0.69
Age, y, mean (SD) 65.3 (7.2) 64.1 (9.5) 0.14
TIA 16 (73) 40 (59) 0.24
Hypertension 18 (82) 55 (81) 0.92
Dyslipidemia 13 (59) 47 (69) 0.39
Diabetes mellitus 1 (5) 7 (10) 0.41
Atrial fibrillation 2 (9) 10 (15) 0.50
Diffusion-weighted imaging lesions, total n 41 N/A N/A
Vascular territory N/A
Left anterior circulation 6 (15) N/A
Right anterior circulation 26 (63) N/A
Posterior circulation 9 (22) N/A
Lesion type N/A
Small cortical 27 (66) N/A
Small subcortical 10 (24) N/A
Territorial 4 (10) N/A
WMH volume, ml, median (IQR) 5.4 (7.9) 5.8 (6.4) 0.86
Lacunes 4 (18) 11 (16) 0.83
Territorial infarcts 1 (5) 8 (12) 0.33
Microbleeds† 1 (7) 5 (10) 0.70
Time from event to DWI, days, median (IQR) 3 (2) 3 (3) 0.48
Time from event to DTI, months, median (IQR) 6.7 (2.6) 8.1 (16.0) 0.02
Normalized total brain volume, mean (SD) 0.74 (0.04) 0.74 (0.06) 0.10
FA skeleton, x 10-2, mean (SD) 48.47 (2.97) 49.55 (2.85) 0.13
MD skeleton, mm2/s x 10-3, mean (SD) 0.73 (0.03) 0.73 (0.03) 0.58
AD skeleton, mm2/s x 10-3, mean (SD) 1.17 (0.03) 1.17 (0.04) 0.70
RD skeleton, mm2/s x 10-3, mean (SD) 0.52 (0.03) 0.51 (0.04) 0.35
Values are n (%) unless stated otherwise. AD indicates axial diffusivity; DWI, diffusion-weighted imaging; 
FA, fractional anisotropy; IQR, interquartile range; MD, mean diffusivity; RD, radial diffusivity; SD, standard 
deviation; TBSS, tract-based spatial statistics; WMH, white matter hyperintensities of presumed vascular 
origin.
*Difference using Student t test, Pearson χ2, or Mann-Whitney U test as appropriate.
†T2*-weighted imaging performed in 65 patients.
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Table 2 presents patient, DWI lesion, and DTI characteristics stratified by DWI status. Of all 
patients with DTI at follow-up, 22 (24%) had signs of recent ischemia on baseline DWI. DWI-
positive patients had a significantly shorter time interval from event to DTI (p=0.02) than DWI-
negative patients. Results remained unchanged when delay was maximized at 18 or 24 months 
(data not shown). The mean number of DWI-positive lesions per patient was 1.8 (SD 1.4) and 
TNA patients more often had multiple lesions than TIA patients (p=0.05). Most lesions were of 
the small cortical type and located in the right anterior circulation area.
Mean FA of the skeleton was marginally lower in the DWI-positive group, B = -0.012 (95% 
confidence interval -0.024 to 0.000; p=0.055, adjusted for age, sex, time from event to DTI, and 
normalized TBV), while mean MD, AD, and RD were not different between DWI groups. There 
were no significant differences in DTI parameters between TIA and TNA patients.
The presence of signs of recent ischemia on DWI at baseline was significantly associated 
with a lower FA at follow-up compared to patients without a DWI-positive lesion, particularly 
in the left frontal and parietal white matter tracts and to a lesser extent parts of the corpus 
callosum on the left side (Figure 1a). In the right hemisphere, there was a trend for the same 
associations, albeit not statistically significant (p-corrected < 0.10). Findings were independent 
of DWI lesion location. Additional adjustments for WMH volume, lacunes, territorial infarcts, and 
microbleeds did not change the relation between FA and DWI-positivity in the abovementioned 
areas. Comparable results were found for RD, albeit not statistically significant (p-corrected < 
0.07; Figure 1b). There were no associations between DWI lesion presence and AD or MD, nor 
between clinical diagnosis (TIA or TNA) and any DTI metrics. 
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Figure 1. Differences in fractional anisotropy (panel a; p < 0.05) and radial diffusivity (panel b; p < 
0.07) between DWI-positive and DWI-negative TIA and TNA patients. Results of voxel-wise analysis with 
permutation-based statistical interference tool for non-parametric approach, with the number of permutation 
tests set to 5000. X=115, Y=106, Z=103.
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DISCuSSIoN
Our study shows that in patients with an event of acute onset neurological symptoms lasting less 
than 24 hours, signs of recent ischemia on initial DWI were marginally associated with lower white 
matter integrity at least six months later. This association was independent of macrostructural 
cerebrovascular damage, was most outspoken in the frontal and parietal white matter tracts, and 
to a lesser extent the corpus callosum.
A strength and novelty of our study is the inclusion of both TIA and TNA patients referred to 
a specialized TIA clinic. This more accurately reflects the normal referral population than by 
selecting only on the clinical diagnosis of TIA.64, 111 Also, we prospectively collected the data, 
which is especially important in the case of TNA as retrospective case ascertainment might lead 
to a shift towards a clinical diagnosis of TIA. Finally, we used detailed and validated assessments 
of both DWI and DTI. Nevertheless, some methodological issues need to be addressed when 
interpreting our results. First, we found only minor associations and trends between several 
parameters of microstructural integrity and DWI lesion presence. As patient numbers were 
relatively small, power and therefore precision may be affected. However, for both FA and RD 
there was a trend, and in some areas significantly reduced white matter integrity was found in 
DWI positive patients. Furthermore, these areas had a considerable structural overlap. Therefore 
our results seem to imply a genuine difference in microstructure between DWI-positive and DWI-
negative patients. Second, the cross-sectional nature of our DTI-analysis limits causal inference 
and the possibility to investigate any differences in change of white matter microstructural integrity 
over time. Also, differences in time interval from event to DTI could have played a role in the 
associations we found. Ongoing cerebrovascular disease and new, clinically silent events could 
lead to worsening of white matter microstructural integrity.108, 148 Time from event to follow-up DTI 
was significantly longer in the DWI-negative group, which could have weakened the relationship 
between DWI-positivity and reduced white matter microstructure. Next, not all patients included 
in CONNECT underwent DTI at follow-up, which could potentially have induced selection bias. 
Since no selection was applied and patients with and without DTI did not differ on demographic 
factors, we feel that patients with DTI at follow-up are a representative sample of our cohort. 
Finally, our results remain to be validated in larger cohorts.
The difference in white matter microstructural integrity between DWI-positive and DWI-negative 
patients suggests a difference in prognosis. TIA with an accompanying DWI lesion has a worse 
short-term prognosis concerning subsequent stroke and is now considered to be an infarct by 
the American Heart Association.13, 24 Whether this also applies to DWI-positive TNA patients is 
unknown, as these patients have not been included in previous prognostic studies.4 Damage 
to the white matter microstructure is associated with cognitive impairment, mood disturbances 
and gait disorders.141, 149, 150 Both TIA and TNA are associated with cognitive impairment and 
dementia, unexplained by macrostructural signs of cerebrovascular disease.12, 42 Furthermore, 
TIA patients often report mood disturbances and may have unrecognized gait impairment.113, 
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151 As signs of cerebrovascular damage on conventional neuroimaging fail to explain these 
associations, compromised white matter architecture may be related to these possible sequelae 
of TIA and TNA.
From an etiological point of view, the association between DWI lesion presence and subsequent 
reduced white matter microstructural integrity could be explained by concomitant and ongoing 
cerebrovascular disease. However, other markers of cerebrovascular damage such as lacunes 
and WMH, as well as vascular risk factors, were not different between DWI-positive and DWI-
negative patients. Even after adjusting for macrostructural vascular brain damage, baseline 
DWI-positivity was still related to reduced FA at follow-up. This implies either that the process of 
microstructural damage to the white matter develops independently from macrostructural signs 
of cerebrovascular disease, or that the ischemic insult of the TIA or TNA causes microstructural 
disturbances. Most DWI lesions were cortically located, which implies that any microstructural 
white matter change would be caused by Wallerian degeneration. The latter hypothesis is 
however not supported by our data, which showed a left-sided predominance in the correlation 
between DWI-positivity and reduced skeletal FA, while baseline DWI lesions were more often 
right-sided. Study size and associated reduced precision could partly explain the pronounced 
asymmetry in voxel-wise analyses regarding the relation between DWI-positivity and FA after 
applying a significance level of p < 0.05.
Diagnostic uncertainty concerning TIA and TNA could be another explanation for the relation 
between DWI-positivity and reduced microstructural integrity of the white matter. Even 
experienced stroke neurologists have low agreement on the clinical diagnosis of TIA.64 The 
presence of a DWI lesion is the only possible confirmation of an ischemic etiology of the event. 
The group of patients without DWI abnormalities probably contains both actual cerebrovascular 
events and mimics, which might explain the overall better microstructural integrity.
Other prospective studies on white matter microstructural integrity generally employed far longer 
follow-up durations than in our study.63, 152 This may partly explain the relatively minor associations 
we found between DWI-positivity and reduced white matter microstructural integrity in TIA 
and TNA patients. From a prognostic point of view, it is important to discern whether reduced 
white matter microstructural integrity is a risk marker for DWI-positive TIA and TNA, or if the 
ischemic insult causes changes in the white matter. Based on our data, the first option appears 
more probable, although there is a certain independence from other cerebrovascular disease 
markers. In order to unravel these relationships, future studies should include more patients, 
employ a longer follow-up duration, and perform repeated DTI measurements. Nevertheless, 
the relation between transient neurological events with accompanying DWI abnormalities and 
reduced white matter integrity implies a difference in prognosis between DWI-positive and DWI-
negative patients, as well as a possible explanation for cognitive sequelae of both TIA and TNA 
which are increasingly recognized.12, 123
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The diagnosis of TIA is often difficult to establish. Although early DWI may show signs of recent 
ischemia in roughly one third of patients, the patient’s account of events and its interpretation by 
a medical professional remain the cornerstone of the clinical diagnosis TIA. The determinants 
of DWI-positivity in TIA patients are unclear. Nevertheless, DWI-positive TIA patients have a 
considerably higher short-term risk of stroke than those without a DWI lesion. This observation 
has launched a major debate about the accuracy of the widely used, time-based diagnosis 
of TIA. Rather, the use of a new, tissue-based definition is advocated, thereby more clearly 
identifying those individuals with the highest risk of subsequent neurovascular events.
In the absence of focal neurological symptoms, an attack of short-lasting neurological symptoms 
is often not considered to be a TIA. When no clear alternative diagnosis is present, this if referred 
to as a transient neurological attack (TNA). Although generally considered to have a favorable 
prognosis, TNA patients also have an increased risk of subsequent cardiovascular events and 
dementia.
Both TIA and TNA harbor the term transient in their names, suggesting that symptoms reside 
completely. However, many patients report cognitive and other complaints well beyond the point 
of initial symptom resolution. Prospective studies on post-TIA and post-TNA cognitive function 
are lacking, which contrasts with the large amount of studies on post-stroke cognition and 
dementia.
Given the well-established increased short-term risk of stroke after TIA, a timely and adequate 
diagnosis is of the utmost importance. Moreover, it is unclear whether TIA and TNA lead to 
cognitive decline and what the determinants of post-TIA and post-TNA cognitive function are. 
This thesis attempts to further unravel the etiology and cognitive prognosis of the spectrum of 
transient neurological attacks. Most chapters within this thesis originate from the Cohort study 
ON Neuroimaging, Etiology, and Cognitive consequences of Transient neurological attacks 
(CONNECT), which is described in chapter 2.
As transient neurological attack is not a diagnosis, but rather an umbrella term for acute onset, 
short lasting attacks of neurological symptoms for which no clear diagnosis is available, it is 
important to first establish etiological subgroups within this spectrum of attacks. Especially, it 
is of the utmost importance to adequately distinguish patients with a cerebrovascular etiology 
from the large group of patients with a possible TIA, since the short-term risk of stroke after TIA 
is largely dependent on the presence of signs of recent infarction on brain imaging. In chapter 
3 we therefore established the value of the traditional definition of TIA in identifying patients with 
a DWI lesion within those referred for a possible TIA. Based on the patient’s account of events 
and answers to a structured interview concerning the presence of specific focal and nonfocal 
neurological symptoms, three stroke-specialists classified each event as a TIA or TNA. Next, the 
prevalence of signs of recent infarction (cytotoxic edema) on DWI performed within 7 days after 
the qualifying event was determined. DWI-positivity was prevalent in 31% of TIA-patients but also 
in 23% of TNA-patients [p for difference 0.41]. We concluded that clinically diagnosing TIA fails 
to adequately identify those patients with proven cerebral ischemia.
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In the next part of this thesis, we explored the possible neurocognitive consequences of 
transient neurological attacks. In chapter 4 we first focused on clinically defined TIA patients 
and systematically reviewed the prevalence of cognitive impairment after TIA in different study 
populations, in order to define the size of the problem and identify possible determinants. We 
found that throughout different populations, mild cognitive impairment was on average present in 
more than a third of TIA patients and had a profile comparable with vascular cognitive impairment, 
i.e. mainly nonamnestic impairment. However, there was considerable heterogeneity between 
studies concerning timing of cognitive testing, definitions of cognitive impairment, and study 
populations, which limited further conclusions about potential causative factors.
In order to more clearly identify the prevalence of cognitive impairment after TIA, while limiting 
the possible effects of concomitant neurodegenerative disease and repeated neurovascular 
events, we performed a cross-sectional study of cognitive function in a cohort of 107 TIA patients 
(chapter 5). Age was limited to 65 years or younger and all patients were cognitively tested 
within three months after the initial TIA. Furthermore, patients with clinically manifest stroke 
before the TIA were excluded. Cognitive function was compared to a matched control group 
and impairment was defined as a z-score <-1.65 within ≥1 cognitive domain. TIA patients 
performed worse on every cognitive domain and more than one third had cognitive impairment 
three months after the initial event (OR 5.9 [95%-CI 2.4-14.5]). The cognitive domains of working 
memory and attention were most often affected and impairment was independent of the 
presence of SBI or WMH. The influence of neurodegenerative disease and prior neurovascular 
damage on cognitive performance was limited in this study, suggesting a possible role for the 
TIA itself in the occurrence of cognitive decline. However, the cross-sectional design of the study 
limited inferences about causality. Furthermore, inclusion was limited to clinically defined TIA; a 
diagnosis that we already showed in chapter 3 has limited value in identifying definite underlying 
cerebral ischemia as etiology.
Therefore, we performed a prospective study of cognitive function after both TIA and TNA (chapter 
6) in 121 patients from the CONNECT cohort. A comprehensive neuropsychological test battery 
was administered within seven days after TIA or TNA, and repeated six months later. Domain-
specific compound scores for executive function, attention, information processing speed, and 
episodic memory were calculated by averaging z-scores of individual tests within each domain. 
Repeated measurement analysis was used to test for differences in domain-specific cognitive 
performance over time between DWI-positive and DWI-negative patients, as well as between TIA 
and TNA patients. Within the first six months after both TIA and TNA, executive function declined, 
irrespective of clinical diagnosis or DWI-status (mean change in compound score -0.23, p = 
0.01 adjusted for age, sex, education). DWI-positive patients performed worse at baseline than 
those without signs of recent ischemia (compound scores -0.21 vs. 0.06, p = 0.048), which 
persisted throughout the study period (p = 0.04). There were no differences between TIA and 
TNA patients, which was to be expected given the similar prevalence of DWI lesions in both 
clinical categories.
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Given the observation that many TIA patients report ongoing subjective cognitive impairment, 
anxiety, depressive symptoms, and fatigue beyond the point of focal symptom resolution, we 
also set out to prospectively determine the prevalence and course of these subjective complaints 
after both TIA and TNA, and identify the relationship with clinical diagnosis (TIA or TNA) and DWI-
status (chapter 7). Different questionnaires were used to assess subjective cognitive impairment, 
anxiety, depressive symptoms, and fatigue shortly before the TIA or TNA, and six months later. 
With repeated measurement analysis the associations between DWI lesion presence or clinical 
diagnosis (TIA or TNA) and subjective complaints over time was determined in 103 patients. 
Subjective cognitive impairment and to a lesser extent fatigue were highly prevalent in TIA and 
TNA patients, both shortly before the event and six months later. Subjective cognitive impairment 
increased in severity only in DWI-positive patients (p = 0.02), as did fatigue (p = 0.01).
Having established the high prevalence of cognitive impairment and subjective complaints in 
both TIA and TNA patients, the association with DWI-positivity, and the lack of associations with 
conventional imaging markers of cerebrovascular damage, we hypothesized that event itself 
could have led to cerebrovascular damage at another level. Possibly, the short-lasting ischemia 
that underlies the DWI lesion also caused damage to the white matter microstructure. This loss 
of microstructural integrity could in turn be a potential determinant for secondary cognitive 
dysfunction and several subjective complaints. As a first step in establishing a ground for this 
hypothesis, we performed a cross-sectional analysis of white matter microstructural integrity after 
TIA or TNA and determined the relationship with DWI-status at baseline (chapter 8). A subset 
of patients (n = 90) from CONNECT underwent additional DTI-imaging at least six months after 
the qualifying TIA or TNA. Different measures of microstructural integrity (FA, MD, AD, RD) were 
calculated with tract-based spatial statistics. Differences in DTI metrics between categories of 
clinical diagnosis (TIA or TNA) and DWI-status were calculated for the TBSS skeleton as well as 
voxel-wise. DWI-positive TIA and TNA patients had a lower FA and higher RD than DWI-negative 
patients, especially in the frontoparietal white matter and to a lesser extent the corpus callosum. 
These observations were independent of macrostructural signs of vascular brain damage. 
Although differences were only marginal they represent a first step in identifying a possible 
explanation for lasting neurocognitive sequelae after short-lasting cerebral ischemic events.
In conclusion, the studies described in this thesis show the wide spectrum of symptoms with 
which transient cerebral ischemia may present, and underline the shortcomings of the clinical 
definition of TIA as well as the additional value of early DWI in the diagnostic process of transient 
neurological attacks. Furthermore, they show that although focal symptoms rapidly dissolve, 
TIA and TNA patients can have ongoing cognitive decline and increasing subjective complaints 
within the first months after the attack, which challenges the word transient within TIA and TNA. As 
the presence of signs of recent ischemia on early imaging was associated with a worse objective 
and subjective cognitive outcome, DWI may additionally play a role in identifying patients at 
risk of cognitive deterioration. The observation of reduced white matter integrity in DWI-positive 
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patients can serve as a first step in further unraveling the etiology of these ongoing processes. 
Future studies should explore the relationship between white matter microstructure, cerebral 
networks, and cognitive outcome in TIA and TNA patients, as well as the long-term (neuro)
vascular and cognitive outcomes. Given the distinguishing role early DWI plays in the short-term 
vascular and cognitive prognosis, DWI-status rather than clinical diagnosis alone should be an 
essential factor in future studies.
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This thesis was dedicated to transient ischemic attacks (TIA) and transient neurological attacks 
(TNA) and aimed to unravel the etiology and prognosis of this spectrum of transient episodes 
of neurological dysfunction. Most studies in this thesis are based on CONNECT, a prospective 
cohort study on etiology, neuroimaging and cognitive function in TIA and TNA patients. In this 
chapter I will first discuss some important methodological considerations when interpreting our 
study results. Next, I will reflect on how our main findings relate to existing literature and how 
they may influence the current concept, diagnosis, and treatment of TIA and TNA. Finally, future 
directions for research are suggested.
MeThoDoloGICAl CoNSIDeRATIoNS
Study population
The CONNECT study is a hospital-based, prospective cohort study consisting of 150 patients 
aged ≥45 years and a recent diagnosis of TIA or TNA.65 All patients referred to a specialized 
outpatient TIA clinic because of a possible TIA who underwent clinical evaluation including MRI of 
the brain within seven days after the qualifying event were eligible for participation. Patients who 
agreed to participate additionally underwent extensive cognitive testing during the same visit. All 
participants were free from dementia at baseline. As TIA is often a difficult clinical diagnosis in 
which expert opinion is leading, three specialized stroke neurologists defined the final diagnosis 
as either TIA, TNA or a specified alternative diagnosis.64 Six months after baseline, MRI and 
cognitive testing were repeated.
CONNECT was designed as a pragmatic study. Every patient referred to a specialized outpatient 
TIA clinic for a possible TIA and in whom no other diagnosis than TIA or TNA could be made, 
was included. This reflects daily practice considering this category of patients as closely as 
possible. Given the innate uncertainty of the clinical diagnosis TIA, as well as the fact that TNA 
is not a diagnosis but rather a description, the choice to include all these patients probably led 
to a heterogeneous population with respect to diagnosis and etiology. However, our goal was 
to provide answers to questions considering all patients with possible TIA. A second important 
point in the design of CONNECT was to include only patients who presented within seven days 
after their TIA or TNA. Ideally, DWI imaging takes place within hours after the start of clinical 
symptoms, although there are some doubts about the sensitivity of DWI in the first 24 hours 
after cerebral ischemia, especially in the posterior circulation.153-155 However, most TIA and TNA 
patients present much later after their event, mainly caused by patient delay.156 For reasons of 
feasibility, the maximum delay between qualifying event and evaluation was set at seven days, 
thereby minimizing the potential influence of DWI lesion reversal, which generally starts after ten 
days.68, 69 On the other hand, this delay increased the chance of new and clinically unrelated 
DWI lesion occurrence. In addition, follow-up duration was set at six months. Our goal was to 
establish potential effects of TIA and TNA on cognitive function, and by applying this short follow-
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up interval we attempted to decrease the effects of concomitant progressive cerebrovascular 
disease (e.g. incident stroke, silent brain infarcts, progression of WMH). Nevertheless, any 
changes in cognitive performance within this short time interval will most probably be minor, 
possibly reducing the chance of finding significant changes. Finally, for reasons of feasibility, 
small but relevant differences were present between imaging protocols at baseline and follow-up. 
The baseline protocol was less extensive than at follow-up. By accepting the use of a standard 
clinical MRI-protocol at baseline (without 3D-T1, DTI, and resting-state fMRI sequences) the 
number of potential inclusions was maximized. This however limited the analysis of changes in 
cerebrovascular damage over time.
Measurement error can be either random or non-random; the latter causes information bias 
and will be discussed below (part on validity). Random error causes dilution of measurements, 
leading to false-negative studies. Increasing precision of measurements minimizes random 
error and leads to findings that deviate less from the true value.157 There are two ways to 
improve precision: by increasing the number of measurements and by increasing the accuracy 
of measurements. We tried to increase precision by including a large number of patients. We 
increased the accuracy of measurements in our studies by standardizing circumstances during 
measurements, using objective instruments, well-validated questionnaires, and previously 
defined cut-off scores. Nevertheless, in several studies in this thesis, outcome measures were 
susceptible to measurement error. Random misclassification could for instance have effected 
measurements on fatigue or depressive symptoms. Both may fluctuate over days and are 
influenced by factors such as the quality of last night’s sleep or relational issues. Performance 
on cognitive screening tests is probably also dependent on these external factors and may 
therefore differ from the true value. This is also random measurement error, as it is independent 
of DWI status or clinical diagnosis. Larger sampled studies applying at least the same level of 
measurement precision are needed to confirm our findings. Misclassification may also have 
occurred in the determination of the final diagnosis of patients in CONNECT. This was done 
without knowledge of imaging results, and therefore largely based on expert opinion. Some 
uncertainty is inherent to the diagnosis TIA (and TNA), as clinical symptoms have almost always 
disappeared before examination takes place. Furthermore, expert opinion remains the gold 
standard.1 In clinical practice, imaging results are used to obtain objective evidence of cerebral 
ischemia (DWI lesions). In CONNECT we specifically set out to investigate the association 
between the clinical diagnosis and imaging results. Patients were therefore classified as either TIA 
or TNA, but also as either DWI-positive or DWI-negative. Both classifications were subsequently 
used in the analysis of outcomes. Therefore, diagnostic misclassification per se has not played 
a role in our results, but rather we have shown the discrepancy between clinical and radiological 
diagnoses in this difficult patient category.
518780-L-bw-van Rooij
Processed on: 30-4-2018 PDF page: 143
General discussion and perspectives
143
10
Internal validity
Internal validity of a study involves the reliability of results and conclusions based on the collected 
data. Reducing systematic error or bias increases internal validity. Three types of bias can be 
distinguished: selection bias, information bias, and confounding. 
Selection bias results from differences in associations between determinant and outcome for 
participants and non-participants. Selection bias occurs when participation in a study is not 
random, but dependent on the relation under study.157 In CONNECT, data from patients eligible 
for the study but who refused to participate were not systematically recorded. Therefore it is 
unknown whether non-participants differed from participants. It is possible that the foresight of 
cognitive testing and a follow-up visit may have led to more non-participation in individuals with 
a worse general health, an older age, or with pre-existent cognitive problems. If selection bias 
would indeed play a role, it would probably have led to an underestimation of the association 
between determinant and outcome. Not all patients who agreed to participate at baseline 
remained to do so at follow-up. Those lost to follow-up were more often women but otherwise 
did not differ with regard to age, level of education, or the presence of vascular risk factors. 
Selective dropout is therefore not likely.
Information bias may arise when the measurement error of a determinant is dependent on 
the outcome variable and vice versa, for instance when a researcher is aware of a patients’ 
diagnosis when administering tests.157 In CONNECT, study researchers were blinded for the 
clinical diagnosis of a patient, and neurologists responsible for the final classifying diagnosis 
(TIA, TNA, or a specified alternative diagnosis) were unaware of results from cognitive tests and 
imaging. Therefore, this form of bias is not likely to have occurred in CONNECT. Recall bias 
is also a form of information bias. Especially with the use of questionnaires, patients may not 
always adequately remember the presence or absence of symptoms. In CONNECT, information 
loss due to reduced recall was minimized as the baseline questionnaires were administered 
within seven days after the qualifying event and follow-up assessments concerned complaints 
in the past weeks. Furthermore, there is no actual bias when reduced recall is random (random 
misclassification). Only when there are differences in recall between relevant patient groups (for 
instance TIA and TNA patients) this would introduce bias. All included patients had very recently 
experienced an attack of neurological symptoms, either focal or nonfocal. By administering 
baseline questionnaires before the clinical diagnosis was discussed with the patient, recall bias 
was limited. During follow-up however, patients were aware of their clinical diagnosis. Although 
we found no differences in questionnaire results between TIA and TNA patients, TIA patients 
may have focused more on potential symptoms and reported a higher number of subjective 
complaints, since they had started with secondary preventive measures and TNA patients had 
not.
Confounding is the third form of bias to consider when assessing internal validity. Confounding 
occurs when an extraneous factor is associated with both determinant and outcome without 
being part of their causal chain.157 Effects may than mistakenly be attributed to the determinant 
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under study. Age, sex, and level of education are important confounders to consider in our 
studies, since these factors are related to the risk of TIA as well as cognitive function, but also 
to fatigue, depressive symptoms, and other outcome variables we studied. More specifically 
for analyses involving DTI parameter outcomes, factors such as brain volume, white matter 
hyperintensity load, and the presence of lacunes may be additional confounding factors. We tried 
to attain internal validity by adjusting for these potential confounders in analyses. It is important 
to realize that a factor can sometimes be both a confounder and an intermediate in the causal 
chain.157 With respect to the studies in this thesis, this may be the case for several imaging 
variables. In the relationship between DWI lesions and cognitive function, WMH, lacunes, and 
microbleeds are possible confounders, since they related to each other, are associated with 
cognitive decline, but are also a proxy for cerebrovascular disease.19, 20 However, their status 
as proxy for cerebrovascular disease puts them in the causal chain between DWI lesions and 
cognitive decline. Adjusting for a factor in the causal chain results in underestimation of effects. 
Furthermore, we compared two groups of patients (DWI-negative and DWI-positive), between 
which there were no differences in prevalence and severity of WMH, lacunes, and microbleeds. 
The only distinctive feature between these patients was the presence or absence of signs of 
acute infarction on DWI. For these reasons, we chose not to adjust for these factors in the 
prospective studies on cognitive function or subjective complaints after TIA and TNA (chapters 
6 and 7). Contrary, in chapter 5, in which cognitive function in TIA patients was compared in a 
cross-sectional study with a control group, we specifically determined the effects of WMH and 
lacunes, and found a relationship between TIA and cognitive impairment independent of these 
factors.
external validity
External validity is the extent to which study results can be generalized to the population from 
which the sample was taken. A prominent feature of CONNECT is the inclusion of all patients 
suspected of TIA, even when the final clinical diagnosis was TNA. Patients were not in advance 
excluded based on the clinical diagnosis, which we have shown has a low correlation with 
objective signs of recent cerebral ischemia.111 Thereby, CONNECT is more representative of the 
population actually at risk of having had a short-lasting event of cerebral ischemia than studies 
solely including clinically diagnosed TIA. Furthermore, patients were included in CONNECT at 
both a general and an academic hospital, and were invariably first-opinion referrals. As such, our 
study results can be applied to the spectrum of patients presenting to a GP or neurologist with a 
possible TIA and be used as sources of information regarding etiology and cognitive prognosis 
in this patient category.
However, there are factors that limit the external validity of results in this thesis. We included only 
stroke-free and non-demented individuals in our studies, and furthermore applied a minimal 
age-limit of 45 years. Also, in all but one study in this thesis, patients with a TIA or TNA >7 days 
earlier were excluded. Results of CONNECT are therefore not generalizable to patients with a 
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previous stroke, those younger than 45 years or with a TIA or TNA more than one week earlier. 
Compared to other studies on TIA and cognition, patients in our studies were relatively young.123 
Correspondingly, the presence and severity of cerebrovascular lesions on MRI was lower than 
that in previous studies on TIA or cerebral small vessels disease, which probably is also related to 
the exclusion of patients with prior stroke.121, 158, 159 The prevalence and development of cognitive 
symptoms after TIA and TNA as described in this thesis may therefore be an underestimation 
of the actual problem in the general TIA and TNA population. This however does not have to 
influence the described causal relation between TIA or TNA and cognitive decline. To further 
determine external validity, results need to be replicated in other TIA and TNA populations. Within 
this thesis, one study concerned another cohort than CONNECT, in which the limitation of a 
recent (<7 days earlier) TIA was extended to three months. Of note, in this study inclusion was 
limited to TIA, an upper age limit of 65 years was applied, and the primary outcome measure was 
cognitive impairment (cognitive domain-specific z-score <-1.65 compared to control group) 
rather than cognitive function. Both samples are otherwise largely comparable, therefore the 
conformation of results at least tests the internal validity. Nevertheless, the results presented in 
chapter 5 are a first attempt to also extend the external validity of this thesis.
Causal inference
The relationship between a proposed determinant and an outcome variable is not by definition 
a causal one. In epidemiologic literature, a set of several criteria has been proposed with 
which causality can be judged.157 These have been subject of extensive debate, and although 
insufficient to establish causality, they can be used to evaluate a possible causal relationship. 
Perhaps the most important criterion for causality is temporality. Several studies in this thesis had 
a cross-sectional design, which by definition is unsuitable to establish temporality. For example, 
in TIA and TNA patients we found an association between the presence of a baseline DWI 
lesion and lower white matter microstructural integrity at follow-up. This however not necessarily 
implies that a DWI lesion reduces white matter integrity. Reverse causality may also explain 
this association: reduced white matter microstructural integrity is an early sign of cerebral small 
vessel disease, which in turn increases the chance of DWI lesions to occur. By establishing a 
temporal relationship, causality can be made more probable. In two studies in this thesis, a 
prospective design with repeated measures was applied in an attempt to establish a causal 
relationship between the presence of DWI lesions and both objective and subjective cognitive 
decline in TIA and TNA patients. However, such a temporal relationship was only found to 
some extent for subjective cognitive complaints. With respect to objective cognitive function, 
baseline differences between DWI-positive and DWI-negative patients remained stable over 
time. In the absence of a temporal relationship, we cannot with certainty conclude that DWI 
lesion presence in TIA and TNA patients directly leads to cognitive decline. To further explore 
the temporal relationship and thus make inferences regarding causality between TIA/TNA and 
cognitive function as well as structural brain changes, studies with a longer follow-up duration 
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and repeated imaging are needed. Besides temporality, causality should furthermore be judged 
on the basis of consistency of findings, biological plausibility, and experimental data.
GeNeRAl DISCuSSIoN
unraveling the etiology of transient attacks of neurological symptoms: is it all 
transient cerebral ischemia?
Despite the emergence of new imaging techniques such as DWI, the interpretation of neurological 
symptoms and their clinical localization remains the cornerstone of diagnosing a TIA. The 
general opinion is that an episode of focal neurological symptoms with an acute onset and 
rapid clearance constitutes transient cerebral ischemia.1 Vice-versa, an attack consisting solely 
of nonfocal neurological symptoms does not fit in the concept of TIA and is generally considered 
to have other causes than cerebral ischemia.26 However, our finding that signs of recent ischemia 
on DWI are almost equally prevalent in TIA and TNA patients constitute a major challenge to the 
accuracy of this assumption.111 What could be the consequences of these findings?
The classic dichotomy between ischemic and nonischemic transient attacks of neurological 
symptoms caused a concentration of research on TIAs rather than TNAs. The risk of new vascular 
events after TIA is well established and has led to the emergence of specialized TIA clinics for 
rapid diagnosis and secondary prevention, a strategy that has been proven to be effective in 
reducing stroke risk.11 In addition, a further prognostic distinction within the TIA population can 
be made, based on the results of neuroimaging. TIA patients with signs of recent infarction on 
DWI have an alarming 18-fold higher risk of subsequent stroke within 7 days than those without 
these signs.24 Extrapolating these observations to the TIA and TNA population as a whole seems 
justified, as our results suggest that clinical evaluation of transient neurological events even by 
stroke specialists fails to adequately distinct between ischemic and nonischemic causes.111 This 
could mean that a considerable amount of clinically defined TNA patients are denied adequate 
secondary prevention, with potentially devastating consequences. Nevertheless, definite proof 
of a similar prognosis for DWI-positive TIA and TNA patients has yet to be provided. Furthermore, 
results from DWI studies in both TIA and TNA patients leave us with another unsolved issue: do 
those patients without a DWI lesion definitely have a nonischemic etiology of their symptoms?
Contrary to stroke patients, the incidence of signs of recent ischemia in clinically defined TIA 
patients is remarkably low.4, 160 Although multiple factors for DWI-positivity in TIA patients have 
been proposed, results of individual studies are very heterogeneous and as yet there are no 
clearly established determinants.4 The difference in sensitivity of DWI between stroke (99%) and 
TIA (34%) seems too large to be explained solely by factors such as longer symptom duration 
or differences in delay from onset to imaging. Rather, it reflects the intrinsic uncertainty of the 
clinical diagnosis of TIA.64 It may very well be that a large amount of DWI-negative TIA patients 
actually has other etiologies than ischemia for their transient symptoms. Subsequently, TNAs 
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without signs of recent ischemia on DWI may also be nonischemic events. Evidence for these 
assumptions is however not available, leaving interpretation by a specialist as the only option to 
discriminate between a potentially ischemic event and an attack of other origin.
Interestingly, two population-based studies on transient attacks of neurological dysfunction 
suggested cardiac arrhythmias as a possible cause for TNA, especially for attacks with combined 
focal and nonfocal symptoms (mixed TNA). They based their suggestion on an increased 
risk of ischemic heart disease during long-term follow-up.12, 74 Despite differences in patient 
categorization and lack of brain imaging, it seems appropriate to combine the results from these 
long-term studies with those from CONNECT. Since the majority of patients in CONNECT had 
no signs of acute ischemia on DWI and therefore no definite confirmation of a cerebrovascular 
event, the suggested cardiac etiology is a distinct possibility in these DWI-negative patients. 
Both TIA and TNA are associated with an increased risk of subsequent stroke and vascular 
dementia,12 which at least suggests common underlying cardiovascular disease, perhaps with 
different manifestations. From a neuroanatomical point of view, it is nevertheless unclear why 
cardiac arrhythmias would lead to a mix of focal and nonfocal neurological symptoms, instead of 
nonfocal symptoms only. This may however be a reflection of the innate uncertainty of symptom 
description and categorization of TIA and TNA.
It is important to realize that TNA is not a diagnosis. Rather, it represents a concept to describe 
events of sudden onset, difficult to localize, neurological symptoms which complete resolve within 
24 hours and for which no alternative diagnosis can be found.5, 12 Among this heterogeneous group 
of patients, it is important to discriminate those with a cerebrovascular etiology in order to start 
adequate secondary prevention. Neurological symptoms originating from posterior circulation 
ischemia are notoriously difficult to localize can therefore be misinterpreted as nonischemic.72, 
73 But nonfocal symptoms can also originate from anterior circulation ischemia.161 Results from 
our study suggest that among TNAs, events of sudden onset, short-lasting confusion or positive 
sensory symptoms are most often associated with recent ischemia on DWI.111 However, there 
are no clear discriminating signs and symptoms that predict the presence of recent ischemia 
on DWI.
When could TNA be considered a separate diagnostic entity? This would not only depend on 
identifying those patients with a cerebrovascular event (actual TIAs), but also on further narrowing 
of the heterogeneous spectrum of entities within the current concept of TNA. Without sensitive 
and specific biomarkers to detect alternative diagnoses such as epilepsy, cardiac arrhythmias, 
migraine, or conversion disorders, this exploration and categorization of TNAs should be based 
on prognostic variables. More specifically, given the current theories on etiology of transient 
attacks of neurological symptoms, the long-term risk of epilepsy, migraine, stroke, and cardiac 
disease has to be determined for those TNA patients in whom DWI shows no signs of recent 
infarction. This knowledge could thereafter be applied to discern a category of patients with a 
favorable prognosis, for whom the “diagnosis” TNA can be used.
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Given the potentially devastating consequences of misdiagnosing ischemic events as 
nonischemic and the lack of clinically discriminating factors, we propose a central role for early 
DWI in the analysis of both TIA and TNA. In clinically defined TIAs it can be used to distinguish 
between high-risk and low-risk patients, and in TNAs it is able to identify those patients with 
a definite ischemic etiology of the event. In TIA patients with early MRI, the commonly used 
ABCD2-score for short-term risk of stroke has hardly any added value in case of negative DWI. 
DWI lesion presence in TIA patients is associated with a 7- to 25-fold increased risk of stroke 
within 7 days compared to DWI-negative TIA patients.24 DWI-positive TIA patients deserve rapid 
investigations and start of secondary prevention, possibly even clinical observation. Whether 
this also applies to DWI-positive TNA patients remains to be determined. Awaiting results from 
further studies, TNA patients should undergo DWI and when positive, should receive the same 
etiological investigations and secondary preventative actions as TIA patients. Concerning DWI-
negative patients, those clinically diagnosed as TIA should also receive adequate secondary 
stroke prophylaxis. The evidence for the beneficial effects of secondary prevention after TIA 
arises from studies in clinically defined patients.162 Despite the considerably lower short-term risk 
of stroke after DWI-negative TIA, there is as yet no evidence to assume secondary preventive 
measures are not useful in reducing the incidence of recurrent vascular events in DWI-negative 
TIA patients. With regard to those patients clinically defined as TNA and without a lesion on 
early DWI, it seems reasonable to apply primary preventive action in case of vascular risk factor 
presence, but we feel there is insufficient scientific evidence to start secondary stroke prevention 
given the a priori low chance of a cerebrovascular origin of the event.45, 111
Cognitive function after TIA and TNA
The most pronounced symptoms of acute cerebral ischemia are the focal neurological deficits 
with which a patient presents, for example hemiparesis or aphasia. However, stroke can also 
have less obvious direct consequences, such as cognitive impairment, fatigue, and mood 
disturbances. These symptoms often last well beyond any recovery of focal neurological deficits 
and progression over time is not uncommon.18, 163 With regard to TIA and TNA, the association with 
cognitive function is less well established. In this thesis, we showed that cognitive impairment is 
prevalent in a substantial amount of TIA patients and is most prominent in the domain of executive 
function (chapters 4 and 5). The finding of domain-specific cognitive impairment with a focus 
on the non-memory domains is in line with studies on vascular cognitive impairment, even in the 
absence of overt signs of stroke.110 In addition, subjective complaints are highly prevalent in both 
TIA and TNA patients, especially subjective cognitive impairment and fatigue (chapter 7). In 
several previous studies, the correlation between objective and subjective cognitive impairment 
in cerebrovascular disease was relatively weak.122, 129, 164 Subjective cognitive complaints are 
probably mediated by a complex interaction with other subjective problems such as depressive 
feelings, anxiety and fatigue, as well as objective cognitive deterioration.128, 136, 165 Nevertheless, 
they can serve as a first indication that cognitive function has changed and may have a negative 
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impact on quality of life.133, 136 Over the time of six months, executive function deteriorates in TIA 
and TNA patients, which is not explained by the occurrence of new clinical symptoms of TIA, 
TNA or stroke (chapter 6). The decline in executive function performance is not accompanied by 
a global increase of subjective cognitive impairment, fatigue, or depressive symptoms within the 
same period (chapter 7). Whether this means that the observed decrease in executive function 
performance is not clinically relevant, or that measures of subjective complaints are insensitive 
to executive function decline, is unknown. Other longitudinal studies on cognitive function after 
TIA or TNA are scarce, and in our study we prospectively measured cognitive function rather than 
impairment.17 Nevertheless, the observation of cognitive impairment in a substantial amount of 
TIA patients and the decline in cognitive function in both TIA and TNA patients is in line with the 
results of a large population-based study on the long-term cognitive prognosis after TIA and 
TNA, in which an association with future vascular dementia was found.12
Possible mechanisms of cognitive decline after TIA and TNA
In this thesis we showed that cognitive function after TIA or TNA is not static, but deteriorates 
within the first six months afterwards, especially concerning executive function (chapter 6). 
Furthermore, the presence of signs of recent ischemia on DWI performed within one week after 
TIA or TNA was associated with persistent worse executive functioning during the following six 
month, as well as with an increase in subjective cognitive complaints and fatigue (chapters 6 
and 7). These observations implicate several possible underlying developmental mechanisms 
of cognitive impairment. Underlying cerebrovascular disease may cause both TIA/TNA and 
cognitive impairment. The profile of cognitive impairment and the decline in executive function 
both point in this direction. However, we found no association between imaging markers of 
small vessel disease or the presence of vascular risk factors, and the prevalence of cognitive 
impairment (chapter 5). Small vessel disease may give rise to different brain lesions on 
conventional imaging, such as WMH, lacunes, and microbleeds.28 These lesions however only 
partly explain the symptomatology of small vessel disease. Microstructural damage to the white 
matter tracts, visible on DTI, is associated with worse cognitive performance in small vessel 
disease.22, 39, 141 In chapter 8 we found slightly worse white matter integrity in DWI-positive 
versus DWI-negative patients, measured at least six months after the initial event. Although the 
differences were minor, analyses were cross-sectional, and the study sample was small, this 
observation may be an explanatory factor for cognitive impairment in TIA and TNA patients. 
Whether this also explains the progression of executive dysfunction remains to be established. 
Unfortunately, data on progression of imaging markers of small vessel disease are not yet 
available for CONNECT. Another possible mechanism of cognitive decline after TIA and TNA 
is co-occurrence of a progressive neurodegenerative process such as Alzheimer’s disease. 
Vascular and neurodegenerative cognitive impairment often coexist. Furthermore, their underlying 
pathological processes are probably entangled, as suggested by common cerebrovascular risk 
factors, negative effects of Aβ on cerebral blood flow, and experimental evidence of increased 
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Aβ production after ischemia.166 Although not exclusive, there are differences in the profile of 
cognitive impairment between neurodegenerative and vascular causes. Prominent amnestic 
deficits point at Alzheimer’s or associated pathology, whereas a nonamnestic profile with decline 
of executive function and information processing speed is often seen in vascular cognitive 
impairment. The latter is thought to arise from damage to the subcortical-frontal connections, 
disrupting the networks essential in many cognitive processes.110 The nonamnestic cognitive 
deficits and the exclusive decline in executive function suggest that a vascular etiology of 
cognitive impairment is more likely in our population. Moreover, in chapter 5 we specifically 
studied cognitive impairment in relatively young TIA patients, thereby reducing the influence of 
concomitant neurodegenerative disease. The added effect of nonvascular causes of cognitive 
impairment in our studies therefore seems minor. A final possible mechanism of cognitive decline 
after TIA and TNA is a direct effect of the event itself. Strategic ischemic lesions, for example 
located in the thalamus or cingulum, can give rise to acute cognitive deficits. In addition, focal 
ischemia elsewhere may disrupt cognitive processing networks and thereby cause cognitive 
function to decline. TIA by definition is caused by focal cerebral ischemia. Although TNA is 
supposedly not caused by ischemia, we showed in chapter 3 that the prevalence of DWI lesions 
is roughly equal in TIA and TNA patients. In order to establish causality between TIA/TNA and 
cognitive decline, either cognitive function could be measured before the event, a TIA/TNA-free 
but otherwise perfectly matched control group could be compared over time to a patient group, 
or a marker for the severity of ischemia could be used. Given the hospital-based design and the 
lack of a control group in CONNECT, the first two options were unavailable to us. Signs of recent 
ischemia on DWI in the acute phase after TIA or TNA can be considered a marker for the severity 
of the event, as it definitely proves the ischemic nature of the attack. The presence of DWI lesions 
was associated with worse executive function tested within days after the initial event (chapter 
6). However, in the following six months decline in executive function occurred in both the 
DWI-positive and DWI-negative patient groups at a similar rate. Contrary, regarding subjective 
complaints, a baseline DWI lesion was associated with progression of subjective cognitive 
impairment and fatigue after the TIA or TNA (chapter 7). Stating that this is a direct effect of 
the DWI lesion would be a bridge too far, especially given the proposed complex interactions 
underlying these subjective complaints, as well as the observation that before the TIA or TNA, 
DWI-negative patients experienced more complaints than those with a lesion. Concluding, there 
is indirect evidence for multiple mechanisms underlying cognitive decline and impairment in 
TIA and TNA patients. Those with positive DWI have worse cognitive function and progressive 
subjective complaints, which points in the direction of more widespread cerebrovascular damage 
prior to the event, potentially worsened by the event itself.
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Clinical relevance and implications
Diagnosis of TIA and TNA
The diagnosis of TIA is by definition primarily based on expert opinion, as adequate biomarkers 
are lacking. The emergence of DWI has led to a debate concerning its definition. The classic 
time-based definition is increasingly being replaced by the new tissue-based definition, in which 
DWI-positive TIA is considered cerebral infarction or minor stroke.25 This change of perspective 
is partly given in by differences in prognosis between DWI-positive and DWI-negative patients, 
at least regarding subsequent stroke.24 In this thesis we have described additional prognostic 
differences between both patient categories, with respect to objective cognitive function 
and subjective complaints. This is in line with the tissue-based definition of TIA, at least with 
respect to considering DWI-positive and DWI-negative TIAs as separate entities with different 
prognoses. However, irrespective of which definition of TIA is used, it still relies heavily on the 
first impression of whether an event is a possible TIA. Events not passing this initial screening 
are generally not further investigated as potential vascular events. This thesis has shown the 
shortcoming of expert opinion in determining whether an event is a potential TIA. The first step 
in overcoming this shortcoming is the acknowledgement that acute onset nonfocal neurological 
symptoms are not infrequently caused by transient cerebral ischemia. When a clear diagnosis 
for the event is lacking, cerebral ischemia should be considered in the differential diagnosis. 
Subsequently, early DWI has shown its additional value and we advocate its use as standard 
imaging technique in the diagnostic process of both TIA and TNA. This change in practice has 
the potential to adequately diagnose a larger proportion of patients with an acute event of short-
lasting neurological symptoms, and thereby lower stroke incidence. Finally, any patient with 
an attack of transient neurological symptoms should be analyzed as soon as possible. Many 
patients were ineligible for CONNECT due to a delay of more than seven days since symptom 
onset. This patient delay, which is all too often seen, not only reduces sensitivity of DWI but also 
more importantly increases risk of stroke by delayed preventive action.7, 156
Cognition after TIA and TNA
Until now, little attention has been given towards cognitive dysfunction after TIA or TNA (chapter 
4). Focus has been on ascertaining complete recovery of focal neurological symptoms, as well 
as initiating secondary prevention as soon as possible to prevent new events.10, 11, 13 While this 
is undoubtedly important, ignoring potential cognitive deterioration and subjective complaints 
may negatively affect quality of life. Cognitive impairment and subjective complaints are highly 
prevalent after TIA and TNA. Although the implication of these findings on everyday life is yet 
to be determined, attention to the possibility of cognitive deficits in this patient category seems 
justified. Patients should be informed that although the most prominent symptoms have receded 
completely, they might experience problems in functions such as planning, oversight, and 
attention. The extent to which these possibilities should be mentioned in patient information is a 
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matter of debate. Overemphasizing could give rise to concerns and thereby negatively influence 
wellbeing. Nevertheless, patients have a right to receive adequate information regarding their 
illness and should at least to some extent be informed about potential cognitive sequelae of 
their TIA or TNA. Both patients and healthcare workers must be aware of the fact that recovery 
from TIA or TNA is more than just walking and talking again.167 In order to timely recognize 
cognitive problems interfering with everyday life, a standardized follow-up including at least some 
questions on cognitive functioning should be offered to all TIA and TNA patients. When cognitive 
impairment is suspected, formal screening can take place. Without knowledge of the impact of 
our findings on quality of life, it seems unjustified to perform standard cognitive screening.
Directions for future research
The conclusions of this thesis and the suggested clinical implications remain to be further 
investigated, as several issues require further elucidation. First of all, our results will have to be 
replicated in other cohort studies. Prospective imaging of cerebral microstructure as well as 
network analyses using functional MRI may further differentiate the underlying pathophysiological 
mechanisms of cognitive deterioration after seemingly minor cerebral ischemia. Secondly, the 
prognosis of cognitive function after TIA and TNA will have to be further determined. A longer 
follow-up duration in larger sample studies, preferably population-based, will allow determining 
the incidence of new-onset dementia. This should include brain imaging (MRI) to guarantee 
case-ascertainment (DWI-positive or DWI-negative) as well as prevalence and progression of 
cerebrovascular damage over time. The impact of subjective complaints and cognitive decline 
on quality of life will also have to be determined. Larger sample studies including both (clinically 
defined) TIA and TNA might provide insight in the influence of symptom type and duration on 
the presence of signs of recent ischemia on DWI. Potentially, clinical characteristics of TNA can 
be found which allow a more adequate distinction between vascular and nonvascular events. 
Finally, the question remains whether it is appropriate to start vascular screening and secondary 
prevention in all TNA patients.
Concluding remarks
The diagnosis of TIA remains difficult, and distinguishing vascular form nonvascular events 
seems most important. Neuroimaging, especially DWI, can help in determining which patients 
deserve vascular work-up and secondary prevention. Nevertheless, in the absence of a reliable 
biomarker, a diagnosis of TIA or TNA will continue to carry some uncertainty. Finally, although the 
word transient is incorporated in both TIA and TNA, many patients experience symptoms that are 
far from transient and deserve further attention.
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Het is vaak moeilijk om de diagnose transient ischemic attack (TIA) te stellen. Hoewel diffusie 
gewogen MRI (diffusion-weighted imaging; DWI) kort na de TIA in ongeveer een derde van alle 
patiënten tekenen van recente ischemie toont, blijft het verhaal van de patiënt en de interpretatie 
daarvan door een specialist de hoeksteen van de klinische diagnose TIA. De determinanten 
van DWI-positiviteit in TIA-patiënten zijn nog onduidelijk. Wel is bekend dat DWI-positieve TIA-
patiënten een fors hoger kortetermijnrisico hebben op een herseninfarct dan DWI-negatieve 
patiënten. Deze observatie heeft geleid tot een internationale discussie over de juistheid van 
de algemeen gebruikte, time-based definitie van TIA. Een nieuwe, tissue-based definitie is 
voorgesteld, waarmee de patiënten met het hoogste risico op een herseninfarct beter kunnen 
worden onderscheiden.
Een aanval van kortdurende neurologische klachten zonder focale symptomen wordt meestal 
niet als een TIA beschouwd. Indien een duidelijke alternatieve diagnose niet voorhanden is, wordt 
gesproken van een transient neurological attack (TNA). Hoewel men er vaak vanuit gaat dat een 
TNA prognostisch gunstig is, blijken deze patiënten ook een verhoogd risico op cardiovasculaire 
aandoeningen en dementie te hebben.
De term transient in zowel TIA als TNA suggereert dat de symptomen volledig verdwijnen. 
Veel patiënten rapporteren echter cognitieve en andere problemen ver na het moment waarop 
de initiële symptomen zijn hersteld. Er zijn vrijwel geen prospectieve studies naar cognitief 
functioneren na een TIA of TNA, hetgeen in schril contrast staat tot de grote hoeveelheid studies 
naar post-stroke cognitie en dementie.
Gezien het duidelijk verhoogde kortetermijnrisico op een herseninfarct na een TIA, is een tijdige 
en adequate diagnose uiterst belangrijk. Verder is het onduidelijk of en in hoeverre een TIA of 
TNA tot cognitieve achteruitgang leidt en wat de determinanten van cognitief functioneren nadien 
zijn. In dit proefschrift proberen we de etiologie en cognitieve prognose te verduidelijken binnen 
het volledige spectrum van kortdurende aanvallen van neurologische symptomen. De meeste 
hoofdstukken in dit proefschrift zijn onderdeel van de Cohort study ON Neuroimaging, Etiology, 
and Cognitive consequences of Transient neurological attacks (CONNECT), die in hoofdstuk 2 
wordt beschreven.
Omdat een transient neurological atack geen diagnose is, maar eerder een parapluterm 
voor acute, kortdurende aanvallen van neurologische symptomen waarvoor een duidelijke 
diagnose ontbreekt, is het belangrijk om eerst etiologische subgroepen binnen dit spectrum 
van aanvallen vast te stellen. Het is met name belangrijk om adequaat de patiënten met een 
cerebrovasculaire etiologie te onderscheiden van de grote groep patiënten met een mogelijke 
TIA, aangezien het kortetermijnrisico op een herseninfarct gerelateerd is aan de aanwezigheid 
van tekenen van recente ischemie op cerebrale beeldvorming. Om die reden hebben we in 
hoofdstuk 3 de waarde onderzocht van de traditionele definitie van TIA bij het identificeren van 
patiënten met een DWI-laesie binnen de groep van mogelijke TIA. Drie vasculair neurologen 
classificeerden iedere aanval als een TIA of TNA, gebaseerd op de anamnese van de patiënt 
en een gestructureerd interview betreffende de aanwezigheid van vooraf gedefinieerde focale 
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en niet-focale symptomen. Vervolgens werd de prevalentie bepaald van tekenen van recente 
ischemie (cytotoxisch oedeem) op DWI, vervaardigd binnen 7 dagen na de TIA of TNA. DWI 
toonde recente ischemie in 31% van de TIA-patiënten, maar ook in 23% van de TNA-patiënten [p 
voor verschil 0.41]. Wij concludeerden dat de klinische diagnose TIA onvoldoende die patiënten 
met bewezen cerebrale ischemie identificeert.
In het volgende deel van dit proefschrift hebben we de cognitieve gevolgen van TIA’s en TNA’s 
nader onderzocht. In hoofdstuk 4 hebben we gefocust op klinisch gedefinieerde TIA-patiënten. 
Middels een systematische review hebben we de prevalentie van cognitieve stoornissen na een 
TIA in verschillende studiepopulaties onderzocht, om op die manier de omvang van het probleem 
te verduidelijken, maar ook mogelijke determinanten aan te wijzen. In verschillende populaties 
vonden we dat milde cognitieve stoornissen in gemiddeld een derde van TIA-patiënten aanwezig 
was en dat het cognitieve profiel vergelijkbaar was met dat van vascular cognitive impairment, 
namelijk een non-amnestisch profiel. Er was echter sprake van forse heterogeniteit tussen studies 
betreffende de timing van cognitieve testen na de TIA, definities van cognitieve stoornissen en 
studiepopulaties, hetgeen de identificatie van mogelijke oorzakelijke factoren beperkte.
Om meer duidelijkheid over de prevalentie van cognitieve stoornissen na TIA te verkrijgen, 
terwijl mogelijke effecten van gelijktijdig optredende neurodegeneratieve ziekte en herhaalde 
neurovasculaire gebeurtenissen zo veel mogelijk worden beperkt, hebben we in hoofdstuk 
5 een cross-sectionele studie van cognitieve functie uitgevoerd in een cohort van 107 TIA-
patiënten. Alle patiënten waren jonger dan 65 jaar en werden binnen drie maanden na de TIA 
cognitief getest. Verder werden patiënten met een eerder doorgemaakte beroerte uitgesloten van 
deelname. Cognitieve functie werd vergeleken met een gematchte controlegroep en cognitieve 
stoornis werd gedefinieerd als een z score <-1.65 in ≥1 cognitief domein. In ieder cognitief 
domein presteerden TIA-patiënten slechter dan de controlegroep en meer dan een derde 
had cognitieve stoornissen drie maanden na het originele event (OR 5.9 [95%-CI 2.4-14.5]). 
De cognitieve domeinen werkgeheugen en aandacht waren het meest frequent aangedaan 
en cognitieve stoornis was onafhankelijk van de aanwezigheid van stille herseninfarcten en 
wittestofafwijkingen. Omdat de invloed van neurodegeneratieve ziekte en eerdere neurovasculaire 
schade beperkt was in deze studie, zou er een mogelijke rol voor de TIA zelf kunnen zijn in het 
ontstaan van cognitieve stoornissen. Het cross-sectionele ontwerp van de studie beperkt echter 
de conclusies over causaliteit. Ook is de inclusie beperkt tot klinisch gedefinieerde TIA, een 
diagnose die, zoals aangetoond in hoofdstuk 3, een beperkte waarde heeft in het aantonen van 
onderliggende cerebrale ischemie als oorzaak van de klachten.
Om die reden is in hoofdstuk 6 een studie uitgevoerd naar cognitief functioneren na zowel TIA 
als TNA in 121 patiënten uit het CONNECT cohort. Binnen 7 dagen na de TIA of TNA werd een 
uitgebreide neuropsychologische testbatterij afgenomen, welke 6 maanden later werd herhaald. 
Voor de cognitieve domeinen executief functioneren, aandacht, informatieverwerkingssnelheid 
en episodisch geheugen werden domein-specifieke compound scores berekend op basis 
van de gemiddelde z scores van de individuele testen in ieder cognitief domein. Door middel 
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van repeated measurement analysis werd getest op verschillen in domein-specifiek cognitief 
functioneren over de tijd tussen DWI-positieve en DWI-negatieve patiënten, alsmede tussen 
TIA- en TNA-patiënten. In de eerste 6 maanden na zowel TIA als TNA verminderde executief 
functioneren, onafhankelijk van de klinische diagnose of DWI-status (gemiddelde verandering 
in compound score -0.23, p = 0.01, geadjusteerd voor leeftijd, geslacht en opleiding). DWI-
positieve patiënten presteerden slechter in executief functioneren dan diegenen zonder DWI-
afwijkingen (compound scores -0.21 vs. 0.06, p = 0.048), hetgeen gedurende de studieperiode 
aanhield (p = 0.04). Er waren geen verschillen tussen TIA- en TNA-patiënten. Dit werd ook 
verwacht gezien de vergelijkbare prevalentie van DWI-laesies in beide patiëntencategorieën.
Gegeven de observatie dat veel TIA-patiënten voortdurende subjectieve cognitieve problemen, 
angstklachten, depressieve symptomen en moeheid rapporteren ver na het punt waarop de 
focale klachten herstellen, werd in hoofdstuk 7 prospectief de prevalentie en het beloop van 
deze subjectieve klachten na zowel TIA als TNA onderzocht, waarbij speciale aandacht was voor 
de relatie met klinische diagnose (TIA of TNA) en DWI-status. Middels verschillende vragenlijsten 
werden subjectieve cognitieve beperkingen, angst, depressieve symptomen en moeheid kort 
voor TIA of TNA alsmede 6 maanden later in kaart gebracht. De associaties tussen DWI-status 
en klinische diagnose (TIA of TNA) enerzijds en subjectieve klachten over de tijd anderzijds 
werd middels repeated measurement analysis in 103 patiënten bepaald. Subjectieve cognitieve 
beperkingen en in mindere mate moeheid waren zeer prevalent in TIA- en TNA-patiënten, zowel 
kort voor het event als 6 maanden later. Alleen in DWI-positieve patiënten namen de subjectieve 
cognitieve beperkingen (p = 0.02) en moeheid (p = 0.01) in ernst toe.
Na te hebben vastgesteld dat cognitieve beperkingen en subjectieve klachten zeer prevalent 
zijn in TIA- en TNA-patiënten, dat ze geassocieerd zijn met DWI-laesies en het gebrek aan 
associaties met conventionele imaging-markers voor cerebrovasculaire schade, stelden we de 
hypothese op dat de gebeurtenis zelf (dus de TIA of TNA) tot cerebrovasculaire schade op 
een ander niveau kan hebben geleid. Mogelijk leidt de kortdurende ischemie welke de DWI-
laesie veroorzaakte, ook tot schade aan de microstructuur van de witte stof. De verminderde 
microstructurele integriteit die hiervan het gevolg is, zou vervolgens een potentiële determinant 
voor secundaire cognitieve dysfunctie en verschillende subjectieve klachten kunnen zijn. Als een 
eerste stap in het vestigen van een basis voor deze hypothese hebben we een cross-sectionele 
studie uitgevoerd naar witte stof integriteit na TIA of TNA en de relatie met initiële DWI-status 
(hoofdstuk 8). Een deel (n = 90) van de deelnemers aan CONNECT onderging additionele 
diffusion tensor imaging (DTI) minstens 6 maanden na een TIA of TNA. Middels tract-based 
spatial statistics (TBSS) werden verscheidene, complementaire maten voor microstructurele 
integriteit berekend (fractionele anisotropie (FA), gemiddelde diffusiviteit (mean diffusivity, MD), 
axiale diffusiviteit (AD) en radiale diffusiviteit (RD)). Verschillen in DTI-maten tussen klinische 
diagnose (TIA of TNA) of DWI-status werden zowel voor het gehele TBSS skelet als voxel-wise 
berekend. DWI-positieve TIA- en TNA-patiënten hadden een lagere FA en hogere RD dan DWI-
negatieve patiënten, met name in de frontopariëtale witte stof en in mindere mate in het corpus 
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callosum. Deze associaties waren onafhankelijk van macrostructurele tekenen van vasculaire 
hersenschade. Hoewel de verschillen marginaal waren, representeren ze een eerste stap in het 
identificeren van een mogelijke verklaring voor aanhoudende neurocognitieve gevolgen van een 
kortdurende cerebrale ischemische gebeurtenis.
Concluderend beschrijft dit proefschrift het brede spectrum van symptomen waarmee 
voorbijgaande cerebrale ischemie zich kan presenteren, tonen ze de tekortkomingen van de 
klinische diagnose TIA en de additionele waarde van vroege DWI in het diagnostische proces van 
een mogelijke TIA of TNA. Voorts laten we zien dat, hoewel de focale symptomen snel verdwijnen, 
TIA- en TNA-patiënten voortdurende cognitieve achteruitgang en toenemende subjectieve 
klachten kunnen hebben in de eerste 6 maanden na de initiële gebeurtenis. Deze bevindingen 
staan haaks op de term transient (voorbijgaand) in TIA en TNA. Aangezien de aanwezigheid van 
tekenen van recente ischemie op vroege beeldvorming geassocieerd was met een slechtere 
objectieve en subjectieve cognitieve prognose, zou DWI een additionele rol kunnen spelen in het 
identificeren van patiënten met een verhoogd risico op cognitieve achteruitgang. De observatie 
van verminderde witte stof integriteit in DWI-positieve patiënten kan dienen als een eerste stap 
in het verder ontrafelen van de etiologie van deze voortdurende achteruitgang. Toekomstige 
studies dienen de relatie te onderzoeken tussen witte stof integriteit, cerebrale netwerkfuncties 
en cognitief functioneren na TIA en TNA, alsmede de langetermijnprognose op (neuro)vasculair 
en cognitief gebied. Gezien de onderscheidende rol die vroege DWI speelt in de vasculaire en 
cognitieve prognose op korte termijn, zou DWI-status een meer prominente rol moeten spelen 
dan klinische diagnose in toekomstige studies.
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DANKWOORD
DANkWooRD
Het laatste stukje tekst van dit proefschrift is misschien wel het moeilijkst om te schrijven. 
Want hoewel de inhoud van dit hoofdstuk het minst toetsbaar en evidence-based is, wordt 
het door de meeste personen gelezen en is daarom absoluut significant. Door het schrijven 
van dit dankwoord besef ik me weer hoeveel hulp en ondersteuning ik de afgelopen jaren heb 
gehad om dit project tot een goed einde te brengen. En daarvoor ben ik veel mensen dank 
verschuldigd; zonder jullie inzet was dit proefschrift er nooit gekomen! Een aantal personen wil 
ik graag speciaal benoemen.
Allereerst gaat mijn grote dank uit naar alle TIA en TNA patiënten die belangeloos hebben 
meegedaan aan de CONNECT studie. Twee of soms wel drie keer een MRI-scan, meerdere 
uitgebreide cognitieve testen en vele vragenlijsten, vaak kort na een eerste TIA of TNA; het is niet 
niks wat we van u hebben gevraagd. Hartelijk bedankt voor uw inzet! Door de vele gesprekken 
tijdens de onderzoeken ben ik me gaan beseffen wat een impact een TIA of TNA heeft op 
iemands leven en ik hoop dat dit proefschrift helpt in het beter onder de aandacht brengen van 
deze problemen.
Beste dr. van Dijk, beste Ewoud, ik kan me nog goed herinneren dat je tijdens een borrel vertelde 
dat je net een subsidie toegewezen had gekregen. Na de nodige rondjes aan de bar, bood je 
me korte tijd later de kans om onderzoek te doen op het raakvlak van vasculaire en cognitieve 
neurologie. Het project heeft veel tijd en energie gekost en ook de nodige tegenslagen gekend, 
maar mede dankzij jouw enthousiasme en inzet is het tot een goed einde gekomen. Bedankt 
daarvoor! Ik bewonder jouw enorme klinische en epidemiologische kennis en je enthousiasme 
voor het vak. Ik heb niet alleen als onderzoeker, maar ook als arts veel van je geleerd en ik hoop 
dat we elkaar nog vaak spreken, bij voorkeur aan de bar!
Beste prof. dr. de Leeuw, beste Frank-Erik, jij was vanaf het begin nauw betrokken bij dit 
project. Met een scherp oog voor klinische relevantie en een grote nadruk op kort en bondig 
schrijven, heb je menig stuk naar een hoger niveau getild. Ik vind het ongelooflijk knap hoe je de 
neurovasculaire onderzoeksgroep in het Radboudumc de afgelopen jaren vorm hebt gegeven 
en tot een toonaangevend instituut hebt weten te maken. Dank voor je betrokkenheid en ik hoop 
ook in de toekomst nog veel met je te kunnen samenwerken!
Beste prof. dr. Klijn, beste Karin, jouw komst naar Nijmegen viel samen met het laatste deel 
van mijn promotietraject. Hartelijk dank voor je persoonlijke betrokkenheid en je terugkerende 
vragen naar de status van het proefschrift: mede hierdoor is de snelheid in de laatste fase flink 
opgevoerd!
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Ik dank de leden van de manuscriptcommissie, prof. dr. Olde Rikkert, prof. dr. Assendelft en dr. 
de Kort, voor de bereidheid om mijn proefschrift kritisch te beoordelen.
Mijn opleiders neurologie, prof. dr. Padberg en dr. Kappelle, hebben mij gedurende mijn 
opleiding alle ruimte en tijd geboden om wetenschappelijk onderzoek te kunnen doen. Maar 
veel belangrijker nog, mijn opleiders (en daarmee bedoel ik de hele staf neurologie) hebben 
ervoor gezorgd dat ik de neuroloog heb kunnen worden die ik nu ben. Eventuele tekortkomingen 
(en die zijn er ongetwijfeld) zijn voor mijn rekening, want ik heb naar mijn bescheiden mening de 
beste neurologie-opleiding gehad!
Dank ook aan alle medeauteurs voor hun inzet en waardevolle bijdragen aan de manuscripten 
in dit proefschrift. Prof. dr. Kessels, beste Roy, jouw input is van grote waarde geweest voor 
dit proefschrift. Je hebt een manier gevonden om neuropsychologie begrijpelijk te maken voor 
simpele neurologen. Bedankt voor de laagdrempeligheid waarmee ik mijn vragen aan je kwijt 
kon. Dr. Richard, beste Edo, ik ben blij dat jij betrokken raakte bij de CONNECT studie. Met je 
vaak frisse blik op de data en manuscripten zijn deze alleen maar beter geworden. Dank voor de 
vele zeer gedetailleerde beoordelingen van mijn manuscripten! Prof. dr. Koudstaal, beste Peter, 
je hebt al vanaf de eerste opzet van de CONNECT een grote bijdrage geleverd. Ook gedurende 
het verloop van de studie is jouw inzet belangrijk geweest voor het uiteindelijke slagen ervan. 
Dank ook voor je snelle en waardevolle beoordelingen van de diverse manuscripten.
Een speciaal woord van dank voor iedereen die zich heeft ingezet voor de dataverzameling, en 
daarvoor kan ik niet anders dan beginnen bij Sharon Romviel. Sharon, je hebt ongelooflijk veel 
werk verzet om al die NPO’s te kunnen laten doorgaan. Je was altijd bereid om nog “even een 
NPO’tje” erbij te doen en zelfs toen ik je vertelde dat er een complete nieuwe follow-up ronde 
aankwam knipperde je niets eens met je ogen. Heel hartelijk bedankt voor al je inzet en de fijne 
samenwerking! Dank ook aan alle andere collega’s die tussen de bedrijven door NPO’s wilden 
uitvoeren: Saskia, Karin, Dirk, Suzanne, Wendy en Nicole. Nicole Plaizier, jij daarnaast ook nog 
bedankt voor het analyseren van cognitieve data en het meeschrijven aan twee papers. Dank 
aan alle stafleden en arts-assistenten neurologie van het Radboudumc en Rijnstate voor het 
includeren van alle patiënten. Dank ook aan Paul Gaalman voor de hulp en ondersteuning bij 
het scannen: nu kan ik altijd nog een carrière in de MRI-wereld beginnen! Ik ben ook zeker niet 
vergeten hoeveel tijd en energie Cindy Frentz en Olfat Sefati hebben gestoken in het tot een 
goed einde brengen van zo’n 100 extra MRI-scans, bedankt daarvoor!
De arts-assistenten van het Radboudumc wil ik bedanken voor de fantastische opleidingstijd die 
ik heb gehad; jullie zijn een geweldig team en ik mis jullie nog heel vaak! Ook alle collega’s van 
de vasculaire onderzoeksgroep bedank ik voor de prettige samenwerking de afgelopen jaren. 
Speciaal wil ik mijn onderzoekscollega’s van de “mannenkamer” bedanken voor het delen van 
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(onderzoeks)lief en –leed, de gezelligheid en de vele koppen koffie! Joery, Bas, Anil en Kees, 
het dartbord in de werkkamer is er nooit van gekomen, maar Tropic Thunder moeten we nu toch 
echt eens samen gaan kijken! Anil, we hebben het grootste deel van onze opleiding samen 
doorlopen. Ik ben vaak onder de indruk van je kennis en kunde als arts, maar waardeer je vooral 
als de persoon die je bent. Jouw wetenschappelijke expertise heeft het laatste stuk van dit 
proefschrift er doorheen gesleept en ik ben erg blij dat je vandaag naast me staat!
Beste collega’s van het Medisch Centrum Leeuwarden, jullie hebben mij met open armen 
ontvangen en dat heeft de grote sprong naar het hoge noorden een stuk makkelijker gemaakt. 
Ik ben er van overtuigd dat ik geen betere maatschap had kunnen treffen. Dank daarvoor en voor 
de tijd en ruimte die jullie mij boden om dit proefschrift af te ronden!
Mijn vrienden van de studie: Bart, Olivier, Ed en Kevin. De afgelopen jaren zijn we allemaal in 
een andere uithoek van het land terecht gekomen en dat heeft zijn weerslag gehad op hoe 
vaak we elkaar zien. Ik hoop dat we snel weer eens samen een goed restaurant bezoeken of 
een nieuw onvergetelijk weekend in een willekeurige stad hebben. Met dit proefschrift is in ieder 
geval één excuus uit de weg geruimd! Olivier, we kennen elkaar al zo ongeveer sinds het eerste 
responsiecollege (dat we uiteraard oversloegen) en hebben sindsdien veel mooie momenten 
meegemaakt. Ik ben blij dat je ook op dit moment weer naast me staat!
Familie en schoonfamilie, bedankt voor jullie steun maar vooral voor de gezellige en broodnodige 
afleiding. Lieve Lidy en Bennie, ontzettend bedankt voor alle keren dat jullie konden oppassen 
zodat ik weer eens aan het proefschrift kon werken. Maar vooral bedankt voor alle gezelligheid 
en leuke momenten de afgelopen jaren, jullie zijn heel belangrijk voor ons gezin! Lieve broers, 
ik hoop dat er na de afronding van dit proefschrift weer meer ruimte komt voor broertjes-dagen! 
Paul, bedankt voor je betrokkenheid bij ons en de jongens en vooral voor al je geduld als ik 
weer eens belde voor een probleem met de auto! Lieve Tim en Moniek, het is altijd een gezellige 
afleiding om bij jullie en Max op bezoek te gaan. Dat houden we er de komende tijd in!
Dit proefschrift heb ik opgedragen aan mijn ouders, als dank voor alles wat ze voor mij hebben 
betekend en gedaan. Lieve mama, je hebt altijd alles voor ons over gehad, dank je wel! Lieve 
papa, ik wou dat je hierbij kon zijn…
Tenslotte het thuisfront, dat veel belangrijker is dan dit proefschrift. Allerliefste Pepijn en Kasper, 
met jullie vrolijkheid, slimme opmerkingen en aanstekelijke enthousiasme zorgen jullie er altijd 
voor dat drukte en zorgen als sneeuw voor de zon verdwijnen! Allerliefste Kim, je wist me altijd 
weer te motiveren om dit proefschrift af te ronden en hebt me op alle mogelijke manieren 
gesteund. We hebben al zoveel mooie dingen meegemaakt en er gaan er nog veel meer 
volgen…! Zullen we beginnen met de fotoalbums?
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For a successful research institute, it is vital to train the next generation of young scientists. 
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Selcetive admission and assessment centers guarantee the enrolment of the best and most 
motivated students.
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environment as lab coordinators, technical support or policy advisors. Upcoming possibilities 
are positions in the IT sector and management position in pharmaceutical industry. In general, 
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For more information on the DGCN as well as past and upcoming defences please visit:
http://www.ru.nl/donders/graduate-school/
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